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Abstract
Prostate cancer is an important and increasing public health problem in Scotland. It is
the second most common cancer in men after lung cancer, with prostate cancer (PCa)
incidence and mortality rates continuing to increase rapidly. It is therefore of great
importance that opportunities for prevention are examined and identified. Although
the aetiology ofPCa remains largely unknown, there is gathering evidence that diet
may play an important role, with recent epidemiological studies demonstrating
associations between fat, animal products and plant-based nutrients (including
selenium, isoflavones and tocopherol) and PCa risk.
This thesis examines the association between diet and PCa in Scottish men, based on
the PCANDIET study: A population based case-control study ofPCa in relation to
inherited susceptibility and diet. Data on the habitual diets of 433 cases diagnosed
with PCa and 483 controls were collected using a validated food frequency
questionnaire. From these, individual daily intakes of specific nutrients and food
items (chosen a priori as being hypothesised to be associated with PCa risk) were
estimated for the comparison between case and control groups.
Significant odds ratios (ORs) (adjusted for energy intake, age, family history of PCa,
Carstairs deprivation index, smoking and EI: BMR ratio) for highest intake versus
lowest intake (reference) categories were observed for cholesterol (OR 1.57, 95%CI
1.04-2.37); red meat (OR 1.64, 95%CI 1.09-2.48); vegetables (OR 0.62, 95%CI
0.41-0.93); consumption of alcohol (OR 0.62, 95%CI 0.42-0.90), total alcohol (OR
0.66, 95%CI 0.44-0.99); wine (OR 0.38, 95%CI 0.19-0.74) and spirits (OR 0.48,
95%CI 0.29-0.79). Significant associations were also observed for protein (OR 2.34,
95%CI 1.13-4.87) and red meat (OR 3.74, 95%CI 1.70-8.15) within younger
subjects, and for selenium (OR 0.61, 95%CI 0.37-0.99), vegetables (OR 0.60, 95%CI
0.36-0.99), wine (OR 0.21, 95%CI 0.08-0.52) and spirits (OR 0.49, 95%CI 0.26-
0.91) within older subjects.
These results suggest that cholesterol and red meat are both associated with a 60%
increase in PCa risk, whereas vegetables and alcohol are associated with a 40%
reduction in PCa risk. The results also suggest that protein and red meat are
associated with over a two-fold and three-fold increase in PCa risk respectively in
younger men. Whereas, selenium and vegetables are associated with 40% reduction
in PCa risk in older men, in addition to a further reduction in risk ofPCa associated
with wine and spirits (80% and 50% respectively).
This evidence - the first of its kind in a Scottish population - suggests that the
promotion of a healthier diet in a population traditionally known for its bad diet (high
in fats and meat products and low in fruit and vegetables) may have a great influence
on the incidence of PCa in addition to other known diet related diseases.
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Glossary of abbreviations
95%CI 95% confidence intervals
BrCa Breast cancer
BMR Basal metabolic rate
CRUK Cancer Research UK
DepCat Carstairs deprivation index
DES Dietary energy supply
DNS Dietary and nutritional surveys
El Total energy intake
EI:BMR Energy intake: Basal metabolic rate ratio
EU European Union
FAO Food and Agriculture Organisation for the United Nations
FFQ Food frequency questionnaire
FHPCa Family history of prostate cancer
FSA Food Standards Agency
GNP Gross national product
GP General practitioner
HEBS Health Education Board for Scotland
HER High energy responder
HPLC High-performance liquid chromatography
LER Low energy responder




PCANDIET Study A population based case-control study of PCa in relation to inherited
susceptibility and diet.
PUFA Poly unsaturated fatty acids
RCT Randomised controlled trial
Retinol equivalent The sum of vitamin A provided by preformed retinol and carotenoids1
RR Risk ratio / relative risk





US United States of America
USDA United States Department of Agriculture
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1 . Chapter 1: Background - Prostate cancer
1.11ntroduction
In common with many other countries, prostate cancer is an important and increasing
public health problem in Scotland. It is the second most common male cancer after
lung cancer, and accounts for 10% of all male cancer related deaths, making it the
third most common cause of cancer death after lung and colorectal cancer2.
Furthermore, it is very common for the quality of life ofmen with prostate cancer
(PCa) to deteriorate due to the experience of unpleasant side effects of therapy,
including urine incontinence and impotence, whereas others may experience years of
symptoms related to the slow progression to metastatic disease. PCa has therefore
become a major concern for both Scottish men and also health service providers.
This is due not only to the increasing burden of PCa, but also the rapidly growing
costs for diagnosis and treatment and also the impending possibility of a national
PSA screening program (which will most likely lead to an increase in diagnosed
cases of PCa requiring treatment). It is therefore of great importance that
opportunities for prevention are identified. The most promising of these is diet. There
is gathering evidence that diet plays an important role in the aetiology and prevention
ofPCa, and unlike fixed risk factors such as age and family history ofPCa which can
not be altered, the exposure to these factors can be modified by changing dietary
habits. It is within this context that I have embarked on this thesis. My aim is to
investigate certain foods and nutrients commonly consumed by Scottish men and
which have been hypothesised to be associated with PCa, in order to examine their
association with PCa amongst the Scottish male population. To my knowledge this is
the first time that dietary factors for PCa within the Scottish population alone have
been investigated.
In this chapter, geographical and temporal trends in PCa incidence and mortality will
be discussed and interpreted in terms of the aetiology of PCa and established risk
factors will be discussed. A brief overview of the natural history ofPCa will also be
presented, in order to give a helpful insight into the aetiology of this disease.
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1.2 The prostate
The prostate is a small accessory sex gland of the male reproductive tract. It is
located at the base of the bladder and surrounds the upper part of the urethra, see
Figure 1.1. The main function of the prostate is poorly understood, but it appears to
be related to the production of secretions that aid sperm function. The growth and
development of the prostate is largely controlled by sex hormones, in particular
testosterone , which diffuses from plasma into the prostate where it is converted to
dihydrotesterone (DHT), a more biologically potent steroid, by the enzyme 5-alpha
reductase.
Figure 1.1: Location of the prostate gland
FimiU Snl<" vjirw
1.3 Natural history of PCa
Most PCa tumours are adenocarcinomas, they range from incidentally discovered,
low-grade, microscopic focal tumours to tumours that are highly aggressive locally
and have a high potential for metastatic spread. PCa is often asymptomatic, the
majority of PCa tumours being relatively slow growing with many remaining
dormant until death from other causes intervenes4. However, PCa can also present
with symptoms of lower urinary tract obstruction, which are indistinguishable from
those produced by benign prostatic hyperplasia (BPH)2, PCa therefore tends to be
diagnosed only during routine rectal examination or by the incidental finding of a
Background: PCa page 2
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tumour when a transurethral resection of the prostate (TURP) is performed for BPH5.
Increasingly and particularly in the US, PCa is diagnosed as a result of screening by
the measurement of serum prostate specific antigen (PSA) and also by digital rectal
examination (DRE)5. However, as both these diagnostic procedures are prone to low
sensitivity and specificity and, for DRE in particular, are subject to human error, it is
important that the diagnosis is histologically confirmed .
1.3.1 Clinical grading & staging
The histological grade is a strong predictor of the biological behaviour of PCa,
including invasiveness and the metastatic potential. Of the many grading systems
that have been proposed, the Gleason system6is the most commonly used system in
the UK and US. It is based on the degree of glandular differentiation, from very well
differentiated (Grade 1) to very poorly differentiated (Grade 5).
PCa staging ascertains how far the tumour has spread by determining the anatomic
extent and burden of tumour. The Tumour / Node / Metastasis (TNM) classification
is considered the international standard for PCa staging. It separately assesses the
tumour (T), lymph nodes (N) and metastases (M), and is classified into four stages
for both tumour and lymph nodes and two stages for the metastases. See Table 1.1
for summary ofTNM classification.
Another staging system which has been used by several US studies on diet and PCa
to stratify risk by PCa stage, including Giovannucci et al8'9 and Whittenmore et al10,
is the Jewett-Whitmore System. This system is classified into grades A to D and was
the most common staging system in the US until recent years when it has been
increasingly replaced by the more descriptively detailed TMN system. See Table 1.2
for a summary of the Jewett-Whitmore System.
Background: PCa page 3
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Table 1.1: Summary of TNM classification
Tumour (T) Lymph Nodes (N) Distant Metastases (M)
TO No evidence of tumour NO No regional lymph nodes
metastasis
MO No distant metastasis
T1 Incidentally detected and
clinically inapparent
tumour
N1 Metastasis in a single
lymph node (< 2 cm)
M1 Distant metastasis
T2 Tumour confined to the
prostate capsule
(localised)
N2 Metastasis in a single
lymph node (2 - 5cm); or
multiple lymph node
metastases (< 5cm)




N3 Metastasis in a lymph
node (>5cm)
T4 Invasion of bladder neck,
rectum or external
sphincter
N.B. Tumour stages are also categorised (a, b or c) according to the extent of the tumour spread within the area
defined by the stage.
Table 1.2: Summary of the Jewett-Whitmore System
Stage Description Equivalent TNM Stage
A Nonpalpable, incidentally detected and clinically
inapparent tumour
T1
B Tumour confined to the prostate capsule T2
C Tumour has extended beyond the prostate capsule T3
D Tumour has metastasised to regional lymph nodes
and/or other parts of the body
T4, N1-3, M1
N.B. Tumour stages are also categorised (0,1,2) according to the extent of the tumour spread within the area
defined by the stage.
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1.3.2 Latent PCa
As mentioned before, PCa can be asymptomatic, so much so that the estimated
number ofmen with PCa that is never detected or diagnosed during their lifetime is
far greater than the number of those with clinically diagnosed PCa.
The term latent PCa is used to describe a tumour that is malignant by
histopathological criteria but found only on post-mortem examination of the
prostate". These tumours tend to be small, typically unifocal and usually categorised
as well to moderately differentiated11, in this context the terms microfocal and
subclinical are also sometimes used. 'Latent' cancers that are detected by chance
during a transurethral resection of the prostate (TURP) are also known as incidental
PCa. It has been assumed that these tumours are dormant and therefore clinically
insignificant12 as opposed to 'clinically important / significant' tumours which are
usually diagnosed as a consequence of procedures used in cases of suspected PCa.
However, it is not known whether the origins and natural history of latent PCa are
distinct from tumours that become clinically significant or whether they represent a
continuum on a linear progression toward aggressive disease .
Autopsy studies from different geographical areas around the world suggest that
latent PCa may be observed in 20-30% ofmen in their 50's rising to nearly 80% of
men in their 80's4'13. These same studies also observed that the prevalence of latent
PCa varies slightly across the world, with age-adjusted prevalence being higher for
US blacks (37%) and whites (35%) than for native Japanese (21%)13.
N.B. In order to distinguish between clinically important / significant PCa and latent
PCa within this thesis. Clinically apparent / significant PCa from now on will be
referred to as PCa, whereas latent PCa will remain termed as latent PCa.
Background: PCa page 5
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1.4 Incidence andmortality rates
1.4.1 Geographical trends
PCa incidence
Compared to the prevalence of latent PCa, incidence and mortality rates of PCa vary
dramatically across the world. There is approximately a 90-fold difference in the
incidence ofPCa around the world, see Figure 1.2. The lowest age-standardised
incidence rates are generally in Asia, in particular the population of Tianjin, China
(1.9 per 100,000 per year), and the highest are in North America and Scandinavia,
especially for African-American men in the US (137 per 100,000 per year)14. The
incidence rate within the Scottish male population is ranked in the middle (31.2 per
100,000 per year) just above England and Wales (28.0 per 100,000 per year).
This wide range of incidence, which should be noted includes both clinically
significant PCa and incidental tumours usually identified through PSA testing,
maybe due to combination ofmany underlying differences, including genetic
susceptibility and exposure to risk factors such as lifestyle and diet. Artifactual
reasons such as the variations in diagnostic methods, such as TURP and PSA testing
in US and Sweden, and the accuracy of cancer registers may also be a cause of this
variation, for example, it has been suggested that the relatively low reported
incidence in most African countries may, in part, be due to under-reporting15.
PCa mortality
International mortality rates of PCa are far lower than those for PCa incidence, there
is also considerable less variation between countries, see Figure 1.3, although
African-Americans still represent the highest (34.3 per 100,000 person years) and
Japanese, the lowest (3.8 per 100,000 person years) age-standardised mortality
rates16. Mortality data for Tianjin, China were not available. As with PCa incidence,
the age-standardised PCa mortality rate within the Scottish population is ranked in
the middle (15.0 per 100,000 person years)17, just below that of England and Wales
(16.3 per 100,000 person years)16, and similar to that ofUS whites (15.7 per 100,000
person years).
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PCa mortality data have the advantage over incidence data of not being distorted by
the presence of diagnosed latent (incidental) PCa that should, in principle, not appear
on a death certificate. The rates of which are therefore probably more genuinely
comparable between countries than those of incidence, as they should not be
influenced by the artefactual effects ofTURP and PSA testing18. However, these too
must be interpreted with caution as the underlying cause of death given on the death
certificates may be much less accurate for the oldest age groups in which PCa is
particularly common19, death certificates may also be affected by attribution bias in
which diagnosis of PCa during life may increase the likelihood of PCa being
90
recorded as a certified underlying cause of death .
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1.4.2 International temporal trends
PCa incidence
The incidence of PCa in most Western countries, including Scotland, has risen
sharply during the last decades. In 15 years time, PCa is predicted to be the most
• 91
common cancer in men . This has mainly been attributed to the ageing population,
with fewer men dying from other causes such as cardiovascular disease, and also to
improved diagnostic methods, although it is highly possible that an increase in
exposure to underlying risk factors is also an influence. Increased use ofTURP in the
1980's and PSA testing in the 1990's are responsible for marked increases in
incidence of prostate cancer in all Western countries, in particular the US and
Sweden16. Even Asian countries, where incidence is far lower, have observed a large
rise in PCa incidence16'22, this has been mainly attributed to the 'Westernisation' of
these countries. Between 1973 and 1992, increases in incidence has ranged from
25%-l 13% in high-risk countries (e.g. US and Sweden) to 16%-104% in low risk
countries (e.g. Japan and China)16.
PCa Mortality
PCa mortality in all countries, with the exception of Sweden, has increased between
1973 and 1992, although the rises were less rapid than those ofPCa incidence16. The
changes in mortality rates during this 20 year period ranged from -3.7% in Sweden
to nearly 95% in Asian countries, with mortality increasing by 39% in England and
Wales16. More recent data shows that mortality rates in some countries including the
US and England and Wales have started to decrease in the last decade. A decrease in
PCa mortality of 6.7% has been observed in the US since 199223, whereas in England
and Wales age-standardised mortality fell from 27.1 per 100,000 person years in
1992 to 24.7 per 100,000 person years by 199724. Recent mortality rates for Scotland
have not yet been published.
The recent decline in mortality rates suggests that earlier diagnosis due to screening
and enhanced survival due to improved disease treatment may be influencing PCa
mortality, especially among US whites15. The suggestion that PSA testing in
particular has attributed to this decrease in PCa mortality has been the subject to
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much discussion, with the opposing opinion that PSA screening in the US is unlikely
to have made a major contribution to this reduction in PCa mortality as it has
occurred too soon after the widespread introduction of PSA testing and that similar
reductions in PCa mortality have been observed in countries were PSA testing is
relatively scarce24;25.
1.4.3 PCa trends in Scotland
Within the last three decades, PCa incidence in Scotland has increased dramatically.
Age-standardised rates have more than doubled from 15.3 per 100,000 person years
in 1960 to 35.2 per 100,000 person years by 1994, see Figure 1.4, this rate has
increased rapidly within the last decade in particular. PCa mortality in Scotland has
also increased, though not as rapidly, with age-standardised rates rising by over a
third from 12.5 per 100,000 person years in 1960 to 16.8 per 100,000 person years by
1994, see Figure 1.5.
N.B. Both PCa incidence and mortality age-standardised rates differ slightly from
those reported for Scotland in the previous section describing geographical
differences, due to the use of different time periods over which the standardised rates
were calculated.
The use PSA testing in Scotland has increased recently since its introduction in
25 21989 , although it is still restricted to a minority ofmen . This and the prior
increased rates ofTURP have been suggested to be the main cause of the observed
increase in PCa incidence in Scotland since 197025. Although they do not wholly
account for the increase in incidence, suggesting that an increased exposure to
underlying risk factors, in particular lifestyle and dietary factors may have attributed
to this increase.
So far there is no evidence that the increased detection ofPCa due to PSA testing in
some parts of Scotland has resulted in substantial reduction in mortality from the
25disease . As seen in Figure 1.5, mortality has continued to rise since PSA testing
was introduced. This maybe due to the aforementioned attenuation bias, or that it is
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simply too soon to detect a reduction in mortality resulting from PSA testing,
oc
especially in the absence of an organised screening programme .
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Figure 1.4: Age-standardised PCa incidence (world standard) in Scotland (1960-1992)
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Figure 1.5: Age-standardised PCa mortality (world Standard) in Scotland (1960-1994)
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Future trends in Scotland
In Scotland, PCa incidence has been predicted to double by 2014 (if present trends
continue) with an increased use ofPSA testing adding a further 15%2, whereas PCa
mortality has been predicted to increase by 25% by 2014, with an increased use of
PSA testing attributing to a modest reduction of PCa mortality by around 40 deaths
per year , Table 1.3 shows these trends, with the estimated effect of increased PSA
testing, over the next decade in more detail.
Table 1.3: Predicted numbers of cases and deaths in Scotland
Time period PSA testing
effect applied
Cases per year Deaths per year
1990-94 No 1498 695
1995-96 No 1832 760
1995-9 No 1948 759
Yes 1948 759
2000-4 No 2849 804
Yes 2537 791
2005-9 No 3241 877
Yes 3372 847
2010-12 No 4303 990
Yes 4494 953
N.B. Data for incidence and mortality in Scotland reported in this section were
calculated as part of the Cancer Scenarios for Scotland Study, 200126. A study in
which I was involved in the data management and analysis / projection estimations
for several main cancer sites including PCa. It should also be noted that the data used
in this study were available for years 1960-1996 only. Since it's publication,
complete data for the years up until 2000 (PCa cases) and 2002 (mortality data) have
become available.
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1.5 Established risk factors
The exact underlying reasons for the variation in PCa incidence and mortality, both
geographically and temporally, are currently unknown. The variation of incidence in
particular is one of the largest amongst cancers and may offer a unique insight into
PCa aetiology. However, despite the substantial international prevalence of PCa, age,
ethnicity and family history ofPCa are the only established risk factors27. Evidence
for other risk factors, including diet, genetic factors, alcohol, smoking, hormonal
factors, sexual behaviour, socio-economic status and occupational exposures, vary
—
. . O O ,OQ 1A
from being promising but inconclusive (dietary ' and genetic factors ) to
conflicting (sexual behaviour31 and occupational exposures32).
1.5.1 Age
PCa is rare before the age of 50, accounting for <0.1% of all cases33 after which
incidence increases rapidly for each subsequent decade of life. Although PCa is
typically considered a disease of older men, the high overall frequency in western
countries makes PCa a common cancer in men between the ages of 50 and 70.
Figure 1.6 shows the age-specific incidence rates of PCa in Scotland, a rapid increase
in incidence with age can be seen after the age of 50 years, which starts to trail off
after the age of 80. This same pattern can also be seen in the age-specific mortality
rates, see Figure 1.7, although the sharp increase with age starts slightly later and the
trend towards a stable rate above the age of 80 does not appear.
N.B. As with the previous data for incidence and mortality in Scotland, the age-
specific rates were calculated as part of the Cancer Scenarios for Scotland Study,
200126.
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Figure 1.6: Age-specific PCa incidence in Scotland (1960-1994)
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1.5.2 Family history of PCa
Many epidemiological studies, as reviewed by Ross & Schottenfield34 and Stanford
3 C
and Ostrander , have consistently observed that men with a first degree relative
diagnosed with PCa have approximately twice the risk of developing PCa than do
men without affected relatives, particularly among young-onset cases . The risk is
higher still for men with more than one affected relative and for men with a relative
who developed PCa at a young age34. This pattern of familial PCa accounts for
approximately 10-20% of PCa cases in the US35. This clustering of PCa in families
may be due to shared genetic susceptibility as well as common environmental
3 3
exposures or by chance alone given the high incidence of this cancer .
Although an increasing number of candidate high-penetrance genes for hereditary
3 C
susceptibility have been identified (as reported by Stanford and Ostrander ) such as
3 A
the HPC1 gene, only 5-10% ofPCa cases may arise from these genes . Other
genetic factors, in combination with possible environmental / dietary risk factors,
may be of greater importance. These include genetic polymorphisms that are far
more common in the population than the high-penetrance PCa susceptibility genes30.
For example, the Androgen Receptor gene (AR gene), which is polymorphic with a
highly variable number of the trinucleotide microsatellite repeats CAG and GGC, has
been observed to have a significant association with PCa, as reviewed in Coughlin &
Hall30. Other genetic polymorphisms that may be associated with PCa risk include 5
a-Reductase Type II gene (SRD5A2) and the Vitamin D Receptor gene (VDR)30.
1.5.3 Ethnicity
The international variation in PCa incidence and mortality may also be attributed to
variation ofPCa risk between different ethnic groups. This variation is also seen
between ethnic groups within countries, such as the US. African-Americans are
prone to the highest risks ofPCa, with both PCa incidence and mortality rates being
far higher than for US whites16. Socio-economic status and education factors are not
associated with the increased incidence, presentation at a more advanced stage and
an overall worse prognosis in African-Americans compared to their white
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counterparts . The underlying causes of these ethnic differences within the US
remain unknown.
Many studies ofmigrant populations moving from areas of low PCa risk to countries
with higher PCa risk show an upward shift in both PCa incidence and mortality
37
rates . More recent migration studies have shown that when Japanese people
emigrate from Japan to the US, PCa incidence in these people increases, although
this increase is only to about 50% of the rate for US whites38'39. Although some of
the difference in incidence between native Japanese and Japanese-Americans will be
due to differences in health care between countries40, the result ofmigrant studies
appear to show a real shift in incidence toward rates in the new host country. This
provides evidence that the international and ethnic differences in PCa incidence are
not entirely based on genetic disposition, but on environmental and lifestyle factors
too.
1.6 Conclusion
As discussed above, observed geographical and temporal trends in PCa incidence
and mortality cannot be explained by genetic factors, ethnicity and differences in
health care / cancer registration alone. It is therefore very possible that lifestyle and,
in particular, dietary factors may also attribute to these variations, thereby suggesting
that they play a major role in the aetiology of PCa. It is these factors that will be
considered in the next chapter.
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2 . Chapter 2: Background - Diet
2.1 Introduction
This chapter will first examine briefly the international variations and temporal
trends in diet in the context ofPCa incidence and mortality, before introducing the
concept of nutritional epidemiology. Individual dietary factors will be discussed in
the next chapter.
2.2 Geographical variations of diet
The consumption ofmajor food groups varies considerably across the world.
International food consumption data, as reviewed by the Food and Agriculture
Organisation for the United Nations (FAO)41 and by the World Cancer Fund42, show
that in most Asian countries cereals are the staple food, with more than half of total
energy being supplied by cereals (e.g. 67.9% of the Dietary Energy Supply (DES) in
China41). In addition, Asian diets tend to contain few animal foods and only small
amounts of vegetable and fruits, the majority ofAsian populations also consume
low-fat diets42. Whereas in Westernised countries, where the consumption ofmeat
and dairy products is high (e.g. 25% ofDES in the US41), cereals, although still an
important source of energy, provide less than one quarter ofDES41. In addition,
western diets tend to contain high levels of fat, in particular animal fats (total fat
supply: 154 g/day per capita in the US, compared to 52 g/day per capita in China41).
Fruit and vegetable intake is relatively high, accounting for up to 6% of DES in the
US and Mediterranean countries42, whereas Alcohol consumption is high ranging
from 5% ofDES in the US to 8% ofDES in Germany and Portugal42.
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N.B. The food consumption information above was extracted from food balance
sheets containing information about average food availability per head. These are
calculated by the FAO from the food produced and imported for countries as a
whole (minus food exported, fed to animals, or otherwise not available to
humans), divided by the number ofpeople the respective country. Although food
supply data is, in general, a relatively accurate proxy for actual food
consumption42, it does tend to overestimate food consumption in westernised
countries, where substantial amounts of food are wasted or fed to pets, and can
underestimate food consumption in developing countries where people tend to
grow their own food.
The supply of various foods has been expressed as a percentage of total dietary
energy supply (DES). This is because the amounts of different foods reported
represent the commodities as produced, with no correction for the inedible portion
nor for wastage and losses, thereby leading to varying levels of overestimation in
the foods reported. However, the nutrient and energy content of foods has been
calculated to account for this, therefore by expressing the data as the percentage
contribution of each food group to the DES, these errors are attenuated and the
distortion of the reported dietary profile is reduced42.
2.3 International temporal trends in diet
Over the last couple of decades food consumption throughout the world has changed
markedly. Since 1960, the food consumption in Asian countries has changed
dramatically, reflecting the rapid industrialisation and urbanisation. Most of these
countries have shown a decrease in cereal consumption, whereas meat intake has
risen considerably, for example by over 300% in both China and Japan42, fat
consumption, in particular animal fats, has also increased accordingly. Food
consumption in most Westernised countries has remained relatively stable, in
particular for meat and fat intake42.
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2.4 Diet in Scotland
The Scottish diet is one of the worst in Western countries, it is high in fat, sugar and
salt but low in fruit and vegetables and complex carbohydrates. After smoking, it is
the most significant cause of Scotland's poor health record, contributing to a range of
serious illnesses including coronary heart disease, stroke, diabetes and certain
cancers4^ and has recently started to take over from more traditional public health
44
concerns .
2.4.1 Components of the Scottish diet
The FAO food balance sheets show that the UK diet has one of the highest
proportions of animal products and lowest proportion of fruit and vegetables in
Europe. Recent Diet and Nutrition Surveys45"47 and National Food Surveys48 confirm
these findings. For example, UK men consume on average 1602g ofmeat produce
per week, compared to only 962g of vegetables45. For dairy products, 976g of semi-
skimmed milk (the most commonly consumed type ofmilk) and 36g of animal-based
fat spreads (which are rich in saturated and trans-fatty acids, but low in poly¬
unsaturated fatty acids) are consumed by men per week45. Alcohol consumption
within the UK is also relatively high in relation to other countries, although it is still
lower than that of other European countries (21,9g/day46 compared to approximately
27g/day in France and Italy42).
For Scotland in particular, the consumption ofmeat products is high (1784g per
week within meat consumers), with just over half ofmen (54%) reporting to eat meat
two to four times a week44. The consumption of vegetables in Scotland is nearly half
that of consumption in London and the South-East (1025g compared to 2029g per
week)45, with only 35% of Scottish men reporting to eat five or more helpings of
green vegetables per week44. The intake of animal-based fat spreads is also far higher
in Scottish men compared to those in London and the South-East45. Alcohol
consumption is similar to that of the UK average46. A more detailed account of
dietary intake can be found under the respective dietary factors in the next chapter.
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2.4.2 Social class variations
Reported regional differences in food consumption, such as lower consumption of
green and root vegetables in Greater Glasgow compared to the rest of Scotland44,
may in part reflect the impact of different behavioural patterns linked to social
classes and socio-economic status49. The Scottish Health Survey44 reported that the
consumption of'healthy' foods was far more prevalent among informants in Social
Classes I and II than among those in Classes IV and V. In particular, half ofmen in
Social Classes I and II consumed green vegetables five or more times a week
compared to only a third ofmen in Social Classes IV and V. Similar differences were
observed for using semi-skimmed / skimmed milk and consuming fruit, raw
vegetables, oily fish and wholemeal bread. Whereas, two thirds ofmen in Social
Classes IV and V consumed fried food two or more times a week, compared to just
over a third ofmen in Social Classes I and II. Men in Social Classes IV and V were
also more likely to consume red meat two or more times a week than men in Social
Classes I and II. Higher intakes of energy, protein, fat, carbohydrates and alcohol,
and lower intakes of vitamin E, retinol and beta-carotene have also been reported in
manual, compared to non-manual workers50.
2.4.3 Temporal trends
The last couple of decades have seen a substantial change in dietary habits and food
consumption patterns within the United Kingdom. These changes, termed the
'Consumption Revolution'51 are suggested to have been caused by fundamental
changes in the attitudes and social behaviour ofUK households in addition to
economic factors such as the growth in household income.
Since 1970, the meat consumption in general has declined steadily, in particular red
meat52, see Figure 2.1. Recently, poultry has become a major component ofmeat
intake and is now more important than beef. For fat spreads consumption, there has
been a general decrease in the consumption of full-fat and animal fat products,
whereas the consumption of low- / reduced-fat spreads has increased dramatically
since their introduction in the early 1980's , see Figure 2.2.
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For Scotland, within the last decade in particular, although patterns of general dietary
consumption have tended to remain stable, the consumption of several food groups
has been observed to change. Whilst the consumption ofmeat products has been
observed to have declined slightly, see Table 2.1, the amount ofmen consuming
wholemilk and butter have halved, with semi-skimmed milk consumption increasing
substantially45'53. The consumption of vegetables has in general remained constant,
although the number ofmen consuming carrots has increased, as has the number of
men consuming fruit, especially apples and pears45'53. This finding has been
confirmed by the Scottish Health Surveys of 1995 and 1998, which found that 45%
ofmen reported eating fruit at least once a day in 1998, compared to 39% in 199544.
However these observations should be interpreted with caution as only two data
points are available and therefore it is difficult to interpret whether the observations
do indeed infer a trend. It should also be noted that the sizes of study populations for
the Dietary and Nutritional Surveys (DNS)45'53 used are very small and therefore may
not provide an accurate summary of the food consumption of the Scottish population
as a whole.
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Figure 2.1: Meat consumption in the United Kingdom, by time period (extracted from
National Food Survey data52)
Time period
—•—Traditional fat spreads
• - * • ■ Low and reduced fat spreads
Figure 2.2: Fat spread consumption in the United Kingdom, by time period (extracted
from National Food Survey data52)
1971 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999
Time period
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Table 2.1: Food groups consumption within the Scottish population for the first53 and
second45 Diet and Nutrition Survey of British Adults (DNS).
Food Group % of men reported to have consumed food
1st DNS53 2nd DNS45
1986-1987 2000-2001
Bacon and Ham 79% 77%
Beef and Veal 84% 80%
Whole Milk 80% 40%
Semi-skimmed milk 40% 75%
Butter 58% 32%
Leafy green vegetables 38% 38%
Carrots 36% 47%
Tomatoes (raw) 61% 58%
Apples and Pears 45% 54%
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2.5 Nutritional epidemiology
The assessment of diet and its use in epidemiological studies to investigate the
aetiology of chronic disease, especially cancer, has progressed substantially over the
past twenty years. The recent development of nutritional epidemiology, both in terms
of an expansion of the literature and in improvements in the methodological basis of
nutritional epidemiology, has been motivated by the evidence of large world-wide
variations in cancer incidence and mortality suggesting that these variations could be
related to differences in diet and lifestyle between populations54. Nutritional
epidemiological studies, which, in the context of the classical definition of
epidemiology, may be defined as the study of the nutritional determinants of disease
and their distribution within a population55, have contributed immensely in providing
useful insights into the association between diet and cancer aetiology. It is indeed of
general consensus that diet plays a major role in cancer aetiology, although exactly
which of the dietary components are associated with cancer aetiology remain
unresolved.
Unlike other exposures of risk, such as smoking, the complex nature of diet poses a
particularly difficult challenge to epidemiologists56. The effects of individual dietary
components on cancer are notoriously difficult to detect due to the high degree of co-
variance and interaction. And even when an association is observed, the relative risk
of developing cancer rarely exceeds 2.0 or lies below 0.5. This is, in part, due to the
methods used to assess diet, which are generally unable to distinguish precisely
between different components of the diet within a population. It is this lack of
accurate and practical methods to assess diet which is probably the most serious
limitation to nutritional epidemiological research.
2.5.1 Diet assessment
There are four main methods of dietary assessment, Diet Recalls (usually 24 hours),
and Diet Records assess current intake only, whilst Diet Histories and Food
Frequency Questionnaires (FFQs) can focus on usual intake both post and present.
As the main factors of interest in epidemiological studies tend to occur in the past,
57
usually at a point in time that coincides with the induction of the disease , or as a
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long-term exposure58, it is the latter two methods which are most appropriate in
epidemiological research, in particular the FFQ. In addition to this, retrospective
methods, especially the FFQ, are usually quick and cheap to administer, also they
need only low subject motivation and can be used to assess subjects with low literacy
and numeracy skills.
FFQs are the most widely used technique for assessing diet in epidemiology studies.
They consist of a list of food items (varying in length, depending on the study and
hypothesis being tested) for which subjects are asked about the frequency and
portion usually consumed. These FFQs can be either interviewer- or self-
administered and can be formulated to measure diet in the past.
However, most methods of diet assessment have the inherent problem in that they
depend entirely on individuals' ability to recall accurately the frequency and quantity
of food and drink they usually consume. With the exception of diet records where
subjects are asked to record their intake as they eat, this is a potential source of
between-subject variation other than dietary intake, in particular memory and
conceptualisation skills, which may contribute to measurement errors. This is a
particular problem in the young and elderly who are less likely to recall diet
accurately. Bingham et at1 suggest that subjects over the age of 60 should be given
a simple mental ability test to ensure that basic memory skills are intact. However,
unless memory is associated with the disease of interest, the distribution ofpeople
with good and bad memories should be randomly spaced throughout the study
population, leading to random misclassification at most57. Another major problem of
diet assessment is illustrated by the Heisenberg Uncertainty Principle, ".. .as you stop
something to measure it, you change its behaviour...". It has been well documented
that subjects consciously and/or unconsciously distort their reported diet57'59.
Various reasons include the unwillingness to confess consumption of certain types of
food (e.g. sweets and alcohol) and the wish to report a diet that they believe will be
acceptable in the eyes of the interviewer.
Individual nutrient intakes can be estimated from dietary assessment methods using
food composition tables. These food tables tend to be nationally based, in order to
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assess the nutritional components of foods and brands commonly eaten in the
respective country. In the UK, the most commonly used food composition table is
McCance and Widdowson's The Compostition of Foods (5th edition)60 and related
supplements61"69, whereas in the US it is the USDA Composition of Foods: Raw,
Processed and Prepared (Agricultural Flandbook No. 8)70. Supplemental food
databases may also be used to estimate nutrients that are not adequately covered by
the main food tables, such as the Isoflavone Food Database71 which contains food
composition data for isoflavones in foods and brands commonly eaten in Scotland.
Food composition tables can also be an important source of potential error, as the
nutrient composition of each food item, in particular processed and convenience
foods, can vary between brands and also when and where it was produced or
processed. This is particularly true of isoflavones, the main source ofwhich is soy - a
commonly used bulking agent for processed foods in the UK. The amount of
isoflavones in these foods can vary due to soy flour or soy protein concentrate being
added in differing amounts according to the product and brand 72. Additionally,
substantial variation in isoflavone content of soybeans and soy products may occur
because of genetic differences of various varieties, season of harvesting, where the
soybeans are grown, maturity, and food-processing procedures73'74.
Lastly, random measurement errors, unassociated with the true dietary intakes being
measured, can cause the estimates of relative risk or other measures of diet-disease
association to be weakened (an effect known as attenuation bias) and reduce the
statistical power of epidemiological studies75. At the same time, a tendency for the
assessment method to over- or under-estimate dietary intakes systematically at a
group level may lead to a distortion of the scale on which differences in dietary
intakes are measured 76;77. Both random and systemic measurement errors can thus
compromise the interpretation and estimation of relative risk. The assessment of the
validity of the diet assessment method to be used (i.e. how accurately it measures
true dietary intake) is therefore essential.
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2.5.2 Diet validation
Various methods have been used to assess the performance of diet assessment
methods to estimate dietary intake accurately. Within the diet assessment method
itself, markers of internal validity can be incorporated by including questions that ask
for the same information in different ways. The answers of which can be compared
for consistency.
The reproducibility ofmeasurements made by the diet assessment method on two or
more separate occasions can produce a useful preliminary estimation of diet
assessment performance. However, care must be taken in deciding the period of time
between administrations of the diet assessment. Too short, and the subjects may tend
to remember their previous responses. Too long, and true changes in dietary intake
may contribute to a reduced reproducibility.
The comparison of individual nutrient intakes with an independent 'standard'
measure of diet can be used to assess the validity of the diet assessment method.
However, as there is no perfect measure of dietary intake, it is important that the
measurement errors ofboth assessment methods be as independent and uncorrelated
as possible to avoid spuriously high estimates of validity77. With the FFQ, the most
feasible comparison method, which is likely to have the least correlated errors, is the
Diet Record. The major sources ofmeasurement error associated with FFQs
(restrictions imposed by a fixed list of foods, memory, perception of portion sizes
and interpretation of questions) are minimally shared by diet records. As diet records
are open-ended, they allow direct assessment of portion sizes by measurement of
weight or dimensions and they do not depend on memory58. However, one source of
error likely to remain correlated is that of the food composition data. Nutrient
intakes are usually calculated from each assessment method using a similar body of
published data. Therefore, for nutrients whose content varies greatly in individual
food items, the calculated values from the diet record may be incorrect, but still
correlated with the FFQ. An alternative to the use of diet records as a standard is the
collection ofmultiple 24-hours recalls. Although the errors of 24-hour recalls are
more likely to be correlated with those of FFQs (both rely on memory and perception
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of serving sizes), they may be the only feasible standard available, especially if
subjects have low literacy skills or low compliance.
The use of biomarkers as a standard in the validation of diet assessment methods has
the main advantage in that the potential sources of random error occurring with
biomarkers are different from those of diet assessment methods. Therefore, it is fair
1ft
to assume that the errors are independent between the two measurements . They are
also objective indicators of dietary intake, and therefore not effected by recall and
observer bias78. However, these biomarkers are unlikely to be influenced by habitual
dietary intake alone, physiological, absorption and metabolic processes of the body
are also factors which may vary between individuals78. Other potential sources of
variation include genetic and lifestyle differences, daily variation in dietary intake,
which will cause temporal fluctuation in biomarker levels, and technical error
associated with laboratory measurements. The net effect of these factors is to
weaken the association between dietary intake and biomarkers. The observed
correlation between biomarker and diet assessment measurements can therefore be
interpreted only as a lower limit for the true correlation between diet and biomarkers,
even if adjustments are made for the attenuating effects due to variation in the
biomarker over time76. Another limitation is the lack of suitable biomarkers for many
dietary factors ofmajor interest including the intake of total fat and carbohydrates.
For other nutrients where biomarkers do exist, homeostatic regulation is so strong
that the biomarker's association with dietary intake is weakened dramatically,
making the biomarker ofminimal use to validation studies. Such highly regulated
7Q
nutrients include plasma levels of retinol and calcium .
Validation studies usually take place on a random sample of 100-200 of the main
study population79. In the analysis of the validation data, it is important to adjust
nutrient intakes for variables that are ultimately controlled for in an epidemiological
analysis, for example age, sex and EI79'80. As dietary intake values and biomarker
levels tend to be skewed, it is also important that transformations to increase
normality should be considered, alternatively, non-parametric tests could be used
such as the Spearman's Rank correlations.
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2.5.3 Other important methodological and epidemiological considerations
Study design
The two main types of analytical epidemiological study designs, cohort and case-
control studies, have been used extensively to test hypotheses and confirm findings
gained from previous ecological and geographical studies regarding dietary factors
associated with PCa.
The case-control study tends to be the most commonly used study design,
particularly in older studies, due to its relatively short completion time and the lesser
expense entailed compared to cohort studies. However, there are many potential
methodological limitations attached to this design, such as the potential for disease
status to influence dietary intake and recall bias, these limitations will be discussed
further in the next section.
In cohort studies, the exposure of interest is usually measured at the beginning of
follow-up and therefore before the disease / outcome of interest occurs, thereby
reducing the likelihood of recall bias. These studies also provide an absolute measure
of risk, whereas a case-control study can only provide estimates of relative risk. All
these determinants make the cohort study design a more robust method of assessing
dietary factors associated with PCa. However, cohort studies may also be subject to
misclassification, as dietary information is usually collected at a single point in adult
life, and so will not be able to take into account any temporal changes in dietary
habits, they also tend to be expensive and time consuming. Several studies have used
cohort analysis methods in randomised controlled trials (RCTs) to examine the
association between baseline characteristics and PCa, whereby the analysis is
stratified by the intervention arm or is included as a potential confounding factor.
These RCTs include the a-tocopherol and P-carotene RCT study (ATBC) 81,82 and
the Physicans' Health Study83.
Another type of study design that has been used in a number of nutritional
epidemiological studies is the nested case-control study, in which a case-control
analysis is conducted with a cohort study or RCT (i.e. cases and controls are selected
from the cohort population). This type of study is particularly useful if complex and
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expensive procedures are being used to collect data. It has been used in several
cohort studies, including the Health Professionals Follow-up Study84 and the CLUE I
Of.O/
& II cohort studies ' , and also in RCT studies, including the Physicians Health
Study87'88, the Carotene and Retinol Efficacy Trial (CARET)89 and the a-tocopherol
and P-carotene RCT study (ATBC)90'91. A similar design is the case-cohort approach,
as used in the Netherlands Cohort Study92"95 this method differs from the normal
nested case-control method, as whilst cases are derived from the entire cohort
(providing numerator information for calculation of cancer incidence rates), the
accumulated person years at risk in the total cohort are estimated using a random
sub-cohort sample (providing denominator information for the rates)95.
Statistical power and study size
The sample size of a study is an important determinant of statistical power - the
probability that the study can demonstrate a significant association when a true
association exists. The larger the study, the stronger the statistical power, therefore it
is of utmost importance that the study size be as large as possible, in particular as
most dietary assessment methods are susceptible to at least some degree of
measurement error, whilst also taking into account practical and economical
constraints. Several other factors may also affect the power of a study, including the
strength of the true association, the frequency of the outcome, as given by the
number of cases and controls and the prevalence of exposure among the subjects.
The issue of statistical power is of important consideration when reviewing the
literature on dietary factors for PCa, as the number of subjects recruited in recent
epidemiological studies investigating dietary factors varies substantially.
Subject selection
The way in which subjects are selected must be carefully considered in order to
reduce selection bias. Selection bias occurs when there is a difference in the
characteristics of those people who were selected for a study and those who were not,
and where those characteristics are related to the exposure or outcome of interest.
The effect of selection bias is to lead to an incorrect estimate of risk. It is particularly
a problem for case-control studies where it gives rise to non-comparability between
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cases and controls, i.e. the controls are not representative of the population that
produced the cases. An ideal case-control study, where there is no selection bias, is
one where:
• There is a clearly defined population (reference population)
• All cases in that population are included in the study
• Controls are a random sample of that population
Hospital-based case-control studies are particularly prone to selection bias, especially
if admission to hospital for other conditions is related to exposure status. Also people
in hospital often do not represent the general population, they tend to be poorer,
smoke and drink more, and live in worse conditions than the population of potential
hospital users. Most recent case-control studies investigating dietary factors for PCa
have been population- rather than hospital-based.
Epidemiological studies investigating risk factors for PCa tend to identify cases
through either population-based cancer registries or by hospital admission data, once
identified and recruited, it is very important that the PCa diagnosis is confirmed
histologically and/or pathologically, in order to avoid subject misclassification.
As mentioned previously, the 'clinical' PCa is of far greater epidemiological and
aetiological importance than 'latent' or incidental PCa. It is therefore of great
importance, especially in countries such as the US where PCa screening is common,
that a distinction is made between clinical PCa and 'latent' PCa detected by
screening. Some US studies, for example Giovannucci et al8;9;96;97 omitted Ai stage
PCa, thereby concentrating on 'clinical' PCa only. It is also quite possible that many
of the 'disease-free' controls recruited in to case-control studies may have, as yet,
undiagnosed asymptomatic PCa, which can lead to errors due to subject
misclassification. One solution to this is to use Benign Prostatic Hyperplasia (BPH)
patients (i.e. diagnosed with BPH as a consequence ofTURP in which no PCa was
detected ) as controls, thereby ensuring that the control group is PCa free.
Another interesting line of investigation that may give a further insight it to PCa
aetiology is that of studying the effect of dietary intake on PCa according to cancer
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stage (localised Vs advanced) and grade (well differentiated Vs undifferentiated).
These categories, which have been discussed previously in Chapter 1, give an
indication of the progression and /or aggressiveness of the tumour. Cases with
advanced tumours are of particular importance as it is these cancers which are most
likely to be fatal and also have a greater burden on health service provision, they are
also most likely to be the most distinct from controls who have the potential for
undiagnosed latent tumours98 and most importantly, are possibly most related to
environmental exposures such as diet, compared to the latent form of disease.
Subject participation
The success of any epidemiological study, in particular case-control studies, in
accurately investigating the association of exposure and disease depends on
achieving a high response / participation rate amongst the potential subjects. High
rates of non-participation (i.e. subjects who refuse to take part in the study or do not
respond), in addition to reducing statistical power of the study if the non-participants
are not replaced, may allow for selection and/or non-responder bias. This is
especially true if the exposure of interest differs between participants and non-
participants or if participation rates differ between cases and controls. It is therefore
ofutmost importance that special care is taken to ensure that response rates are as
high as possible and comparable for case and controls. The use of reminder letters
and methods that ensure that data collection is as easy and non-invasive for the
subjects as possible may help to increase participation rates.
Information bias
Errors leading to inaccurate information being collected on the exposure of interest
and/or the disease may cause the estimate of the strength of the association between
dietary factors and PCa to be biased. The extent and direction of this bias will depend
upon the nature of the misclassification involved. Non-differential misclassification,
in which the probability of exposure being misclassified is the same regardless of
disease status, has been discussed previously in context with the dietary assessment
method within the diet assessment section. The other main type of information bias is
differential misclassification, in particular recall bias, especially within case-control
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studies whereby cases recollect their eating behaviour differently from controls. This
can be particular serious when trying to study a possible risk factor that the general
public are aware of. Observer bias is another type of differential misclassification
and can occur when information of disease status influences that of exposure. It is
more likely to occur with an increased element of subjective judgement that is
required in order to classify exposure / disease status, especially if the observer is
aware of the disease / exposure status. Observer bias can be reduced by blinding the
observers to the disease / exposure status, and also by reducing the subjective
element by provided observers with clear instructions and criteria for obtaining
information. Both these types of differential misclassification can bias the estimates
of the association in either direction and, hence, it can be responsible for associations
that prove to be spurious.
Confounding
Confounding occurs when an estimate of the association between an exposure and an
outcome is mixed up with the real effect of another exposure on the same outcome
and which is correlated with the first exposure. Therefore, a potential confounder is
any factor which is believed to have a real effect on the risk of the disease under
investigation (including factors, such as age and social class, that are good proxy
measures ofmore direct unknown causes) and is correlated with the exposure of
interest. Potential confounders which are specific to studies investigating dietary
factors include the following:
Age and ethnicity
As mentioned previously, age is one of the 'confirmed' factors associated with
increased risk ofPCa. The process of ageing is also associated with economic,
psychological and social changes that can affect dietary habits and impair nutrient
intake. It is therefore very probable that age is a confounding factor for the
association between dietary intake and PCa, and so must be adjusted for, either by
age- or age-frequency matching controls to cases, by stratifying the analysis by age
group or by including age in the final multi-variable statistical model. Within studies
containing various ethnic or racial groups, it is also important that ethnicity, another
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'confirmed' risk factor for PCa, is controlled for, as dietary intake can also vary
between different ethnic groups.
Total energy intake
Probably the most important potential confounding factor that must be controlled for
in any dietary study is total energy intake. Total energy intake is highly correlated
with many dietary components, in particular fat, carbohydrates and protein, due to
the high energy content of these components. It is therefore difficult to separate the
intrinsic effects of high-energy dietary components from those associated with higher
energy intake, unless total energy intake is controlled for. Even with dietary
components that do not contribute to energy intake, total energy intake is still an
issue as it is also a proxy for the total amount of food consumed80, this is especially
important if total energy intake is associated with the disease under study.
Due to methodological limitations in early / non-validated dietary assessment
methods, initial epidemiological studies were unable to assess total energy intake
accurately, therefore making the precise adjustment for energy intake impossible.
Unlike age and ethnicity, controlling for total energy intake can only take place at the
analysis stage. Several methods used to control for total energy intake have been
reviewed by Willet80, they include: The Nutrient Density Method, in which nutrient
intake is expressed as a percentage of total energy intake; the Energy- Adjusted or
Residual Method, in which 'energy-adjusted' nutrient intakes are computed as the
residual from the regression model with total caloric intake as the independent
variable and absolute nutrient intake as the dependent variable, thereby providing a
measure of individual nutrient intake uncorrelated with total energy intake; and the
Standard Multivariate Model, in which total energy is adjusted for by including it in
the final model.
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3 . Chapter 3: Dietary factors
3.1 Introduction
The reported geographical and temporal variations in both PCa and dietary intake, as
discussed in Chapters 1 and 2, suggest a correlation between PCa and diet. More
over, PCa incidence in several countries show a high correlation with corresponding
rates of several other cancers thought to be related to dietary factors, such as breast,
98
ovarian and colorectal cancers .
Evidence of an association between PCa and diet was first reported in the mid 1970's
by ecological studies observing significant correlations between PCa mortality and
dietary intake, in particular a positive correlation with fat consumption54'99'100. In the
light of these observations, the PCa-Diet hypothesis that fat intake is associated with
increased risk of PCa was proposed. Subsequent ecological101 and other
epidemiological studies alluding to other dietary factors have lead to more
hypotheses being suggested, such as that plant-based nutrients, including beta-
carotene and isoflavones, have a protective effect against PCa.
It is these dietary factors hypothesed to be associated with PCa that will be discussed
in this chapter. The first section will discuss the literature review methodology,
followed by a discussion of each proposed dietary factor and their respective
literature. The chapter will close with a general discussion of the dietary factors and
issues regarding the literature.
3.1.1 Review papers and meta-analyses
Many recent papers have reviewed dietary factors associated with PCa, the most
notable being the general reviews of Kolonel28, Giles and Ireland29 and the World
Cancer Research Fund42, who have given a comprehensive though not necessarily
systematic review of the literature up till 1996. Important review papers for
individual dietary factors will be discussed in the following sections. However, only
three meta-analyses of dietary factors associated with PCa have been published,
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A literature search ofMedline® and the Web of Science® using the keywords:
Prostate Cancer (and associated MeSH subject headings), Diet (and associated MeSH
subject headings) and the respective risk factor under study, was undertaken to
identify epidemiological studies investigating dietary factors associated with PCa,
see Table 3.1. Search results were limited to humans, English language and for years
1980 to May 2004. Additional studies were identified through previous reviews on
nutrition and PCa28'29 and citations of study papers.
Studies were restricted to analytical epidemiological studies that measured dietary
intakes, studies based solely on serum nutrient concentrations were excluded from
the review. Details regarding the study design, size and methodology, as well as
estimates of risk and the respective confidence intervals or p-values of the dietary
factors examined, were extracted. Where results for advanced PCa were given as a
subset of the study, these results were also extracted along with the results for all
cases. Care was taken to include all reported null findings and also to note the
confounding variables each odds/risk ratio were adjusted for. Associations were
deemed to be positive if risk estimates were >1.3, and inverse if risk estimates were
<0.8.
Methodology criteria
A total of eighty-six epidemiological studies (excluding ecological studies)
examining the association between dietary factors and PCa were identified. This
wealth of epidemiological studies of varying types of designs, methodologies and
sizes has given rise to much conflicting evidence, making it increasingly difficult to
allow for a definitive answer to be made about the effect of diet on PCa risk.
Therefore, in order to omit studies from this literature review whose methodology
were deemed inadequate for examining the nutritional aspects ofPCa accurately
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(thereby allowing for the possibility of spurious results to be observed), a rigorous
methodology criteria was used. Those studies not fulfilling two or more of the
criteria, particularly those that did not use a validated diet assessment method nor
adjusted for energy intake were omitted, see Figure 3.1.
For those studies examining individual food groups and items, including alcohol,
rather than nutrient intakes, the diet assessment criterion was disregarded, as a fully
comprehensive and validated diet assessment method and food tables were not a
necessary requirement to measure individual food items.
Table 3.1: Keywords used in the literature search
Dietary Factor Key words
Fat Fat, Saturated fat, Unsaturated fat, MUFA / mono unsaturated fatty acids,
PUFA/ poly unsaturated fatty acids, Cholesterol
Animal products Animal products, Meat, Dairy products, Milk, Eggs
Calcium, Retinol, Vitamin A
Fruit and vegetables Fruit, Vegetables
Carotenoids Carotenoids, Carotenes, (f-carotene, lycopene
Vitamin E Vitamin E, Tocopherol
Selenium Selenium
Phyto-oestrogens Phyto-oestrogens, Isoflavones, Lignans, Soy / Soya, Soy beans / Soya beans
Daidzein, Genistein, Enterolactone, Equol
Alcohol Alcohol, Beer, Wine, Liquor, Spirits
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3.2 Fat
The relationship between fat consumption and PCa has been explored by numerous
studies over the last three decades. However the role of dietary fat in PCa remains
unclear.
Several early epidemiological studies demonstrated an association between PCa and
fat intake, suggesting that increased fat intake is associated with an increased risk in
PCa. However, more recently, as the literature on fat consumption and PCa
expanded, and the design and methodology of such studies improved, the evidence of
a fat-PCa association has become less consistent.
3.2.1 Fat in the diet
The average daily intake of total fat in the UK is 86.5g and 74.7g for men aged 19-64
years46 and > 65 years105 respectively, and provides for nearly 40% of the total
energy intake53, see Table 3.2. These intakes are similar to those ofUS men106, as is
the proportion of total energy, but is approximately twice the average daily intake of
men in China107. The same pattern is seen in the fat components, especially saturated
fat and cholesterol, whereas poly unsaturated fatty acids (PUFA) remains similar
between the UK / US and China.
The main sources of fat include dairy products, such as butter and margarine, meat
products and oils. Fat is also found in nuts, fatty fish and cereal products such as
cakes and biscuits.
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3.2.2 Components of fat
The main components of fat are organic compounds called fatty acids (FAs). Fats
can be categorised into three major classes, according to the main type ofFAs of
which they are composed, and which in turn depend on the presence and number of
carbon-carbon double bonds:
1) Saturated FAs, which contain no carbon-carbon double bonds, an example of
which is stearic acid, found in animal fats.
2) Mono-unsaturated FAs (MUFAs), which contain one carbon-carbon double bond
and include oleic acid which is found in olive oil.
3) Poly-unsaturated FAs (PUFAs), which contain two or more carbon-carbon
double bonds. These include: linoleic acid, found in various vegetable oils; a-
linolenic acid, found in both vegetable oils and animal products; and
eicosapentaenoic acid (EPA), found in fish oils. PUFAs can be classified further
according to the position of the first carbon-carbon double bond, for example:
omega-3 FAs, such as a-linolenic acid and eicosapentaenoic acid, and omega-6
fatty acids, such as linoleic acid.
MUFA and PUFA can also occur in two different geometric arrangements, cis- and
trans-. The most common form is cis-, whilst trans- fatty acids are mainly produced
during the manufacturing process of vegetable and fish oil products such as
margarine.
Another component of fat is cholesterol, a sterol compound found only in foods of
animal origin. Eggs and offal are the main dietary source of cholesterol. Dietary
cholesterol is similar in structure to bile acids, sex hormones and vitamin D and is an
important precursor in their production by the body.
Fatty acids can differ in their biologic properties depending on the degree of
saturation and length of the carbon chain and the position of the first carbon-carbon
double bond. Hence, it has been suggested that different fatty acids have different
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roles in health and disease, and therefore the various components of fat should not be
1 AO
expected to carry the same risk for cancer .
3.2.3 Function of fat and possible biological mechanisms of PCa aetiology
Fat provides a concentrated source of energy, one gram of fat provides 37kJ (9kcal)
which is more than double of that provided by either protein or carbohydrate (17kJ/g
(4kcal) and 16kJ/g (3.75kcal) respectively)109. It is this high energy content that
makes fat intake so highly correlated with total energy intake. It is therefore difficult
to separate the intrinsic effects of fat intake from those associated with higher energy
intake.
At the cellular level, fatty acids (as part of phospholipids) are an integral component
of cellular membranes that function to maintain cellular integrity and regulate the
activities ofmany membrane enzymes. In addition, cholesterol is also a precursor of
sex hormones and bile acids. Humans can synthesise most of their necessary fatty
acids, with the exception of linoleic and a-linolenic acids (that are therefore called
essential fatty acids). These essential fatty acids are obtained from a variety of
dietary sources, including vegetable oils, red meat and dairy products. Linoleic acid
can be further metabolised to arachidonic acid, an important precursor for the
biosynthesis of eicosanoids (e.g. prostaglandins).
Fats, along with other dietary factors, affect several physiologic and cellular
processes that could influence, either positively or inversely, the development of
PCa. Figure 3.2 summarises these processes. The effect of fat on male sex hormone
levels has long been suggested as a possible biological pathway for PCa
development. High dietary fat intake, especially saturated fat, has been observed
increase circulating levels of endogenous androgens, such as testosterone110, which
in turn have been observed to have a positive effect on PCa risk111. Dietary fat has
112
also been observed to affect the hormonal regulation of genes and gene expression .
Other possible mechanisms, as reviewed by Kolonel et al113 include DNA damage
due to the oxidation ofPUFAs by free radicals, the disruption of normal cellular
growth and communication by FAs, the influence of FAs, in particular arachidonic
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acid (metabolite of linoleic acid) on inflammation, immune responses and
prostaglandin production, all ofwhich may play a role in PCa, and tumour growth
and metastasis.
Figure 3.2: Cellular constituents and processes that may mediate the effects of dietary
factors on carcinogenesis
Dietary Factors: Fat page 44
Prostate Cancer & Diet
3.2.4 Literature review
The following section will discuss the findings of recent studies investigating the
association between fat intake and PCa.
Review papers and meta-analyses
Several recent papers have reviewed the association between fat intake and
108 '113 117 •PCa ' " , although the majority of these reviews discussed in depth the available
evidence on fat intake and PCa risk, not one of these gave a systematic and complete
review of all studies, with the possible exception ofKolonel et al10 ,113. The
consensus among these reviews was that dietary fat may indeed be related to PCa
risk, although the specific fat components that are responsible are not yet clear, and
could involve the interplay of fat with other dietary factors, such as antioxidants or
with genetic factors.
To date, only one meta-analysis has been undertaken to examine the effect of linoleic
acid on PCa risk only103, for which a combined relative risk of 1.27 (95%CI 0.97-
1.66) and 0.83 (95%CI 0.56-1.24) were observed for three case-control studies and
two cohort studies respectively.
Analytical epidemiological Studies
A total of thirty-six analytical epidemiological studies (published between 1983 -
May 2004) were identified as examining the association between fat intake and PCa.
Of these, fourteen were omitted from the literature review for not fulfilling the
methodology criteria, see Table 3.3. Of the remaining studies, twelve were case-
control studies, two were nested case-control studies and five were cohort studies.
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Table 3.3: Methodology criteria and omitted studies
Criteria
Studies not fulfilling criteria and which were
subsequently omitted from review
1. Study size appropriate for study design, statistical
power and/or diet assessment method.
Heshmat etal, 1985118
Ohno etal, 1988119
Bravo et al, 1991120
Walker etal, 1992121
Vlajinac et al, 1997122
Lee etal, 1998123
2. PCa cases histologically or pathologically confirmed. Ross et al, 1987124
3. Use of validated dietary assessment method. Graham et al, 1983125
Heshmat etal, 1985118
Ross et al, 1987124
Kolonel etal, 1988126
Ohno etal, 1988110
Fincham et al, 1990 127
Bravo etal, 1991120





de Stephani et al, 2000129
4. Dietary assessment method contains an appropriate
number of food items to estimate nutrient intake
accurately.








Deneo-Pellegrini et al, 1999130
Hayes et al, 1999128
de Stephani et al, 2000129
5. Nutrient intake individually calculated using accurate,
complete and internationally recognised food
composition tables.




Deneo-Pellegrini et al, 1999130
6. ORs / RRs adjusted for energy intake (or an equivalent





Fincham et al, 1990127
Bravo et al, 1991120
Walker etal, 1992121
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Total fat
A total of sixteen reviewed studies reported the association between total fat intake
and PCa, the findings of these studies are summarised in Table 3.4. The majority of
the nine case-control studies that investigated this relationship reported no
association 13 M36. However, Whittenmore et al10 reported a significant positive
association with PCa risk (OR 1.4, 95%CI 1.1 - 1.8), whereas two Canadian
117.110
studies ' reported a non-significant inverse association with PCa risk.
No association between total fat intake and PCa risk was reported by the only nested
Q-i R9*Qf\
case-control study and also by two out of the five cohort studies ' that
investigated the effect of total fat intake on PCa risk. Of the remaining three cohort
studies, non-significant positive / inverse associations were reported by Giovannucci
et al9 and Veierod et al139, and Hsieh et al140 respectively.
Significant to borderline significant positive associations with advanced PCa were
reported in all of the six studies that investigated the effect of total fat on advanced
PCa9'10,96'136, with the exception ofHodge et al141 and Schuurman et al93 who
observed no association. The estimated relative risks ofwhich ranged from 1.3
(95%CI 1.0-1.7)96 to 2.0 (95%CI 1.0-3.9)136. Schuurman et al93 also examined the
effect of total fat on latent cancers, as with advanced tumours no association was
found.
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(95%CI)
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Men aged < 84 yrs
Stratified by ethnicity
ORs adjusted for age residence & education
(El adjusted ORs not presented)











Men aged <80 yrs







Total Fat 0.8(0.5-1.5) Men aged 35-84 yrs
ORs adjusted for El, age & FHPCa






Total Fat 0.9(0.6-1.4) Men aged <75 yrs








Total Fat 1.0(0.6-1.9) Men aged > 45 yrs.
ORs adjusted for age, El, study group,
FHPCa & education.







Total Fat 1.2 (0.9-1.5) Men aged 50-74 yrs.
ORs adjusted for age, residence, smoking,






434 Hosp / Pop
Ctrls
Total Fat 1.2 (0.9-1.6) Men aged < 80 yrs
ORs adjusted for El, age, residence, FHPCa












ORs adjusted for El, age, race, FHPCa,









Total Fat 1.0 (0.8-1.4) Men aged < 70 yrs
ORs adjusted for: El (residual), age, study
centre, year, FHPCa, SES
Age frequency matched















RRs adjusted for El, age, FHPCa & SES
Adv & Latent RRs = per 10g increment
Netherlands Cohort Study
Cont.
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RRs adjusted for El, age, ancestry & BMI
Health Professional Follow-up Study
Men aged 16-56 at baseline
RRs adjusted for El & age
RRs adjusted for El, age
All & Adv RRs = per 33g increment
Health Professional Follow-up Study.
Men aged 50-69 yrs at baseline.
RRs adjusted for age, El, intervention arm,
smoking, education & BMI.
Cohort study from the ATBC RCT study.
Men aged 46-92 yrs
RRs adjusted for age & El (residual)
N.B. cases included both prevalent &
incident cases
N.B
5 Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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Animal and saturated fat
Thirteen studies have reported on the association between PCa and animal and/or
saturated fat intake. The findings for these studies are summarised in Table 3.5.
As with total fat, the majority of the ten case-control studies that investigated this
ill I . 1 T r . 1 ■} C. 1
relationship observed no association ' ' ' . Two Canadian case-control
studies137'138 reported non-significant inverse associations with PCa risk, whereas
Whittenmore et al10 and Ramon et al135 reported significant positive associations with
saturated fat (OR 1.6, 95%CI 1.1-2.4) and animal fat (OR 2.1, 95%CI 1.3-3.2)
respectively. No association was also reported by the only nested case-control
study93, whereas the two cohort studies9'139 reported weak non-significant inverse
associations.
No association between saturated fat and advanced PCa was observed by the
majority of the six studies that investigated this association9'93'131'143, with the
exception of Whittenmore et al10 who reported a significant positive association (OR
2.8, 95%CI 1.5-5.2). Schuurman et a/93 also examined the effect of saturated fat on
latent cancers, as with advanced tumours no association was found.
Cholesterol
Only two case-control studies have reported on the association between PCa and
cholesterol intake131'135. The finding for these studies are summarised in Table 3.5.
No association between cholesterol and PCa / advanced PCa was observed.
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Table 3.5: Summary of results from epidemiological studies of saturated fat, animal fat
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Men aged < 84 yrs
Stratified by ethnicity
ORs adjusted for age residence &
education (El adjusted ORs not presented)



























Men aged <80 yrs











Men aged 35-84 yrs
ORs adjusted for El, age & FHPCa






Saturated FAs 1.1 (0.7-1.7) Men aged <75 yrs












Men aged > 45 yrs.
ORs adjusted for age, El, study group,
FHPCa & education.







Saturated Fat 1.1 (0.9-1.5) ORs adjusted for El & age
Age frequency matched













Men aged < 80 yrs
ORs adjusted for El, age, residence,
FHPCa












ORs adjusted for El, age, race, FHPCa,









Saturated Fat 1.0(0.7-1.4) Men aged < 70 yrs
ORs adjusted for: El (residual), age, study
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Table 3.5, cont.: Summary of results from epidemiological studies of saturated fat,





Odds / Risk Ratio
(95%CI)
$® Notes















RRs adjusted for El, age, FHPCa & SES














RRs adjusted for El, age, ancestry, BMI &
other fat components






Saturated Fat 0.7(0.3-1.5) Men aged 16-56 at baseline
RRs adjusted for El & age
N.B
$ Odds / Risk ratio for highest relative to lowest quartile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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Unsaturated fatty acids (FAs)
Unlike other components of fat, it is only since the mid 1990's that unsaturated fat
intake has been examined with regards to PCa risk. Most of the research has been
focused on total MUFA and PUFA. More recently research has spread to more
specific fatty acids such as a-linolenic and linoleic FAs and EPA and DHA, as
research and measurement methodology has improved and new aetiological
pathways for individual FAs suggested.
Nine case-control studies, two nested case-control studies and two cohort studies
have reported on the association between MUFA and PUFA and PCa. Several of
these studies have also examined specific FAs. The findings of these studies are
found in Table 3.6.
MUFA
No association between MUFA intake and PCa risk was reported in the majority of
eight case-control studies131'132'135'136'142'144, with the remaining two studies reporting
weak non-significant inverse associations137'138. However Norrish et al144 reported a
significant inverse association with MUFA rich oils (OR 0.5,95%CI 0.3-0.9).
Whereas positive associations were reported by the nested case-control study and
two cohort studies that examined MUFA intake, including Giovannucci et al9 who
reported a borderline significant positive association (OR 1.9, 95%CI 1.0-3.5).
Of the four studies which examined the association between MUFA and advanced
PCa, Andersson et al131 and Hodge et al141 reported no association, whereas Kristal et
al136 and Giovannucci et al9 reported positive associations ofwhich one was
borderline significant (OR 2.0, 95%CI 1.0-3.9).
PUFA
No association between PUFA intake and PCa risk was reported in the seven case-
control studies131'132'135"137 that investigated PUFA intake, with the exception of
Ghadirian et al138 and Tzonou et al142 who reported a non-significant and significant
positive association respectively (OR 1.8, 95%CI 1.1-2.8142). A weak non-significant
inverse association was reported by the one nested case-control study to examine
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PUFA intake93, whereas the one cohort study139 to examine PUFA intake reported a
non-significant positive association. Schuurman et al93 also examined PUFAs
according to their geometric structure, both CA-PUFA and Trans-?\JVA intake were
observed to have no association with PCa.
No association was also reported between PUFA intake and advanced PCa 131'136.141_
Specific FAs
In order to elucidate the association between PUFAs and PCa risk further, seven
studies have also examined the effect that specific FAs may have on PCa. The
findings of these studies are also summarised on Table 3.6.
The omega-6 FAs, including linoleic acid and arachidonic acid, were reported to
have no association with PCa risk in both of the two case-control studies which
examined these FAs131'135, no associations with PCa were also reported in the two
nested case-control studies91'93 and cohort study9, with the exception of a weak non¬
significant inverse association between linoleic acid and PCa93 and a weak non¬
significant positive association between arachidonic acid and PCa91. No association
with these FAs and advanced PCa were also reported with the exception of
Giovannucci et al9 who reported a non-significant inverse association.
For the omega-3 FAs, no association was reported between both EPA and DHA and
PCa risk in the one case-control and two nested case-control studies that examined
these FAs91'93'136, with the exception ofMannisto et al91 who reported a weak non¬
significant positive association with DHA. For advanced PCa, Hodge et al141
reported a weak non-significant association and no association with EPA and DHA
respectively. The evidence for a-linolenic acid is less conclusive, of the two case-
control studies, two nested case-control studies and one cohort study to investigate a-
linolenic acid, two reported no association91'131, a further two studies9'135 reported a
positive association, one ofwhich was significant (OR 2.5, 95%CI1.8-3.4135),
whereas Schuurman et al93 reported a weak borderline significant inverse association
(OR 0.8, 95%CI 0.7-1.0). Of the two case-control studies and one cohort study that
examined the association between a-linolenic acid and advanced PCa, Andersson et
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al 131 and Hodge et al141 reported weak inverse associations with advanced PCa, one
ofwhich was borderline significant (OR 0.8, 95%CI 0.6-1.0141), whereas
Giovannucci et al9 reported a significant positive association with advanced PCa (OR
3.4, 95%CI 1.7-7.0).
Of the remaining FAs examined, no significant associations were reported between
PCa risk and stearic acid91'93, oleic acid91'93'141'144, palmitoleic acid91'141 and palmitic
acid91'93.
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Table 3.6: Summary of results from epidemiological studies of unsaturated fat, specific
fatty acids and PCa
Study, year, Subjects Fat Variable Odds / Risk Ratic $® Notes
location (95%CI)
Case - Control Studies
Rohan et a/137 207 Cases MUFA 0.8 (0.4-1.4) ORs adjusted for El, age, FHPCa
1995 207 Pop Ctrls PUFA 1.2 (0.7-2.1) Age frequency matched
Canada
Andersson et aln1 526 Cases MUFA Men aged <80 yrs
1996 536 Pop Ctrls All 1.1 (0.8-1.6) ORs adjusted for El (residual) & age










Ghadirian et alns 232 Cases MUFA 0.8(0.5-1.4) Men aged 35-84 yrs
1996 231 Pop Ctrls PUFA 1.5 (0.7-2.9) ORs adjusted for El, age & FHPCa
Canada Age frequency & residence matched
Key et al132 328 Cases MUFA 0.9 (0.6-1.4) Men aged <75 yrs
1997 328 Pop Ctrls PUFA 0.9(0.6-1.4) ORs adjusted for El & SES
England Age frequency matched
Tzonou et alU2 320 Cases MUFA 1.1 (0.8-1.5) ORs adjusted for El & age
1999 246 Hosp Ctrls PUFA 1.8 (1.1-2.8) Age frequency matched
Greece OR = per increment of 1 SD of daily intake
Norrish et a/144 317 Cases MUFA rich oils 0.5 (0.3-0.9) Men aged 40 - 80 yrs
2000 480 Pop Ctrls Total MUFA n/s ORs adjusted for El, age & SES
New Zealand Animal MUFA n/s Age frequency matched
Oleic FA n/s ORs for MUFA & oleic FA not presented
Ramon et at135 217 Cases MUFA 1.2 (0.9-1.9) Men aged < 80 yrs
2000 434 Hosp/ PUFA 0.9 (0.6-1.2) ORs adjusted for El, age, residence,
Spain Pop Ctrls Omega-6 FAs 1.0 (0.7-1.4) FHPCa
a-linolenic FA 2.5(1.8-3.4) Age frequency & region matched
Kristal et al136 605 Cases MUFA Men aged 40-64yrs
2002 592 Pop Ctrls Local 1.0 (0.7-1.7) ORs adjusted for El, age, race, FHPCa,
US Adv 2.0 (1.0-3.9) education, BMI, PSA testing






Hodge et al141 858 Cases MUFA 0.8(0.6-1.1) Men aged < 70 yrs
2004 (> gleason PUFA 1.0 (0.7-1.3) ORs adjusted for: El (residual), age, study
Australia score 5) Palmitoleic acid 0.8(0.6-1.1) centre, year, FHPCa, SES
905 Pop Ctrls Oleic acid 0.9(0.5-1.0) Age frequency matched
Linoleic acid 1.0 (0.7-1.3)
a-linolenic FA 0.8 (0.6-1.0)
Arachidonic acid 1.0 (0.7-1.4)
EPA 0.8(0.6-1.1)
DHA 1.0(0.7-1.4)
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Table 3.6, cont.: Summary of results from epidemiological studies of unsaturated fat,
specific fatty acids and PCa
Study, year, Subjects Fat Variable Odds / Risk Ratio3® Notes
location (95%CI)
Nested case - control studies
Schuurman et at33 58,279 Men MUFA 1.3 (0.8-2.1) Latent & Advanced PCa RRs similar to
1999 PUFA 0.8(0.6-1.1) those of All PCa
Netherlands 642 Cases Trans-FAs 1.0(0.7-1.4)
Cis-FAs 0.8(0.5-1.2) RRs adjusted for El, age, FHPCa &
Palmitic Acid 1.1 (0.8-1.7) SES
Stearic Acid 1.2 (0.8-1.9)
Oleic Acid 1.4(0.9-2.2) Netherlands Cohort Study
Linoleic Acid 0.8 (0.6-1.1)
Linolenic Acid 0.8 (0.7-1.0)
Arachidonic Acid 1.2 (0.9-1.7)
EPA 1.0 (0.7-1.4)
DHA 1.0 (0.8-1.4)
Mannisto et al91 198 Cases Myristic Acid 1.2 (0.7-2.0) Men aged 50-69 yrs
2003 198 Ctrls Palmitic Acid 0.8(0.5-1.4) ORs adjusted for: El (residual),
Finland Palmitoleic Acid 0.9 (0.5-1.6) (residence, education, BMI, alcohol,
from 29,133 Stearic Acid 1.1 (0.7-2.0) smoking did not effect ORs)
male smokers Oleic Acid 1.0 (0.5-1.7) Age matched
Linoleic Acid 0.9 (0.5-1.6)
a-Linolenic Acid 1.2 (0.6-2.1) ATBC RCT Study




Giovannucci et a/9 47,855 Men MUFA RRs adjusted for El, age, ancestry,
1993 All 1.9(1.0-3.5) BMI & other fat components
USA 300 Cases Adv 1.6 (0.6-4.0)






Veierod ef a/139 25,708 Men MUFA 1.4 (0.6-3.0) RRs adjusted for El & age
1997 PUFA 1.4 (0.6-3.0)
Norway 72 Cases
N.B
s Odds ratio for highest relative to lowest quartile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only, n/s = Non-significant
FA = Fatty acid, MUFA = Mono Unsaturated Fatty Acid, PUFA = Poly Unsaturated Fatty Acid, EPA =
Eicosapentainoic acid, DHA = Docosahexaenoic acid
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3.2.5 Discussion
The evidence gathered from this systematic literature review, unlike previous
literature review papers108'113"117, concludes that, in general, fat and its components
have no effect on PCa risk and therefore does not support the Fat-PCa Hypothesis
that fat and its components are associated with increased PCa risk, with the possible
exception of the effect of total fat on advanced PCa, for which a significant positive
association was consistently observed, and a-linolenic acid which the findings are
less conclusive with both significant inverse and positive associations being observed
for both all PCa and advanced PCa. It should also be noted that MUFA rich oils were
observed to have a significant protective effect against PCa144. However, care must
be taken with the interpretation of this finding, as the observed protective effect
could be attributed to non MUFA components of these vegetable oils, as well as
residual confounding by the strongly protective Mediterranean / healthy dietary
pattern associated with mono-unsaturated fat-rich vegetable oil consumption144. This
could also be the underlying reason behind the varying observed effect of a-linolenic
acid, as this FA is found both in animal and vegetable sources, thereby allowing for
the possibility that a-linolenic acid may be correlated with other dietary factors
associated with a protective effect against or positive risk for PCa depending on
whether intake is from a vegetable or animal source respectively.
Although evidence from many animal and invitro studies (as reviewed by Kolonel et
al108) support the Fat - PCa Hypothesis by observing increased tumour growth with
high fat intake145, or inhibition of tumour growth with a lower fat intake146'147,
148several recent animal and invitro studies have failed to reproduce these findings
15°. It is of great interest that a recent animal study examining the relationship
between PCa and energy and fat intake observed that tumour growth was reduced by
the restriction of total energy intake rather than fat intake, and that tumour growth
was independent of the proportion of fat in the diet as long as the total energy intake
was restricted151. This therefore suggests that energy intake, not just fat, may affect
prostatic tumour growth and also that fat in combination with some other unknown
dietary component may encourage tumour growth .
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3.3 Animal based products
3.3.1 Introduction
The relationship between meat, poultry, fish and dairy product consumption and PCa
has been examined over the last two decades. Due to the strong association with fat
intake (animal products are the main contributor of total and saturated fat intake), the
consumption of animal products was thought to reflect the effect of dietary fat on
PCa. However, recent evidence has shown that other constituents ofmeat and dairy
products may also contribute to the carcinogenic effect on PCa.
Meat, poultry and fish contain around 20% protein, whilst fat content ranges from
less then 4% fat for lean poultry and fish to 30-40% fat for fatty meat from
domesticated farmed animals42. In meat, this fat content is made up of approximately
40-50% saturated FAs, poultry contains a relatively lower proportion of saturated
FAs (35%) and a higher proportion ofPUFAs (15-30% as compared with 10%),
whereas fish contains only 20-25% saturated FAs42. Oily fish are also a rich source
of omega-3 fatty acids. Meat and poultry are also rich sources of iron, zinc, selenium
and the B vitamin group, liver is a rich source of retinol in particular. Fish contains
relatively lower levels of iron, zinc and the B vitamins, but are a rich source of
retinol and vitamin D42. Milk, in particular cows' milk, contains approximately 3%
protein and 4% fat, ofwhich approximately two-thirds is saturated FAs. Dairy
products are rich sources of calcium and also good sources of riboflavin, vitamin Bi2
and retinol, particularly in full-fat dairy products42. Eggs are moderate sources of
protein, fat and retinol.
N.B. The word meat can relate to either all non-fish and non-poultry meat or include
poultry. This ambiguity can present difficulties when comparing results from
different studies. In this study review, the term meat refers to non-fish and non-
poultry meat unless otherwise stated, in particular beef, lamb and pork.
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The consumption ofmeat, poultry and dairy products varies considerably world-wide
this variation, in particular that for Scottish men, has been discussed in Chapter 2.
This section will therefore concentrate on the background of the nutrients associated
with animal products, in addition to a systematic review of the literature.
3.3.2 Specific nutrients associated with animal products
Calcium
Calcium is a mineral found in both animal and some plant foods. Rich sources of
calcium include dairy products and small fish (when eaten with their bones). Calcium
plays an important role in various functions in the body, such as nerve and muscle
activity and bone metabolism. It also is involved with cell proliferation and
differentiation. Calcium metabolism is controlled by various factors including
vitamin D and its metabolite 1,25 dihydroxyvitamin D3 (1,25 D), which in turn
effects levels of circulating 1,25 D153.
In the UK, the average daily intake of calcium is estimated to be 1016mg and 836mg
for men aged 19-6447 and 65 years and over105 respectively, whereas in Scotland the
average daily intake of calcium is estimated to be 1063mg and 777mg for men aged
19-6447 and 65 years and over105 respectively (see Table 3.7). This is relatively high
compared to the average daily intake of calcium in the US and China where intake is
estimated to be at 886mg and 746mg for US men aged > 20years and > 70 years
respectively106 and 582mg for Chinese men 107.
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Vitamin A / retinol
Vitamin A, also known as retinol, is a fat-soluble vitamin found in animal products
such as liver, milk, eggs and fish liver oils. The term vitamin A applies correctly only
to retinol, however, vitamin A intake is generally used to mean the dietary intake of
both retinol (pre-formed retinol) and also pro-vitamin A carotenoids, such as (3-
carotene that are metabolised by the body into retinol1. This section focuses mainly
on retinol, the pro-vitamin A carotenoids are discussed in the following section.
As summarised in Table 3.7, the average daily intake of preformed retinol (from food
sources only) in the UK is 571 pg and 847pg for men aged 19-64 years47 and > 65
years105 respectively, where as in Scotland the average daily preformed retinol intake
is slightly lower at 945pg and 771 pg for men aged 16-64 years53 and > 65 years105
respectively. This is similar to that observed in other Western countries, and is more
107than twice as much as that observed in Far Eastern countries such as China .
The average daily intake of vitamin A in UK (food sources only, measured as retinol
equivalents) is 91 lpg and 1173pg for men aged 16-64 years47 and > 65 years105
respectively, where as in Scotland the average daily vitamin A intake is 1028pg and
1096pg for men aged 19-64 years47 and > 65 years105 respectively. These intake are
similar to the daily average of vitamin A intake in the US, which is 1133pg and
1356pg for men aged > 20 years and > 70 years respectively106.
Vitamin A and its precursors, as well as its role in the visual process, are essential for
the normal growth and physiologic function of the prostate42. Since the discovery of
vitamin A, the observation that the main effects of its deficiency are hyperplasia and
loss of differentiation of the squamous epithelium has raised speculation that vitamin
A may be involved with carcinogenesis. Several early epidemiological studies have
observed an inverse association between vitamin A intake and a number of cancers
including PCa119;154, however due to methodological limitations these studies have
not been included in the following study review.
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3.3.3 Potential bio-mechanisms for PCa aetiology
The aetiological mechanism behind the association between meat and dairy products
consumption and PCa is not fully understood. Initially this association was thought to
reflect a high exposure to dietary fat, in particular saturated fats, since both meat and
dairy products are the major sources of dietary fat. However, due to the inconsistent
findings in recent studies on dietary fat and PCa (as reviewed previously), other
potential bio-mechanisms have been considered, please refer to Figure 3.2 for an
outline of these bio-mechanisms.
The bio-mechanisms involved with meat and meat products have been examined in a
1 AO
review by Kolonel . Firstly, due to the inverse correlations observed between meat
and plant food consumption patterns, diets high in meat and other animal products
may be relatively deficient in certain anti-carcinogenic compounds found in plant
foods, such as P-carotene, lycopene and tocopherol. And secondly, cooking meats at
high temperatures (the most common method of cooking meat) can result in the
formation of heterocyclic amines and polycyclic aromatic hydrocarbons - potent
108
carcinogens which may induce cancer directly by the formation ofDNA adducts .
In addition to the bio-mechanisms involved with dietary fat, dairy products also are
thought to effect PCa aetiology via calcium intake and the vitamin D metabolic
pathway. Vitamin D and its metabolite 1,25 D are anticarcinogenic and have been
shown to inhibit PCa cell growth and development155. As noted earlier, 1,25 D
regulates calcium metabolism and consequently, dietary calcium can suppress
circulating 1,25 D levels. Therefore a high intake of dietary calcium may increase
PCa risk by lowering the level of anti-carcinogenic 1,25 D. Milk intake has also been
linked to higher levels of circulating insulin-like growth factor 1, which in turn has
been observed to increase PCa risk156"158. However the hypothesis that dairy products
increase PCa risk by increasing levels of insulin-like growth factor 1 is very
speculative and requires further study153.
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3.3.4 Literature review
Review papers
Several recent papers have reviewed the association between animal products,
including vitamin A and calcium, and PCa risk108'143'153'159. Although the majority of
these reviews discussed in depth the available evidence, not one of these gave a
systematic and complete review of all studies. The consensus amongst these reviews
confirmed the association between meat and dairy consumption and PCa risk,
whereas the evidence for the association of calcium and vitamin A with PCa risk is
less conclusive. No meta-analyses on the effect of animal product consumption on
PCa risk have been published.
A total of forty-six analytical epidemiological studies have been identified for
examining the association between the consumption of animal products and their
associated nutrients and PCa. Seventeen studies out of the forty-six studies, as shown
in Table 3.8, did not fulfil the methodological criteria and were therefore omitted, a
further four studies that examined both animal products and their associated
nutrients, were omitted for the review of calcium and/or vitamin A, but were
included in the food group review due to not fulfilling the diet assessment and food
table criteria which is an important criteria for nutrient analyses but not so for food
group analyses . Of the remaining studies, eighteen were case-control studies, two
were nested case-control studies and nine were cohort studies.
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Criteria Studies not fulfilling criteria and which were
subsequently omitted from review
Study size appropriate for study design, statistical
power and/or diet assessment method.
PCa cases histologically or pathologically confirmed.
Use of validated dietary assessment method.
Dietary assessment method contains an appropriate
number of food items to estimate nutrient intake
accurately.
Nutrient intake individually calculated using accurate,




Oishi et al, 1988164
Bravo et al, 1991120
La Vecchia et al, 1991160
Walker etal, 1992161
Vlajinac et al, 1997122
Lu etal, 2001162
All studies fulfilled this criteria
Graham etal, 1983125




Bravo et al, 1991120
La Vecchia et al, 1991160
West et al, 199198
Vlajinac et al, 1997122






Le Marchand etal, 1994188
Chan et al, 200183 (calcium only)
Rodriguez et al, 2003169 (calcium only)
Graham et al, 1983125




Walker et al, 1992161
Deneo-Pellegrini et al, 1999130 (vitamin A only)




Severson et al, 1989166
Hsing etal, 1990167
Le Marchand et al, 1994188





Deneo-Pellegrini et al, 1999130 (Vitamin A only)
Mills etal, 1989165
Severson etal, 1989166
Hsing et ai, 1990167
Le Marchand et al, 1994168
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Table 3.8, cont.: Methodology criteria and omitted studies
Criteria Studies not fulfilling criteria and which were
subsequently omitted from review
6. ORs / RRs adjusted for energy intake (or an equivalent Graham et al, 1983125
judgement of energy intake, i.e. BMI, height, weight). Kolonel etal, 1987163
Ohno etal, 1988119
Oishi et al, 1988154
Bravo et al, 1991120
La Vecchia et al, 1991160
Walker et al, 1992161 i
Tavani etal, 2001164
Mills etal, 1989165
Severson et al, 1989166
Hsing etal, 1990167
Le Marchand et al, 1994168
Chan et al, 200183 (calcium only)





Vlajinac et al, 1997122
Rodriguez et al, 2003169 (calcium only)
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3.3.5 Meat products
Total meat
A total of ten case-control studies, one nested case-control study and one cohort
study examined the association between total meat intake and PCa. The findings
from these studies are summarised in Table 3.9. Most studies reported positive
associations128'130'161'170'171 two ofwhich were significant / borderline significant (OR
1.4, 95%CI 1.0-2.0161, OR 1.4, 95%CI 1.0-2.0171 and OR 1.4, p< 0.05128), Talamini
et al161 also reported an even stronger significant association in older men (OR 2.1,
1
95%CI 1.0-4.0). Berndt et al examined the association between animal protein
and PCa, no association was observed.
Three studies also examined the relationship between meat intake and advanced PCa,
both Chan et al171 and Hayes et al128 continued to observe significant positive
associations (OR 1.6, 95%C.I. 1.02-2.5, and OR 1.8, p<0.05, respectively), whilst
Michaud et al173 continued to observe no association.
Red meat
A total of three case-control studies and two cohort studies examined the association
between red meat consumption and PCa. The findings from these studies are
summarised in Table 3.9. The majority of case-control studies reported positive
associations128'130, one ofwhich was significant (OR 1.4, p<0.05)128. However this
association was not reported in the two cohort studies which reported no significant
associations82'173.
Both of the two studies that examined the association between red meat and
advanced PCa reported a positive association128'173, one ofwhich was significant (OR
1.8, p<0.05)128.
Individual meat items
Most of the studies also examined a variety of individual meat items including beef,
pork, poultry, fish, white meat and processed and cured meats. None ofwhich
reported any significant associations with the exception of Jain et al174 who reported
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a borderline significant inverse association between fish consumption and PCa risk
(OR 0.7, 95 %CI 0.5-1.00) and Schuurman et al94 who reported a borderline positive
association with cured meat (OR 1.4, 95%CI 1.0-1.9).
Cooking method and heterocyclic amines
Two case-control studies examined the association between cooking methods and
PCa. Key et al observed no association between grilled / roasted meat and PCa,
whereas Norrish et al175 observed negative non-significant associations between meat
doneness and PCa for both all cases and advanced cases, but no association with
heterocyclic amines and PCa.
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Table 3.9: Summary of results from epidemiological studies of meat products and PCa
Study, year,
location




Talamini et 271 Cases Meat Men aged 45 - 79 yrs.
al'61 685 Hospital All 1.4(0.97-2.0) Stratified by age.
1992 Controls <70yrs 1.3(0.8-2.0) ORs adjusted for age,













Ewings et 159 Cases Meat 2.7(0.5-15.8) Adjusted ORs not presented as
al170 161 BEP Controls Meat Products 0.7(0.3-1.3) similar to crude ORs.
1996 164 Hospital Liver 0.6(0.3-1.2) Age matched.
UK Controls
Gronberg et 406 Cases Beef 0.6 (0.3-1.3) ORs adjusted for age.
al176 1218 Population Pork 1.2 (0.7-2.0) Age matched.
1996 Controls Sausage 0.8 (0.5-1.5) Data collected prospectively.
Sweden Fish 0.99 (0.6-1.7)
Key et al132 328 Cases Meat 0.6 (0.4-1.1) Men aged <75 yrs.
1997 328 Population Roasted / Grilled ORs adjusted for El & SES.
England Controls Meat 1.1 (0.5-2.5) Age frequency matched.
Chan et al171 526 Cases Meat Men aged < 80 yrs.
1998 536 Population All 1.4(1.0-2.0) ORs adjusted for El, age,
Sweden Controls Adv 1.6(1.0-2.5) FHPCa & smoking.
Age frequency matched.
Deneo- 175 Cases Total Meat 1.6(0.8-3.4) Men aged 40-89 yrs.
Pellegrini et 233 Hospital Red Meat 1.7(0.8-3.4) ORs adjusted for age, El, BMI,
al130 Controls White Meat 0.9(0.5-1.8) education, residence & FHPCa.
1999 Poultry 1.3 (0.7-2.4) ORs became n/s when
Uruguay Fish 0.9 (0.5-1.8) controlled for El.
Processed Meat 0.8 (0.4-1.4)
Offal 1.1 (0.6-1.9)
Hayes et al128 932 Cases Meat Men aged 40-79 yrs.
1999 1201 Population All 1.4 (p< 0.05) ORs adjusted for age & race,
USA Controls Adv 1.8 (p<0.05) El adjusted ORs not presented.
Red Meat Age frequency & race & region





Jain et al174 617 Cases Red Meat 1.02 (0.7-1.4) ORs adjusted for age & El.
1999 636 Population Chicken 0.98 (0.7-1.4) Age frequency matched.
Canada Controls Fish 0.7(0.5-1.00)
Cont.
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Men aged 40-80 yrs.
ORs adjusted for age, El & SES.
Age frequency matched.
Doneness = well-done meat Vs





























Men aged 50-74 yrs.
ORs adjusted for age, residence,
smoking, BMI, other food grps,
income & FHPCa.
Age frequency matched.
Men aged < 70 yrs
ORs adjusted for: El (residual), age,

















ORs adjusted for age, FHPCa &
SES.









Red Meat 0.7(0.5-1.1) Men aged 50-69 yrs at baseline.
RRs adjusted for age, El, intervention
arm, smoking, education & BMI.



















Men aged 40-75 yrs.
RRs adjusted for age.






Animal Protein 1.1 (0.6-2.0) Men aged 46 - 92 yrs.
RRs adjusted for age & El.













Men aged 40-75 yrs
RRs adjusted for age, El, fat, lycopene,
retinol, Vit D & physical activity
Health Professionals Follow-up Study.
N.B
s Odds / Risk ratio for highest relative to lowest percentile, except where stated
c Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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3.3.6 Dairy products
Total Dairy products
The majority of the five case-control studies and four cohort studies that examined
the association between total dairy product consumption and PCa reported no
association82'128'141'142'169'173, see Table 3.10. However, two studies by Chan et al83'171
reported borderline significant positive associations between dairy products and PCa
risk (OR 1.5, 95%C.I. 1.01-2.2171 and OR 1.3, 95%C.I. 1.04-1.783).
Four studies also examined the relationship between dairy product consumption and
1 ?R-1M-1 71 'ITT
advanced PCa ' ' ' , two ofwhich reported borderline significant positive
associations (OR 1.6, 95%C.I. 1.0-2.6171 and OR 1.4, 95%C.I. 1.0-1.8173).
Milk
Most of the five case-control studies, one nested case-control study and two cohort
studies that examined the association between milk consumption and PCa reported a
significant / borderline significant association (OR 2.5, 95%CI 1.3-4.9178, OR 1.6,
95%C.I. 1.1-2.4161, OR 1.4, 95%CI 1.0-1.9174 and OR 1.6, 95%C.I. 1.2-2.196), see
Table 3.10. Mettlin et al178 also examined semi-skimmed milk and skimmed milk
consumption, a non-significant positive association and no association was observed
respectively. Talamini et al161 also reported borderline significant positive
associations in younger (OR 1.7, 95%CI 1.0-2.8) and older men (OR 1.9, 95%CI 1.0-
3.8), whereas Giovannucci et al96 reported a significant positive association between
milk consumption and advanced PCa (OR 1.8, 95%C.I. 1.2-2.8).
Other individual dairy items
The majority of the six case-control studies, one nested case-control study and four
cohort studies reported no significant association between individual dairy items and
PCa risk, with the exception of Jain et al174 who reported a borderline significant
negative association between cream and PCa risk (OR 0.8, 95%CI 0.7-1.0) and
Hodge et al141 who reported significant positive associations between PCa risk and
eggs (OR 1.2, 95%CI 1.0-1.6) and margarine (OR 1.3, 95%CI 1.0-1.7). No studies
investigated the association between individual dairy items and advanced PCa.
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Table 3.10: Summary of results from epidemiological studies of dairy products and PCa
Study, year,
location




Mettlin et al178 371 Cases Whole Milk 2.5(1.3-4.9) ORs adjusted for age &
1989 371 Hospital 2% Fat Milk 1.5 (0.4-1.2) residence.
USA Controls Skimmed Milk 0.9 (0.4-2.2)
Talamini et 271 Cases Milk Men aged 45 - 79 yrs.
al161 685 Hospital All 1.6(1.1-2.4) Stratified by age.
1992 Controls <70yrs 1.7(1.0-2.8) ORs adjusted for age,

















Ewings et 159 Cases Total Milk 0.95 (0.5-1.8) Adjusted ORs not presented as
al170 161 BEP Controls Type of Milk: similar to crude ORs.
1996 164 Hospital Skimmed 1.0 (ref) Age matched.
UK Controls Half Fat 0.3(0.1-0.7)
Full Fat 0.7(0.4-1.2)
Fresh Cream 0.6 (0.2-1.8)
Eggs 0.6(0.2-1.8)
Gronberg et 406 Cases Milk 0.8(0.5-1.6) ORs adjusted for age.
al176 1218 Population Eggs 0.9 (0.5-1.5) Age matched.
1996 Controls Data collected prospectively.
Sweden
Chan et al171 526 Cases Dairy Men aged < 80 yrs.
1998 536 Population All 1.5(1.0-2.2) ORs adjusted for El, age,
Sweden Controls Adv 1.6(1.0-2.6) FHPCa & smoking.
Age frequency matched.
Deneo- 175 Cases Dairy Foods 0.8(0.4-1.6) Men aged 40-89 yrs.
Pellegrini et 233 Hospital Eggs 1.4 (0.7-2.6) ORs adjusted for age, El, BMI,
al130 Controls education, residence & FHPCa.
1999
Uruguay
Hayes et al128 932 Cases Dairy Foods Men aged 40-79 yrs.
1999 1201 Population All 1.2 (n/s) ORs adjusted for age & race,
USA Controls Adv 1.4 (n/s) El adjusted ORs not presented.
Age frequency & race & region
matched.
Cont.
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Men aged < 70 yrs
ORs adjusted for: El (residual), age,
















ORs adjusted for age, FHPCa &
SES.












Men aged > 25 yrs at baseline.
RRs adjusted for age.













RRs adjusted for age.
Analysis omitting latent PCa not






































Men aged 40-75 yrs at baseline.









Dairy Products 1.1 (0.7-1.7) Men aged 50-69 yrs at baseline.
RRs adjusted for age, El,
intervention arm, smoking,
education & BMI.
Cohort study from the ATBC RCT
study.
Cont.
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Dairy Products 1.3 (1.0-1.7) Men aged 50-69 yrs at baseline.
RRs adjusted for age, intervention
arm, smoking, exercise & BMI.














Men aged 40-75 yrs.













Men aged 46 - 92 yrs.
RRs adjusted for age & El.













Men aged 50-74 yrs




s Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls, n/s = non-significant,
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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3.3.7 Calcium intake
All of the five case-control studies, one nested case-control study and three cohort
studies that examined the association between calcium intake and PCa found no
171
significant association, see Table 3.11, with the exception of Chan et al and
Giovannucci et al96 who reported significant positive associations between calcium
and PCa risk (OR 1.9, 95%C.I. 1.2-3.0171 and OR 1.7, 95%C.I. 1.2-2.596).
Five studies also examined the relationship between calcium intake and advanced
PCa. The majority of these studies observed significant / borderline significant
positive associations (OR 2.1, 95%C.I. 1.3-3.6171, OR 2.1, 95%C.I. 1.0-4.4136 and
OR 3.0, 95%C.I. 1.6-5.596).
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Men aged < 80 yrs.














Men aged 40-79 yrs.
ORs adjusted for age & race,
El adjusted ORs not presented.



















Calcium 0.7(0.5-1.1) Men aged < 80 yrs.
ORs adjusted for age, El, BMI,
FHPCa & residence.








Calcium 1.2 (0.8-1.9) Men aged < 79yrs.
ORs adjusted for age, BMI,













ORs adjusted for El, age race
















ORs adjusted for age, FHPCa &
SES.
Case - Cohort approach.
Netherlands Cohort Study.
Cont.
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Men aged 40-75 yrs at baseline.















Men aged 50-69 yrs at baseline.
RRs adjusted for age, El,
intervention arm, smoking,
education & BMI.







Calcium 1.3(1.1-1.6) Men aged 50-69 yrs at baseline.
RRs adjusted for age,
intervention arm, smoking,
exercise & BMI.







Calcium 0.9(0.5-1.8) Men aged 46 - 92 yrs.
RRs adjusted for age & El.













Men aged 50-74 yrs
RRs adjusted for age, El,
education, FFIPCa, race & fat
CPS-II Nutrition Cohort
N.B
s Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls, n/s = non significant
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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3.3.8 Retinol
All of the seven case-control studies, one nested case-control study and one cohort
study that examined the association between retinol intake and PCa reported no
o
significant association, with the exception of Giovannucci et al who reported a
significant positive association (OR 1.3, 95%C.I. 1.0-1.7), see Table 3.12. Three
case-controls studies also examined vitamin A intake (i.e. the combined intake of
retinol and pro-vitamin P-carotene) all of which reported no significant
associations131'133'137.
Andersson et al131 and Schuurman et al95 also examined the relationship between
retinol / vitamin A intake and advanced PCa, as with the findings for the total PCa
cases, no significant associations were observed.
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Men aged < 80 yrs.













Men aged 35-84 yrs.
ORs adjusted for age, El &
FHPCa.








Retinol 0.9 (0.6-1.3) Men aged <75 yrs.









Vitamin A 1.0 (0.5-2.0) Men aged > 45 yrs.
ORs adjusted for age, El, study







Retinol 1.0 (0.8-1.4) ORs adjusted for age, El,
smoking, vasectomy, BMI,







434 Hosp / Pop
Controls
Retinol 1.2 (0.9-1.6) Men aged < 80 yrs.
ORs adjusted for age, El, BMI,
FHPCa, residence & fat intake.








Retinol 1.1 (0.8-1.5) Men aged < 70 yrs
ORs adjusted for: El (residual),
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Table 3.12, cont.: Summary of results from epidemiological studies of vitamin A and
retinol intake and PCa
Study, year,
location

















Men aged 55-69 yrs at baseline.
RRs adjusted for age, SES,
FHPCa & alcohol.
El & fat adjusted RRs not reported
as El & fat was shown not to be
associated with PCa.










Retinol 1.3 (1.0-1.7) Men aged 40-75 yrs at baseline.
RRs adjusted for age & El.
Adv PCa analysis: results not




J Odds / Risk ratio for highest relative to lowest percentile, except where stated
c Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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3.3.9 Discussion
The evidence gathered from this systematic literature review is consistent with
previous reviews and suggests that some animal products, in particular meat, red
meat and milk play important roles in the aetiology ofPCa. However, no strong
evidence for an affect of either of the reported associated nutrients or cooking
methods and heterocyclic amines on PCa risk was found, although the evidence does
suggest that high calcium intake is associated with advanced PCa. Furthermore,
several possible biological mechanisms that demonstrate a carcinogenic effect of
meat and dairy product constituents other than animal fat have been proposed.
With the exception of calcium and retinol, the compounds in animal products, other
than animal fat, that are responsible for this association remain largely unknown. It is
therefore important that further study of these animal products and their components,
including the covariance with other dietary factors such as vegetables and plant-
based nutrient, is done. This should not only be in the form of epidemiological
studies, but also laboratory and animal model studies that will allow us greater
understanding of the components and biological mechanisms involved, in particular
the suggested role of heterocyclic amines and polycyclic aromatic hydrocarbons and
the vitamin D metabolic pathway.
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3.4 Fruits and vegetables and their associated nutrients
3.4.1 Introduction
The consumption of fruit and vegetables is generally seen as health promoting and
has been recommended over the years in the prevention ofmany diseases including
cancer. There are many biologically plausible reasons for the suggested protective
role that fruit and vegetable intake plays in the aetiology of cancer. These include
the presence in such foods ofpotentially active anticarcinogenic nutrients,
antioxidants and phytochemicals such as the carotenoids, vitamin E, vitamin C,
phyto-oestrogens and selenium. However, despite many recent studies, their specific
role and that of their components in PCa aetiology still remains unclear. As fruit and
vegetable consumption has been discussed previously in Chapter 2, this section will
concentrate on the background of the types of vegetables and the nutrients found in
fruit and vegetables, including their role in PCa aetiology in addition to a systematic
review of the literature.
3.4.2 Types of vegetables and fruits
Vegetables can be grouped into several categories, including cruciferous vegetables
(also known as brassicas and include broccoli, cauliflower and Brussels sprouts),
Allium vegetables (onions, garlic, chives and leeks) and leafy green vegetables
(spinach and lettuce). Whereas fruits tend to be grouped together, with the exception
of citrus fruits (oranges, grapefruits and lemons). The role that fruit and vegetables
play in the aetiology ofPCa has been suggested to vary according to type, as the kind
and amount of individual plant-based nutrients tend to vary across these fruit and
vegetable types.
3.4.3 Soy Foods
Soy / soya foods, although not exactly a vegetable or fruit have been included in this
section for simplicity. Soy foods, as the name suggests, are made from soya beans
that are the seeds of the leguminous soya bean plant. Soy foods include tofu, tempeh,
textured vegetable protein, miso, soya sauces, soya oil and margarine, and soya dairy
alternatives. They are a source of non-animal protein, making them a suitable
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alternative to animal products, and contain phyto-oestrogens which are bio-active
compounds that may have possible anti-carcinogenic activity, see section 3.4.8.
3.4.4 Carotenoids
Carotenoids are fat-soluble pigments synthesised by plants and are widespread in
nature, with over 600 different types of carotenoids have been identified. They can
be classified into two main groups: Carotenes, which include a-carotene, P-carotene
and lycopene; and Xanthophylls, which include lutein, zeaxanthin and P*
i n(\
cryptoxanthin . The specific carotenoids mentioned above account for the majority
of carotenoid dietary intake and are found in detectable concentrations in human
blood and tissues180.
P-carotene is the most abundant carotenoid and is found in orange vegetables and
fruits, such as carrots, pumpkins and melons, and in dark green leafy vegetables.
Carrots are also a rich source of a-carotene, along with avocados, whereas lycopene
is found in tomatoes and tomato products. The predominant carotenoids in spinach,
kale and other greens are the xanthophylls, especially lutein, whilst cryptoxanthin is
found in large amounts in red peppers and pumpkins.
As summarised in Table 3.13, the average daily intake of carotenes (from food
sources only, p-carotene equivalents) in the UK is 2041 pg and 2128pg for men aged
19-64 years in the UK and Scotland respectively47, whereas daily carotene intake in
men aged > 65 years is 1951 pig and 1948pg in the UK and Scotland respectively105.
In the USA mean daily carotene intakes (expressed as retinol equivalents) were
estimated at 544pg and 632pg for men aged > 20 years and > 70 years
respectively106. In China, mean daily intake of carotenoids in men was estimated to
be 1600pg107, whilst in other parts of Asia, the average daily consumption of P-
carotene is estimated to be about 3300pg/day42.
Unlike other carotenes, P-carotene is a precursor to vitamin A known as pro-vitamin
A. Along with pre-formed retinol, it is metabolised by the body to form retinol /
vitamin A, due to this P-carotene is sometimes measured in retinol equivalents (the
sum of vitamin A provided by preformed retinol and carotenoids1). Evidence from
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the early epidemiological studies investigating an inverse association between
vitamin A intake and cancer including PCa reported this association to be stronger
for dietary carotenoids than for prefonned retinol98'154. This gave rise to the
hypothesis that P-carotene, along with the other carotenoids, may be a protective
dietary factor in its own right, and not simply as a precursor of retinol (a nutrient
essential for normal growth of the prostate)181.
Carotenoids act as antioxidants in tissues by deactivating free radicals and protecting
cells from oxidative damage42. Other possible anti-carcinogenic effects of
carotenoids may derive from their influence on immune function and growth
regulation mediated by gap-junction communication179.
In recent years, research has begun to focus on other carotenoids, especially lycopene
o
which has been specifically hypothesed to be protective against PCa . As more
accurate and complete data on the content of carotenoids in foods has become
available over recent years, epidemiologists have been able to examine the
relationship between these individual carotenoids and the risk ofPCa.
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3.4.5 Vitamin E
Vitamin E is a fat-soluble vitamin, which occurs naturally in the form of several
compounds including a-tocopherol, P-tocopherol, y-tocopherol, 5-tocopherol and the
tocotrienols. a-tocopherol is the most biologically active of these components and is
also the most common source of vitamin E in food182. The major dietary source of
vitamin E are vegetable oils and margarines, other sources include nuts, whole
grains, seeds and green vegetables, such as asparagus and lettuce. As summarised in
Table 3.13, the average daily intake of vitamin E (from food sources only) in the UK
is 10.6mg and 9.0mg for men aged 19-64 years47 and > 65 years105 respectively,
where as in Scotland the average daily intake of vitamin E is slightly higher at
11.4mg and 9.4mg for men aged 19-64 years47 and > 65 years105 respectively. This is
similar to that observed in other Western Countries, especially the US106 and also Far
Eastern countries such as China, although intake is reported to vary widely by
107
region .
Vitamin E has been hypothesised to protect against chronic disease, including cancer,
due to its strong antioxidant properties and positive effects on immune function. A
major function of vitamin E involves its role as an intracellular antioxidant,
preventing oxidative damage to cell membrane lipids and also DNA damage42.
Interest in the potential protective effects of vitamin E first arose from the Alpha-
Tocopherol Beta-Carotene Cancer Prevention Study183. This RCT, although designed
primarily to test the hypothesis that vitamin E and P-carotene would reduce lung
cancer risk, reported a negative association between the risk of PCa and the intake of
vitamin E, thereby generating the hypothesis that vitamin E is protective against
PCa183. Recently, y-tocopherol has been suggested to have a similar if not stronger
o c
protective effect against PCa as a-tocopherol .
3.4.6 Vitamin C
Vitamin C, also known as ascorbic acid, is a water soluble vitamin found in
vegetables, such as broccoli, cabbage, potatoes and fruits, especially citrus fruits. As
summarised in Table 3.13, the average daily intake of vitamin C (from food sources
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only) in the UK is 83.4mg and 66.9mg for men aged 19-64 years47 and > 65 years105
respectively, where as in Scotland the average daily intake of vitamin E is 86.4mg
and 60.3mg for men aged 19-64 years47 and > 65 years105 respectively. These intakes
are far smaller than in the US where mean daily vitamin C intakes were estimated at
109mg and lOlmg for men aged > 20 years and > 70 years respectively106.Vitamin C
is a strong anti-oxidant and protects against damage from free radicals. It has also
been observed to inhibit the growth ofPCa cells in vitro by creating reactive oxygen
species that kill these tumor cells184.
3.4.7 Selenium
Selenium is an essential non-metal trace element that occurs in foods such as grains,
fish, meat and dairy products, mainly as organic compounds having entered the food-
chain through plants. Selenium levels in foods are largely dependent on the soil
content in the region in which the original plant foods were grown. Hence dietary
selenium intake varies substantially across populations. In Southern England, the
average daily intake of selenium in a group of elderly men and women was reported
1 X ^
as being approximately 65pg . N.B. The National Diet and Nutrition Surveys
47,105,145 not estimate selenium intake. In the US, the average daily intake of
selenium is 129.6pg and 100.9pg for men aged > 20 years and > 70 years
respectively106, whilst in China the average daily intake of selenium is only
42.3pg107, see Table 3.13. UK selenium intake has declined by about 50% since the
UK joined the EU in the 1970s which caused imports ofhigh-selenium North
186American wheat to be replaced with low-selenium European Union (EU) wheat .
Selenium has antioxidant properties and has been demonstrated to inhibit
187
proliferation ofmalignant cells and tumour growth in in-vitro and in-vivo studies .
Selenium is a cofactor for the antioxidant enzyme glutathione peroxidase, which
1 Q*J
protects DNA and cell membranes from peroxide damage . Selenium is also
i o/r
needed for normal testosterone metabolism .
Until recently, there had been only sparse data on selenium intake and risk of PCa.
Current interest in the protective effect of selenium on PCa arose from the findings
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of the National Prevention of Cancer Trial188. This RCT, although primarily designed
to examine the affect of selenium on the re-occurrence of non-melanoma skin cancer,
reported an inverse association between selenium supplementation and PCa risk,
thereby generating the hypothesis that selenium is protective against PCa.
3.4.8 Phyto-oestrogens
Foods of plant origin contain many bioactive compounds in addition to those
micronutrients and minerals discussed above. These include a group of polyphenolic,
phytochemical compounds called the phyto-oestrogens. As the name suggests these
are chemicals found in plants that possess a oestrogenic affect (albeit a weak one).
There are two main groups of phyto-oestrogens: The isoflavones, which include
daidzein and genistein and their respective metabolites, equol and p-ethylphenol; and
the lignans, the plant precursors ofwhich, matairesinol (MAT) and
secoisolariciresinol (SECO) are metabolised after ingestion by intestinal bacteria into
the lignan mammalian forms of enterolactone and enterodiol respectively.
Isoflavones are found mainly in soya beans in the form of glycoside conjugates, the
content ofwhich varies depending on the time and location of the harvest, as well as
tx • i QQ-1 on
the variety of the soya bean itself ' ' . Lignans, in the form of their precursors,
are found in a wide variety ofplant foods, including cereals, grains, fruits and
vegetables, the richest source being linseed191'192.
Phyto-oestrogens have numerous biological properties including antiviral, anti-
1
angiogenic and antioxidant properties. As reviewed by Griffiths et al , phyto-
oestrogens possess weak oestrogenic activity, in which they compete with oestradiol
for binding to the nuclear oestrogen receptor and also stimulate the synthesis of sex
hormone binding globulin (SHGB) which in turn mediates the plasma levels of
testosterone for which the growth, development, maintenance and function of the
prostate gland is dependant on. Phyto-oestrogens can also inhibit steroid
metabolising enzymes, including: 5a-reductase, Aromatase and also Tyrosine-
specific protein kinases, which are necessary for the function of several growth factor
receptors.
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The observation that Chinese and Japanese populations, that consume relatively large
amounts of soya, have relatively low rates of clinical PCa compared to western
countries has led to the generation of the hypothesis that phyto-oestrogens are
protective against PCa194. However, up until recently relatively few studies have
examined this association. Although new developments in high-performance liquid
chromatography (HPLC), allowing greater accuracy in the determination of phyto-
oestrogen levels in both food and body fluids such as blood and urine, has allowed
for more studies to be undertaken to test this hypothesis.
At present, several published food composition tables for phyto-oestrogens are
available 71'189'190>192;19S"197j however these tables are far from complete, in particular
for the lignan precursors, and have the additional caveats of variations ofphyto-
oestrogen levels in foods not only due to the variation of soya content in soya-based
foods (which is often hidden) and processing methods, but also due to variety and
location of soya bean harvests73'74.
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3.4.9 Literature review
The following section will discuss the findings of recent studies investigating the
effect of fruit and vegetables and their associated nutrients on PCa risk.
Review papers and meta-analyses
Several recent papers have reviewed the association between PCa and fruit and
vegetable consumption and the intake of associated nutrients184'198'199. Although the
majority of these reviews discussed in depth the available evidence, not one of them
gave a systematic and complete review of all studies. The consensus among these
reviews was that there is reasonable, though inconsistent, evidence for a protective
effect of vegetables and some of its associated nutrients, such as lycopene, vitamin E,
selenium and phyto-oestrogens, whereas fruit consumption and vitamin C is not
substantially related to PCa risk. To date, only one meta-analysis has been
undertaken to examine the effect of tomato product and lycopene intake on PCa
risk104, for which combined relative risks of eleven case-control studies and ten
cohort studies / nested case-control studies were 0.89 (95%CI 0.80-1.00) and 0.81
(95%CI 0.71-0.92) for raw and cooked tomato products respectively; whereas the
combined relative risk for lycopene intake was 0.89 (95%CI 0.81-0.98).
A total of forty-nine analytical epidemiological studies have been identified that
examine the association between fruit and vegetables and plant-based nutrients and
PCa. Of these, twenty were omitted from the literature review for not fulfilling the
methodology criteria, see Table 3.14. An additional two studies that examined both
fruit and vegetables and their associated nutrients, were omitted from the review of
the plant-based nutrients, but were included in the food group review due to not
fulfilling the diet assessment and food table criteria which is an important criteria for
nutrient analyses but not so for food group analyses. The remaining studies included
nineteen case-control studies, two nested case-control studies and seven cohort
studies.
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Table 3.14: Methodology criteria and omitted studies
Criteria
Studies riot fulfilling criteria and which were
subsequently omitted from review
Study size appropriate for study design, statistical
power and/or diet assessment method.
PCa cases histologically or pathologically confirmed.
Use of validated dietary assessment method.
Ohno et al, 19881la
Oishi et al, 1988154
Bravo etal, 1991120
Negri etal, 1991200

















Le Marchand et al, 1991206
Negri etal, 1991200
West et al, 199198
Vlajinac et al, 1997122
Lee etal, 1998123
Hayes et al, 1999128 (carotenoid intake only)
Lu etal, 2001162
Mills etal, 1989165
Severson et al, 1989166
Hsing etal, 1990167
Shibata etal, 1992205
Le Marchand et al, 1994168
Parker etal, 1999203
Dietary assessment method contains an appropriate
number of food items to estimate nutrient intake
accurately.
Ross et al, 1987124
Ohno etal, 1988119
Oishi et al, 1988154
Mettlin etal, 1989178
Bravo etal, 1991120
Le Marchand et al, 1991206
Negri etal, 1991200
Deneo-Pellegrini et al, 1999130 (carotenoid intake
only)




Hsing et al, 1990167
Shibata etal, 1992206
Le Marchand et al, 1994168
Parker etal, 1999203
Cont.
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Table 3.14, cont.: Methodology criteria and omitted studies
Criteria
Studies not fulfilling criteria and which were
subsequently omitted from review
Nutrient intake individually calculated using accurate,





Bravo et al, 1991120
Le Marchand etal, 1991206
Negri et al, 1991200





Le Marchand et al, 1994168
Daviglus etal, 1996202
Parker etal, 1999203
ORs / RRs adjusted for energy intake (or an equivalent





Oishi et al, 1988154
Mettlin et al, 1989178
Bravo et al, 1991120
Le Marchand et al, 199121





Le Marchand et al, 199411
ORs / RRs adjusted for age. Ross etal, 1987124
Oishi etal, 1988154
Bravo etal, 1991120
Vlajinac et al, 19971'
Lee etal, 1998123
Knekt etal, 1990204
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Fruit and vegetable consumption
A total of twenty studies have examined the association between the intake of plant-
based foods and PCa, see Table 3.15.
The majority of the seven case-control studies, one nested case-control study and two
cohort studies that examined the effect of total vegetables on PCa risk reported
inverse associations, of which three were shown to be significant / borderline
significant (OR 0.9, 95%CI 0.5-0.9207, OR 0.7, 95%CI 0.6-l.O208 and OR 0.7, 95%CI
0.5-1.0141). Whereas for fruit consumption, including citrus fruit, most of the eight
case-control studies, one nested case-control studies and two cohort studies reported
positive associations including four shown to be significant the ORs of which ranged
from 1.3 (95%CI 1.0-1.8)92 and 1.5 (95%CI 1.1-2.0)174. It is therefore hardly
surprising that two studies examining combined fruit and vegetable consumption
reported no association209"10. Two studies also examined the association between
vegetable and fruit consumption and advanced PCa, Hayes et al128 continued to
report no association, whereas Kolonel et al208 reported a borderline significant
inverse association for total vegetables (OR 0.7, 95%CI 0.5-1.0), but no association
with total fruits.
Cruciferous / brassica vegetables
Six studies also investigated the association between cruciferous / brassica
vegetables and PCa risk, two ofwhich reported a significant inverse association (OR
0.5, 95%CI 0.4-0.8207 and OR 0.8, 95%CI 0.6-1.0208). Kolonel et al208 also reported a
significant association with advanced PCa (OR 0.6, 95%CI 0.4-0.8), whereas
Giovannucci et al209 reported no association.
Allium vegetables
Four case-control studies investigated the association between allium vegetables and
PCa risk, the majority of which reported significant inverse associations, two of
which were significant (ORs 0.5, 95%CI 0.3-0.8)211 and 0.7, 95%CI 0.5-0.9141).
211
Hsing et al also examined individual types of alliums, significant inverse
associations were reported for garlic (OR 0.5, 95%CI 0.3-0.7) and scallions (OR 0.3,
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95%CI 0.2-0.5), significant inverse associations were also reported for advanced
PCa.
Leafy green / green vegetables
The most of the eight studies that examined leafy green / green vegetables reported
no significant associations, with the exception of Jain et al174 and Key et al132 who
reported significant inverse associations with green vegetables (OR 0.5, 95%CI 0.4-
0.7) and peas (OR 0.4, 95%CI 0.1-0.9) respectively.
Tomatoes and tomato products
Many of the eight case-control studies and two cohort studies reported significant
inverse associations with both tomatoes and tomato products, RRs ofwhich ranged
from 0.6 (95%CI 0.5-0.9)174 to 0.8 (95%CI 0.6-0.9)97. These associations were also
reported in advanced PCa (ORs 0.5, p<0.05128, 0.5, 95%CI 0.2-1.0s and 0.7, 95%CI
0.4-1.097).
Soy foods
Inverse associations were reported in all four studies that examined soy products, the
majority ofwhich were significant (OR range: 0.3, 95%CI 0.1-0.9212 to 0.6, 95%CI
0.4-0.9208)
Other individual vegetable items
Significant inverse associations were also reported for baked beans (OR 0.5, 95%CI
0.3-0.8132), legumes (OR 0.7, 95%CI 0.5-0.9174) and carrots (OR 0.7, 95%CI 0.5-
1.0207 and OR 0.6, 95%CI 0.5-0.8208).
Dietary Factors: Fruits and vegetables page 94
Prostate Cancer & Diet








Talamini et 271 Cases Total Vegetables 1.4 (0.9-2.2) Men aged 45-79 yrs.
al161 685 Hosp Total Fruit 1.4 (1.0-2.1) ORs adjusted for age,
1992 Controls education, residence & BMI.
Italy
Ewings et 159 Cases Carrots 1.2 (0.3-4.5) Adjusted ORs not presented as
al170 161 BEP Leafy Green Veg 0.4(0.1-1.5) similar to crude ORs.
1996 Controls Peas & Beans 1.1 (0.2-7.5) Age matched.
UK 164 Hosp
Controls
Key et al132 328 Cases Carrots 0.8 (0.4-1.4) Men aged <75 yrs
1997 328 Pop Leafy Green Veg 1.2 (0.8-1.9) ORs adjusted for SES.
England Controls Onions 0.9 (0.5-1.5) Age frequency matched.
Garlic 0.6 (0.4-1.1)




Baked Beans 0.5 (0.3-0.8)
Citrus Fruit 1.5 (0.8-2.5)
Deneo- 175 Cases Fruit & Vegetables 0.5 (0.3-0.9) Men aged 40-89 yrs.
Pellegrini et 233 Hosp Vegetables 0.6 (0.3-1.1) ORs adjusted for age, El,
al130 Controls Fruit 0.8(0.4-1.4) residence, FHPCa & BMI.
1999 Legumes 1.1 (0.6-1.9)
Uruguay Tubers 1.6(0.8-3.1)
Hayes et al128 932 Cases Vegetables Men aged 40-79 yrs.
1999 1201 Pop All 1.0 ORs adjusted for age & race.
USA Controls Adv 1.1 Age frequency, race & region
Fruit matched.
All 1.1 95% C.l.s not reported, ORs







Jain et al174 617 Cases Total Vegetables 1.0 (0.7-1.3) ORs adjusted for age, El,
1999 636 Pop Total Fruit 1.5 (1.1-2.0) smoking, vasectomy, BMI &
Canada Controls Green Vegetables 0.5 (0.4-0.7) education.
Cruciferous 0.9(0.6-1.1) Age frequency matched.
Tomatoes 0.6(0.5-0.9)
Legumes 0.7(0.5-0.9)
Citrus Fruit 1.5 (1.1-2.0)
Villeneuve et 1623 Cases Total Fruit 1.5 (1.1-1.9) Men aged 50-74 yrs.
al134 1623 Pop Ctrls Total Vegetables 1.0(0.8-1.3) ORs adjusted for age,
1999 Yellow Green Veg 1.1 (0.7-1.6) residence, smoking, BMI, other
Canada Cruciferous 0.9 (0.7-1.1) food grps, income & FHPCa.
Tomatoes 1.0 (0.7-1.3) Age frequency matched.
Lentils & baked beans 1.0 90.7-1.4)
Tofu or Soybean 0.8(0.6-1.1)
Cont.
Dietary Factors: Fruits and vegetables page 95
Prostate Cancer & Diet
Table 3.15, cont.: Summary of results from epidemiological studies of fruits and
vegetables and PCa
Study, Subjects Food Group Odds / Risk Ratio5® Comments
year, (95% C.I.)
location
Cohen et al 628 Cases Tot Vegetables 0.7 (0.45-0.9) Men aged 40-64 yrs.
207
602 Pop Tot Fruit 1.1 (0.7-1.6) ORs adjusted for age, El, race,
2000 Controls Green Leafy Veg 0.8(0.4-1.7) PSA screening, FHPCa, BMI &
USA Cruciferous 0.5 (0.4-0.8) education.





Kolonel et 1619 Cases Total Vegetables Men aged < 84 yrs.
al208 1618 Pop All 0.7 (0.6-0.96) ORs adjusted for age, El, region,






















Norrish et 317 Cases Leafy Green Veg 0.9(0.6-1.3) Men aged 40-80 yrs.
al213 480 Pop Carrots 1.1 (0.7-1.7) ORs adjusted for age & El.
2000 Controls Raw Tomatoes 1.0 (0.6-1.5) Age frequency matched.
New Tomato Based Foods 0.8(0.5-1.2)
Zealand Adv PCa analysis: results not
reported as similar to all cases.
Hsing et 238 Cases Allium vegetables Men aged > 16 yrs
al211 471 Pop Ctrls All 0.5 (0.3-0.8) ORs adjusted for El & age
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Table 3.15, cont.: Summary of results from epidemiological studies of fruits and
vegetables and PCa
Study, year, Subjects Food Group Odds / Risk Ratio*® Comments
location (95% C.I.)
Lee at al214 133 Cases Tofu 0.6(0.4-1.0) Men aged 50-89 yrs
2003 265 Pop Ctrls Combined soy foods 0.5(0.3-0.9) ORs adjusted for El & age
China Age frequency & community
matched
Hodge et al141 858 Cases (> Vegetables 0.7(0.5-1.0) Men aged < 70 yrs
2004 gleason score 5) Alliums 0.7(0.5-0.9) ORs adjusted for: El (residual),
Austrailia 905 Pop Ctrls Legumes 0.8(0.6-1.0) age, study centre, year, FHPCa,
Fruit 1.1 (0.9-1.5) SES
Tomato Foods 0.8(0.6-1.0) Age frequency matched
Nested Case-Control Studies
Schuurman et 642 Cases Total Vegetables 0.8 (0.6-1.1) Men aged 55-69 yrs at baseline.
al92 1525 Subcohort Total Fruit 1.3(1.0-1.8) ORs adjusted for age, SES &
1998 Controls Leafy Vegetables 1.0(0.7-1.3) FHPCa.
Netherlands Brassicas 0.8 (0.6-1.1) Adv PCa analysis: results not
Alliums 0.9 (0.7-1.3) reported as similar to all cases.
Citrus Fruit 1.3 (0.9-1.7)
Pulses 0.7 (0.5-1.0) Nested case-cohort study from
Netherlands Cohort Study.
Cohort Studies
Mills et al165 14,000 Men Tomatoes 0.6 (0.4-0.9) Men aged > 25 yrs at baseline.
1989 Dried / Canned Beans, 0.5(0.3-0.8) RRs adjusted for age.
USA 180 Cases Lentils, & Peas
Citrus Fruit 0.5 (0.3-0.9) 7th Day Adventist Men.
Dried Fruit 0.5 (0.3-0.9)
Vegetarian Protein 0.7(0.4-1.1)
Products (soy rich)
Severson et 7,999 men Total Fruit 1.6(0.95-2.6) RRs adjusted for age.
al166 Tofu 0.4 (0.1-1.4)
1989 174 Cases
Hawaii
Hsing et al167 17,633 men Vegetables 0.7(0.4-1.2) RRs adjusted for age & tobacco.
1990 Fruit 0.9(0.6-1.4) Lutheran Brotherhood Cohort.
USA 149 fatal Cases Cruciferous 1.3 (0.8-2.0) PCa Mortality.
Giovannucci 47894 men Carrots 1.1 (0.7-1.6) Men aged 40-75 yrs at baseline.
et al8 Spinach 1.2 (0.9-1.7) RRs adjusted for age & El.
1995 773 non stage Broccoli 1.1 (0.8-1.3) Adv PCa analysis: most results
USA A1 Cases Tomato Sauce 0.7(0.5-0.9) not reported as similar to all
Tomatoes 0.7 (0.6-0.9) cases.
Tomato based products
All 0.7(0.4-1.0) Health Professionals Follow-up
Adv 0.5 (0.2-1.0) study.
Jacobsen et 12,395 men Soya milk 0.3 (0.1-0.9) Men aged > 25yrs at baseline
al212 RRs adjusted for: age, BMI,
1998 225 Cases coffee, milk, eggs & citrus fruit
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Table 3.15, cont.: Summary of results from epidemiological studies of fruits and
vegetables and PCa
Study, year, Subjects Food Group Odds / Risk Ratio8® Comments
location (95% C.I.)
Chan et al82 27,062 Men Vegetables 0.8 (0.5-1.3) Men aged 50-69 yrs at baseline.
2000 Fruit 1.3 (0.8-2.2) RRs adjusted for age, El, RCT
Finland 184 clinically arm, smoking, education & BMI.
apparent
Cases Cohort study from the ATBC
RCT study.
Giovannucci 47,365 Men Tomato Sauce Men aged 40-75 yrs at baseline.
et al97 All 0.8(0.6-0.9) RRs adjusted for age & El.
2002 2481 Cases Adv 0.7 (0.4-1.0)
USA Health Professional Follow-up
Study.
Giovannucci 47,365 men Total Fruit & Vegetables 1.1 (0.9-1.2) Men aged 40-75 yrs
et al209 Cruciferous RRs adjusted for age, El, BMI,
2003 2969 Non All 0.9 (0.8-1.1) height, smoking, FHPCa,
USA Stage A, Adv 1.1 (0.8-1.5) diabetes, activity, meat, a-
cases linolenic acid, Ca, tomato sauce.
Health Professionals Follow-up
Study.
Key et al210 130, 544 men Total fruit & vegetables 1.0(0.8-1.3) RRs adjusted for El, height, and
2004 from 7 Total Vegetables 1.0 (0.8-1.2) weight.
UK & Europe countries Total Fruit 1.1 (0.8-1.3) Stratified by centre
Cruciferous 1.0(0.8-1.2)
1,104 cases EPIC study
N.B
s Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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Carotenoids
Total carotenoids and carotenes
Inverse associations were reported in the majority of the four case-control studies
that investigated the association between total carotenoid and carotene intake and
PCa risk, see Table 3.16, one ofwhich was borderline significant (carotenes OR 0.7,
95%CI 0.4-1.0135).
f-Carotene
No significant association was observed in the eight case-control studies, one nested
case-control study and two cohort studies that investigated the association between
P-carotene intake and PCa, see Table 3.16, with the exception ofWu et al215 who
reported a borderline significant association with p-carotene intake in younger men.
Two studies also examined the association between P-carotene intake and advanced
PCa95'131, no significant associations were reported.
Lycopene
No significant associations were reported in the five case-control studies and one
nested case-control study that examined the association between lycopene intake and
PCa, see Table 3.16. However, the two cohort studies that examined this association
o
reported borderline significant inverse associations (RRs 0.8, 95%CI 0.6-1.0 and
0.8, 95%CI 0.7-1.097). Schuurman et al95 also examined the association between
lycopene intake and advanced PCa, no association was reported.
Other carotenoids
No significant associations were reported for other carotenoids, with the exception of
Schuurman et al95 who reported a borderline significant positive association between
P-cryptoxanthin and PCa/ advanced PCa (ORs 1.4, 95%CI 1.0-1.9 and 1.6, 95%CI
1.0-2.4, resectively) and Cohen et al207 who reported a borderline significant inverse
association with lutein + zeaxanthin (OR 0.7, 95%CI 0.5-1.0).
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Rohan et al137 207 Cases p-carotene 0.9(0.5-1.7)
1995 207 Pop Controls Other Carotenes 0.7(0.4-1.2)
Canada
Andersson et 526 Cases p-carotene
al131 536 Pop Controls All 0.9 (0.6-1.3)
1996 Adv 0.8 (0.6-1.2)
Sweden
Ghadirian et 232 Cases p-carotene 1.0 (0.6-1.8)
al138 231 Pop Controls Other Carotenes 1.1 (0.6-1.8)
1996
Canada
Key et al132 328 Cases Carotene 0.8 (0.6-1.2)
1997 328 Pop Controls Lycopene 1.0 (0.7-1.5)
England
Meyer et al133 215 Incidental p-carotene 1.0 (0.5-1.8)
1997 Cases a-carotene 1.0 (0.5-1.9)
Canada 593 Hosp Controls Lycopene 1.7(0.9-3.3)
Lutein 0.9 (0.4-1.7)
Jain et al174 617 Cases All Carotenoids 1.1 (0.8-1.5)
1999 636 Pop Controls p-carotene 1.1 (0.7-1.4)




Cohen et al 628 Cases Tot Carotenoids 0.8 (0.6-1.2)
207
602 Pop Controls p-carotene 0.7(0.5-1.1)
2000 a-carotene 0.8 (0.5-1.1)
USA Lycopene 0.9 (0.6-1.3)
Lutein+Zeaxanthin 0.7(0.5-1.0)
p-cryptoxanthin 0.9 (0.6-1.4)
Norrish et 317 Cases p-carotene 1.1 (0.7-1.6)




ORs adjusted for age, El &
FHPCa.
Age frequency matched.
Men aged < 80 yrs.
ORs adjusted for age & El.
Age frequency matched.
Men aged 35-84 yrs.
ORs adjusted for age, El &
FHPCa.
Age frequency & residence
matched.
Men aged <75 yrs.
ORs adjusted for SES.
Age frequency matched.
Men aged > 45 yrs.
ORs adjusted for age, El, study
group, FHPCa & education.
ORs adjusted for age, El,
smoking, vasectomy, BMI,
education & other nutrients.
Age frequency matched.
Men aged 40-64 yrs.
ORs adjusted for age, El, race,
PSA screening, FHPCa, BMI,
education & fat intake.
Age frequency matched.
Men aged 40-80 yrs.
ORs adjusted for age, El, height &
SES.
Age frequency matched.
Adv PCa analysis: results not
reported as similar to all cases.
Ramon et 217 Cases Carotenes 0.7 (0.4-1.0) Men aged < 80 yrs.
al135 434 Hosp / Pop ORs adjusted for age, El, BMI,
2000 Controls FHPCa, residence & fat intake.
Spain Age frequency & region matched
Hodge et al141 858 Cases p-carotene 0.8 (0.6-1.1) Men aged < 70 yrs
2004 905 Pop Ctrls a-carotene 0.8 (0.6-1.1) ORs adjusted for: El (residual),
Austrailia Cases > gleason Lycopene 0.8 (0.6-1.2) age, study centre, year, FHPCa,
score 5 Lutein+Zeaxanthin 0.9 (0.7-1.3) SES
P-cryptoxanthin 0.9 (0.7-1.3) Age frequency matched
Cont.
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Table 3.16, cont.: Summary of results from epidemiological studies of carotenoid intake
and PCa
Study, year, Subjects Intake Odds / Risk Ratio$® Comments
location Variable (95% C.I.)
Nested Case-Control Studies
Schuurman et 642 Cases
al95 1525 Controls
2002































































Giovannucci 47894 men p-carotene 1.1 (0.8-1.3)
et al8 a-carotene 1.1 (0.9-1.4)
1995 773 Non Stage Lycopene 0.8 (0.6-1.0)




47,365 Men Lycopene 0.8 (0.7-1.0)
Men aged 55-69 yrs at baseline.
RRs adjusted for age, SES, FHPCa &
alcohol.
El & fat adjusted RRs not reported as
El & fat was not shown to be
associated with PCa.
Nested case-cohort study from
Netherlands Cohort Study.
Men aged 40-75 yrs at baseline.
RRs adjusted for age, cholesterol,
selenium, vit E, FHPCa, BMI, height,
exercise, smoking & vasectomy.
Age & time matched.
Stratified by age group
Men aged 40-75 yrs at
baseline.
RRs adjusted for age & El.
Adv PCa analysis: results not




RRs adjusted for age, El, BMI
& other nutrients.
Adv PCa analysis: results not





5 Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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Vitamin E and tocopherol
No significant association was observed between vitamin E / tocopherol and PCa
risk, see Table 3.17, with the exception ofTzonou et al142 who reported a significant
inverse association with PCa risk (OR 0.5, 95%CI 0.3-0.9), no association was also
reported between vitamin E and advanced PCa95'131. Hartman et al81 also examined
the association between baseline vitamin E and tocopherol intake and PCa risk
straitified by a-tocopherol intervention arm within the ATBC RCT. Borderline
significant inverse associations were reported within the a-tocopherol arm for
vitamin E (OR 0.5, 95%CI 0.3-1.0) and y-tocopherol (OR 0.6, 95%CI 0.3-1.0),
whilst a borderline significant positive association was reported within the non-a-
tocopherol arm for 5-tocopherol (OR 1.5, 95%CI 1.0-2.2).
Vitamin C
No association between vitamin C and PCa risk was reported by the majority of the
nine case-control studies, one nested case-control study and one cohort study that
examined vitamin C, see Table 3.18. However, Ramon et al135 did report a significant
inverse association with PCa (OR 0.6, 95%CI 0.4-0.9). No association between
vitamin C and advanced PCa risk was also reported95'131.
Dietary Factors: Fruits and vegetables page 102
Prostate Cancer & Diet















Vitamin E No association ORs not reported













Men aged < 80 yrs.







Vitamin E 0.9 (0.6-1.4) Men aged <75 yrs.








Vitamin E 1.5 (0.8-2.8) Men aged > 45 yrs.







Vitamin E 1.1 (0.8-1.6) ORs adjusted for age, El, smoking,




















ORs adjusted for age, El, height, BMI
& education.
OR = per increment of 1 SD of daily
intake.
Age frequency matched
Men aged < 80 yrs.
ORs adjusted for age, El, BMI,
FHPCa, residence & fat intake.








Vitamin E 1.0 (0.8-1.4) Men aged < 70 yrs
ORs adjusted for: El (residual), age,















Men aged 55-69 yrs at baseline.
RRs adjusted for age, SES, FHPCa
& alcohol.
El & fat adjusted RRs not reported
as El & fat not associated with PCa.
Nested case-cohort study from
Netherlands Cohort Study.
Cont.
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Table 3.17, cont.: Summary of results from epidemiological studies of tocopherol &
vitamin E intake and PCa
Study, year,
location




Giovannucci 47894 men Vitamin E 0.9(0.8-1.2) Men aged 40-75 yrs at baseline.
etal8 RRs adjusted for age & El.
1995 773 Non Stage Adv PCa analysis: results not
USA A, Cases reported as similar to all cases.
Health Professionals Follow-up
study.
Hartman et 29,133 Men Vitamin E Men aged 50-69 yrs at baseline.
al81 (inc. supp.s) RRs adjusted for age, El,
1998 317 Cases Non-AT 1.2 (0.8-1.9) intervention arm & BPH.
Finland AT 0.5 (0.3-1.0) Straitified by a-tocopherol
a-tocopherol intervention arm, as significant
Non-AT 1.3 (0.8-2.1) effect modification by a-tocopherol
AT 0.7 (0.4-1.3) intervention was reported.
p-tocopherol
Non-AT 1.4 (0.9-2.3) Cohort study from the ATBC RCT








$ Odds / Risk ratio for highest relative to lowest percentile, except where stated.
® Odds / Risk ratios based on all PCa cases, except where stated.
All = All Cancers, Adv = Advanced cancers only, Agg = Aggressive cancers only.
OR = Odds Ratio, RR = Rate Ratio, El = Energy Intake, PCa = PCa, AT: a-tocopherol arm of ATBC Study, Non-AT:
Placebo arm for ATBC Study, SES = Socio-economic status, FHPCa = Family history of PCa, PSA = Prostate-
specific antigen.
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Vitamin C n/s ORs adjusted for age, El & FHPCa.
Age frequency matched.












Men aged < 80 yrs.








Vitamin C n/s Men aged 35-84 yrs.
ORs adjusted for age, El & FHPCa.
Age frequency & residence matched.






Vitamin C 1.2 (0.8-1.8) Men aged <75 yrs.








Vitamin C 1.1 (0.6-2.2) Men aged > 45 yrs.







Vitamin C 0.8(0.5-1.2) ORs adjusted for age, El, smoking,









Vitamin C 0.8 (0.5-1.1) Men aged 40-64 yrs.
ORs adjusted for age, El, race, PSA








434 Hosp / Pop
Controls
Vitamin C 0.6 (0.4-0.9) Men aged < 80 yrs.
ORs adjusted forage, El, BMI, FHPCa,
residence & fat intake.








Vitamin C 1.2 (0.9-1.7) Men aged < 70 yrs
ORs adjusted for: El (residual), age, study
centre, year, FHPCa, SES
Age frequency matched
Cont.
Dietary Factors: Fruits and vegetables page 105
Prostate Cancer & Diet






















Men aged 55-69 yrs at baseline.
RRs adjusted for age, SES, FHPCa &
alcohol.
El adjusted RRs not reported as El
was not shown to be associated with
PCa.










Vitamin C 1.1 (0.9-1.4) Men aged 40-75 yrs at baseline.
RRs adjusted for age & El.
Adv PCa analysis: results not reported
as similar to all cases.
Health Professionals Follow-up study.
N.B
$ Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls, n/s = no significant association
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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Selenium and phyto-oestrogens
Few epidemiological studies have investigated the effect of both selenium and phyto-
oestrogen intake on PCa risk. No significant associations between selenium intake
and PCa were reported by the one case-control study174 and one cohort study81
examined this association, see Table 3.19. Whereas the two case-control studies
examining phyto-oestrogen intake, reported significant / borderline significant
91 f\
inverse associations for the isoflavone coumesterol (OR 0.5, 95%CI 0.3-0.9 ,
genistein (OR 0.5, 95%CI 0.3-1.0214 and Daidzein (OR 0.6, 95%CI 0.3-1.0214), see
Table 3.20.
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Selenium 0.9 (0.7-1.3) ORs adjusted for age, El,
smoking, vasectomy, BMI,














Men aged 50-69 yrs at baseline.
RRs adjusted for age, El,
intervention arm & BPH.
Straitified by a-tocopherol
intervention arm, as significant
effect modification by a-
tocopherol intervention was
reported.
Cohort study from the ATBC
RCT study.
N.B
s Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
El = Energy Intake, PCa = PCa, OR = Odds Ratio, RR = Rate Ratio, AT: a-tocopherol arm of ATBC Study, Non-AT:
Placebo arm for ATBC Study, SES = Socio-economic status,
FHPCa = Family history of PCa, PSA = Prostate-specific antigen,
All = All Cancers, Adv = Advanced cancers only, Agg = Aggressive cancers only.
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Strom et 83 Cases Isoflavones: ORs adjusted for: age, El,
al216 107 Pop Controls Genistein 0.7(0.4-1.3) FHPCa, alcohol.
1999 Daidzein 0.6(0.3-1.1) Age frequency & race matched.
USA Formononetin 1.0 (0.5-1.8)
















Lee at al214 133 Cases Genistein 0.5 (0.3-1.0) Men aged 50-89 yrs
2003 265 Pop Ctrls Daidzein 0.6 (0.3-1.0) ORs adjusted for El & age
China Age frequency & community
matched
N.B.
5 Odds / Risk ratio for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
Hosp Ctrls = hospital controls, Pop Ctrls = population controls
El = Energy Intake, PCa = prostate cancer, OR = Odds Ratio, RR = Rate Ratio, SES = Socio-economic status,
FHPCa = Family history of PCa, All = All PCa, Adv = Advanced PCa only, Agg = Aggressive PCa only, Local =
Localised PCa only.
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3.4.10 Discussion
Evidence from this systematic literature review suggests that overall vegetable
consumption is associated with a reduced risk in PCa, in particular allium, tomatoes
and soy foods, thereby confirming the conclusions from previous reviews. The
findings for fruit consumption is less consistent with the findings of some studies
suggesting fruit consumption to be associated with increased risk of PCa. The
evidence for a relation between nutrients associated with vegetables and fruit and
PCa is even less consistent.
There is no clear evidence that carotenoids reduce PCa risk, with the possible
exception of lycopene. This is confirmed by the inconclusive findings from several
studies examining biomarkers of carotenoid intake such as carotenoid plasma / serum
O/T O O . 1 rry 1 1 ry 1 Q
concentrations ' ' " , although several invitro and animal studies, as reviewed
by Chan et al184, support the role of carotenoids to protect against PCa. However,
there is some evidence for the protective effect of lycopene, with Giovannucci et
O.Q<7
al ' estimating a 20% reduction in PCa risk with increased lycopene intake. This
association has been confirmed in several studies examining serum / plasma
lycopene concentrations88'162 and also by the aforementioned studies that reported
tomato consumption to be protective against PCa (as tomatoes are the major source
of lycopene).
There is also little evidence from the literature review that vitamins C and E are
associated with PCa risk. This is consistent with the findings of studies examining
biomarkers of intake, with the exception of y-tocopherol, which was reported to have
a protective effect against PCa in several nested case-control studies, such as
Helzlsouer et al85 (OR 0.3,95%CI 0.1-0.7). Plasma vitamin E has also been suggested
to have a protective effect against PCa in a sub-group of smokers (Low vitamin E
OR 3.3, 95%CI 1.3-8.4219). The evidence of the protective effect of vitamin E is also
supported by the findings of the ATBC Trial183, in which a-tocopherol
supplementation was found to significantly reduce both PCa incidence and mortality,
220and also in several experimental and animal studies as reviewed in Shklar et al .
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The limited evidence on the association between selenium intake and PCa makes it
impossible to make any judgements on the effect of selenium intake. However,
evidence of a significant protective effect on PCa has been reported in several studies
that have examined biomarkers for selenium intake (i.e. toenail and serum
concentrations), the ORs ofwhich ranged from 0.2 (95%CI 0.1-0.8)221 to 0.7 (95%CI
0.5-1.00)222.This association is also supported by the findings of the NTPC Trial188 in
which selenium supplementation was found to significantly reduce the incidence of
PCa. Several invitro and experimental studies also support these findings, including
Redman et al223 and Menter et al224.
As with selenium intake, very few studies to date have reported on the relation
between phyto-oestrogen intake and PCa. Borderline significant inverse associations
with these phytochemicals, especially daidzein and genistein, have been reported in
Chinese men214. However, the findings of Strom et al216should be viewed with
caution as it is doubtful that the food table used could accurately estimate intake for
so many different types of phyto-oestrogens, most ofwhich are found in such small
quantities in foods, also the great number ofphyto-oestrogens examined may have
introduced the possibility ofmultiple testing . Nevertheless, the evidence is
supported by several studies who have reported significant inverse associations
between phyto-oestrogen serum / plasma concentrations and PCa, such as Ozasa et
al225 (equol OR 0.4, 95%CI 0.2-1.0, and equol / daidzein ratio OR 0.4, 95%CI 0.1-
0.9) and also in the aforementioned vegetable consumption studies that reported
on8*9 l o
significant protective effects of soyfood consumption ' . Several experimental and
animal studies have also presented evidence for the anti-carcinogenic abilities of
phyto-oestrogens, such as the inhibition of PCa tumour growth, these studies have
996 998
been reported in several reviews " .
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3.5 Alcohol
Alcohol consumption, including heavy use and abuse, has been reported to be
associated with increased risk of some cancers, including cancers of the oral cavity
and pharynx, oesophagus, larynx, breast and liver229, but the findings for PCa are less
conclusive. Alcohol has been assessed as a possible risk factor for PCa in a large
number of studies. Although the majority of these studies have failed to show an
association between alcohol and PCa, due to the fact that alcohol consumption is
very common, any potential association may have a great impact on PCa incidence
and its associated public health concerns.
3.5.1 Consumption
The world average for alcohol consumption is 9g of pure alcohol per day, however
this average masks great regional and national variations, as well as cultural and
religious variations. The lowest consumption is reported in the Middle East and
North Africa where Islam, the predominant religion, bans the consumption of
alcohol. Whereas the highest consumption occurs in European countries, such as the
wine producing countries of France, Portugal and Italy, where consumption is around
27g of pure alcohol per day. Analysis of time trends shows increasing consumption
of alcohol in most countries, especially those in transition to urban-industrial
societies42, and in any population, most alcohol is drunk by men.
Alcohol consumption in the UK has been examined in several surveys using different
age groups, please see Table 3.21. Comparison between these surveys is difficult
because of the variety of different measures used. The data suggest that there may be
a time trend towards lower alcohol consumption; 21.9g/day in 200346 compared to
25.0g/day145 in 1990, although this is more likely to be due to artefactual reasons, i.e.
differences in alcohol measurements and study populations. The total alcohol
53
consumption for Scottish men in the two surveys using age groups 16-64yrs and
19-64yrs46 were similar to that for UK men (24.8g/day53 and 22.0g/day46
respectively), the reported consumption in the most recent survey46 also equates well
to that reported by the Scottish Health Survey44 (19.1 units/week which is
approximately 21.8g/day), which reported 93% ofmen age 16-74yrs consumed
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alcohol. Beer is by far the most popular alcohol type in Scotland, where average
consumption is 12 units (6 pints) per week, compared to two and five units for wine
and spirits respectively 4.
N.B. Alcohol consumption is expressed differently in different countries. In the US
alcohol intake is usually expressed in terms of 'standard drinks' each of which
contains approximately 12-14g of pure alcohol whereas in the UK alcohol intake is
9^0
expressed in terms of 'units' where one unit contains 8 g of alcohol .
Table 3.21: Average alcohol consumption
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- = data not available
Dietary Factors: Alcohol page 113
Prostate Cancer & Diet
3.5.2 Nutritional value and alcohol consumption guidelines
Alcohol is a source of energy, providing approximately 29kJ /g alcohol, many
alcoholic drinks also contain sugars which increase the total energy content
considerably. Alcohol is considered to be a low density food230, meaning that it
provides energy but few essential nutrients. Nevertheless some alcoholic drinks do
have traces of vitamins and minerals, although these do not usually make a
significant contribution to the diet, these nutrients include antioxidants found in wine
and flavonoids which are found in beer, both ofwhich may be associated with a
protective effect against PCa. Alcohol may also contain potential carcinogens
including nitrosamines and polycyclic hydrocarbons, particularly in locally prepared
drinks, although the significance of these carcinogens, which are usually found in
very small concentrations, is still speculative231. The Department ofHealth advises
that alcohol consumption for men should be three to four units per day or less,
consumption above this level may lead to significant health risks.
3.5.3 Biomechanisms
The biological pathway relating alcohol consumption to PCa risk is largely unknown,
though some mechanisms have been proposed to both explain a protective as well as
a positive association between alcohol consumption and PCa risk.
Alcohol consumption tends to result in greater oestrogen and lower androgen serum
levels in both men and women232. As PCa appears to be closely linked to high levels
.9 'ia
of androgens ' , this suggests a protective biological mechanism against PCa.
The association with increased risk of PCa may be explained by biological pathways
which include affects on the permeability of cell membranes to carcinogens,
modification of carcinogen metabolising enzyme activity, and inhibition ofDNA
repair mechanisms ' ' . Alcohol can also alter first-pass metabolism in the liver
of carcinogens, including nitrosomines, and may modify DNA methylation affecting
gene regulation . Furthermore, alcohol contains possible carcinogens, including
nitrosomines and acetaldehyde, a major metabolite of alcohol, is a recognised
9->7
carcinogen and teratogen , please refer to Table 3.2.
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Finally, as diet potentially plays an important role in PCa, alcohol consumption may
be related to PCa indirectly though dietary effects, including malabsorption and the
displacement of other nutrients235. For example, heavy drinkers who are in energy
balance will have markedly lower intake of other nutrients as well as possibly having
230
a diet that is poor in other respects such as a low intake of fruit and vegetables .
3.5.4 Literature review
Meta-analysis of PCa and alcohol
The findings of the meta-analysis by Dennis102 of twenty-seven case-control studies
and six cohort studies published prior to July 1998 showed no association between
alcohol consumption and PCa (pooled RR estimate 1.05, 95%CI 0.98-1.11).
Although small, though borderline significant, positive associations were observed
for beer (pooled RR estimate 1.18, 95%CI 1.07-1.29), wine (pooled RR estimate
1.06, 95%CI 0.96-1.18) and liquor / spirits (pooled RR estimate 1.08, 95%CI 0.99-
1.19). Denis102 concluded that there was no relationship between moderate alcohol
consumption and PCa, and that if any association between alcohol and PCa existed it
appeared to be among heavy drinkers or alcohol abusers.
Review of recent studies since July 1998
Due to the thoroughness of the above meta-analysis in reviewing the association
between alcohol consumption and PCa risk, this systematic literature review will
concentrate on the studies that have examined alcohol consumption that were
published after the meta-analysis. A total of four case-control studies and seven
cohort studies published since Dennis102 have examined the association between
alcohol consumption and PCa.
All studies fulfilled the requirements of the methodological criteria, however, many
• 0^8 OftO
did not adjust for energy intake " (mainly due to the lack of data on energy
intake), but adjusted for BMI instead.
All studies were conducted in Western populations, especially the US, and reported
present drinking habits, with four studies also reporting past drinking
O 3 8 *0 TQ-Oft 1 •Oft'?
habits ' ' • . The majority studies examined the relationship between moderate
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alcohol consumption and PCa, considering risks only up to consumption levels of
about > 4 drinks / day. Whereas Lumey et al238 reported risks for subjects consuming
> 8 drinks /day, a level of consumption considered to be abusive235.
Total alcohol
As found in the meta-analysis, no general pattern of association was observed, with
the majority of studies reporting no association, see Table 3.22. However, two US
studies observed significant associations, Sharpe et al239 observed a significant
positive association (OR =1.6, 95%CI 1.1-2.3) for those subjects reporting to drink
daily, whereas Breslow et al240 reported a significant negative association (OR =
0.23, 95%CI 0.06-0.95). Within those studies examining advanced PCa, Putnam et
al244 observed a strong significant positive association (OR = 6.4, 95%CI 1.4-29.7),
whereas Schuurman et al243 and Platz et al245 continued to observe no association.
Alcohol types
Ten of the twelve studies also examined the association between PCa and alcohol
type (beer, wine and spirits / liquor), see Table 3.22. Different patterns of association
were observed with each alcohol type. Within beer drinkers, beer consumption was
generally associated with decreased PCa risk, significant inverse associations were
reported by Jain et al246(OR = 0.68, 95%CI 0.49-0.94), Villeneuve et al134 (OR = 0.5,
95%CI 0.2-1.0) and Breslow240(OR = 0.34, 95%CI 0.12-0.92). However, Sharpe et
al reported a significant positive association (OR =1.6, 95%CI 1.1 -2.3) for those
subjects reporting to drink beer daily. An inverse non-significant association was
also reported within advanced PCa243.
For wine consumers, no association was reported by the majority of the ten studies
examining the association between wine consumption and PCa risk, with the
exception of two cohort studies which reported positive borderline significant
associations (OR 1.41, 95%CI 1.01-1.96247 and OR - 2.3, 95%CI 1.0-5.3243). This
positive association continued to be significant with advanced PCa (OR = 2.9 95%CI
1.0-8.5)243. Schuurman et al243 also categorised wine consumption by red, white and
fortified wine, significant positive associations continued to be observed for white
and fortified wines, ORs = 3.3 (95%CI 1.2-9.2) and 2.3 (95%CI 1.2-4.7)
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respectively, whereas a non-significant negative association was reported for red
wine.
No significant associations between spirit / liquor consumption and PCa risk were
reported.
Past intake
The evidence for past intake is less consistent, within the four studies that examining
past intake Sharpe et al reported a significant positive association with increasing
cumulative consumption of total alcohol, OR 2.1 (95%CI 1.3-3.3). Whereas Breslow
et al240 consistently reported significant negative associations with heavy alcohol
consumption at ages 25years (OR 0.20, 95%CI 0.06-0.63), 35years (OR 0.30, 95%CI
0.12-0.77) and 45years (OR 0.39, 95%CI 0.17-0.93).
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Table 3.22: Findings from recent epidemiological studies of alcohol and PCa
Study, year,
location
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Dietary Factors: Alcohol page 118
Prostate Cancer & Diet
Table 3.22, cont.: Findings from recent epidemiological studies of alcohol and PCa
Study, year,
location
















Men aged 50-84 yrs at baseline.
RRs adjusted for age, smoking,
BMI, education, fat, fibre, El.














Men aged 40+ yrs at baseline.


















Men aged 45-70 yrs at baseline.
RRs adjusted for age (& El,
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Men aged 20-98 yrs at baseline.




















Men age 40-75 yrs @ baseline
RRs adjusted for age, El BMI,
height, smoking, FHPCa,
diabetes, vasectomy, activity,
Ca, fructose, tomato sauce,
meat, vit E & a-linolenic acid
N.B
5 Odds / Risk ratios for highest relative to lowest percentile, except where stated
® Odds / Risk ratios based on all PCa cases, except where stated
El = Energy Intake, PCa = PCa, OR = Odds Ratio, RR = Rate Ratio,
SES = Socio-economic status, FHPCa = Family history of PCa, PSA = Prostate-specific antigen,
All = All Cancers, Adv = Advanced cancers only, Agg = Aggressive cancers only, C. Consumption = Cumulative
consumption among daily drinkers.
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3.5.5 Discussion
Evidence from studies reviewed in this literature review, although somewhat
inconsistent, suggest that there is no association between alcohol consumption and
PCa, thereby confirming the conclusion made by Dennis102. Nevertheless in recent
studies examining alcohol type, beer consumption was reported to have a protective
effect, whereas wine was reported to have a borderline significant positive
association with PCa risk in several other studies. This suggests that the various
types of alcohol may each have a different effect on PCa.
Evidence is even less consistent for past drinking habits, with one case-control study
reporting a significant positive association between PCa risk and the cumulative
consumption of total alcohol239, whilst Breslow et al240 reported a significant inverse
association with heavy drinking at ages 25 to 45 years. This finding not only suggests
that long-term consumption maybe aetiologically relevant but also that high
consumption of alcohol maybe too. However, these findings should be interpreted
with caution as they were based on small numbers of cases who were heavy drinkers.
Few other studies have examined the association between high / abusive alcohol
consumption and PCa risk. This is probably due to difficulties in examining high
alcohol consumption. Heavy alcohol consumers may tend to be under-represented
among study participants, as they are more likely to refuse or not respond when
asked to take part in a study. Study participants may also tend to under-report alcohol
use, due to an unwillingness to confess true intake that they feel may be less socially
acceptable. If this occurs differentially between cases and controls, substantial bias
may result. Amongst the reviewed studies, where reported, average consumption of
total alcohol ranged from 17.4g/day to 19.6g/day , with the typical highest
categories of alcohol consumption being > 30g/day / > 3 drinks/day. Only Lumey et
238al attempted to examine heavy alcohol consumption (> 8 drinks per day), however
only 8% of the total number of subjects fell within this category .
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As reviewed by Dennis et al235, the findings of several studies that examined abusive
alcohol consumption reported a positive association between alcohol abuse and PCa
OzlQ 0 ^>0
risk " , however, none of these studies provided quantitative information about the
amount of alcohol consumed. In addition, autopsy studies253,254 have reported a lower
prevalence ofPCa in cirrhotics than in controls, suggesting that physiological
changes associated with cirrhosis may reduce PCa risk. However, both these autopsy
studies had small study sizes, plus latent cancers were not distinguished from more
aggressive tumours. No recent studies published since this review have examined the
association between alcohol abusers and PCa.
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3.6 General discussion
3.6.1 Introduction
Evidence gathered from this literature review suggests that several dietary factors
may be associated with PCa risk. In particular, meat product consumption was
observed to be associated with an increased risk in PCa in many studies, whereas
vegetable and soy food consumption and to a lesser extent lycopene, selenium and
phyto-oestrogens were observed to be associated with a protective association with
PCa. Nevertheless, findings for other dietary factors have produced some
contradictory and possibly inconclusive evidence, in particular for alcohol
consumption and most plant-based nutrients.
3.6.2 Covariance of diet
The complex nature of diet, with its many inter-correlated components, makes the
individual effect of different nutrients and foods on disease very difficult to study.
For fat intake in particular, it is not just energy intake that is highly correlated with
this nutrient, many other food components and nutrients are as well. Animal foods,
including meat and dairy products, are a major fat source in western diets and are
therefore also highly correlated with fat intake. In addition to fat, animal products
also contain other components that have been suggested to play a role in PCa
aetiology, such as calcium and retinol. A diet high in meat can also result in exposure
to carcinogenic chemicals (such as aromatic hydrocarbons and heterocyclic amines)
175that are created when meats are cooked by grilling or frying at high temperatures .
High fat/high meat consumption is also generally associated with a lower
consumption of plant foods, such as vegetables and fruit, that contain nutrients which
have been suggested to have a protective effect against PCa184'255'256. It therefore
makes it possible to conclude that it is not so much the high levels of fat / meat
consumption that is a main factor of PCa, but rather the correlated low levels of fruit
and vegetable consumption.
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3.6.3 Methodological considerations
The wealth of epidemiological studies of all types of designs, methodologies and
sizes that have examined dietary factors associated with PCa risk has made it
increasingly difficult to allow for a definitive answer to be made about the effect of
these factors on PCa risk. However, the systematic nature of this review has
permitted for studies with dubious nutritional epidemiological methodologies and
therefore possible spurious findings to be discarded, thereby allowing for a much
clearer picture of the effect that these dietary factors have on PCa risk to be obtained.
As well as the use of a validated and comprehensive dietary assessment method, all
studies included in this review reported ORs adjusted for EI, thereby allowing for the
examination of the effect of each dietary factor whilst controlling for any potential
effect that EI may have on PCa risk. It is interesting to note that the majority of
studies examining fat intake which were omitted because they did not adjust for EI
amongst other methodological reasons, reported significant positive associations
between fat intake and PCa98;i20;I24"126;128 . Also, studies included in the review
which also reported crude relative risks, such as Andersson et al131, reported crude
significant associations between fat and PCa risk, which generally became non¬
significant when EI was adjusted for.
The large variation in the way food groups were classified could also explain
discrepancies in the findings. For example, the lack of consistant evidence for
individual vegetable categories, especially cruciferous vegetables, could have been
due to the wide variation in the classifications and groupings used. Meat product
classification also varied considerably, especially for total meat for which the
inclusion criteria of fish and/or poultry differed from study to study. The range of
countries and populations in which the reviewed studies were conducted also make
comparisons difficult. For example, evidence that phyto-oestrogens are protective
against PCa is mainly reported in studies from China and Japan, where soy is
consumed on a regular basis, thus allowing for a large enough variation in soy
consumption to enable any true association with PCa risk to be examined.
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Another difficulty in data interpretation arises from the lack of reporting of null
findings. Some studies that have reported results for only a few nutrients / food
groups have probably also found null association for other dietary factors, but have
not included these results in their publication. Furthermore some studies have
analysed data for a large number of dietary factors, thus increasing the probability of
finding a significant association for one or a few items due to chance alone.
With regards to alcohol consumption in particular, the inconsistent nature of the
available evidence may, in part, be due to study design and methodological issues not
accounted for in the methodology criteria. In particular, the methodology used to
report alcohol consumption seemed to vary greatly. The type of alcohol assessment
methods ranged from diet histories and FFQs in which usual alcohol consumption
over the past year was reported134'243'246, to interviews regarding current and/or past
9hl-94n,94l
drinking habits ' ' . Within the studies that reported g/day of alcohol, the
calculation methods also varied, Jain et al246 and Schuurman et al243 used alcohol
data from various food composition tables including the United States Department of
Agriculture Food Composition Handbook No. 870, whereas Ellison et al247 estimated
the amount ofpure alcohol based on set proportions of alcohol for different alcohol
types (5% for beer, 13.5% for wine and 40% for spirits). Within alcohol types, the
differences in the choice of reference category could also have caused such
inconsistent findings. Most studies tended to use non-drinkers of each alcohol type as
the reference category, whereas Schuurman et al243, Putnam et al244, Albertsen et al242
and Platz et al245 used non-drinkers of any alcohol as the reference category.
Another reason for the lack of a general pattern in reported risks for alcohol
consumption (and also to a lesser extent for other dietary factors) may be the
considerable variation in the potential confounding factors that were adjusted for.
The extent to which potential confounding factors were controlled for ranged from
age only241 to multivariate models in which demographic, lifestyle, dietary intake and
family history factors were adjusted for134'247.
Energy intake was only adjusted for in a few of the studies examining alcohol
consumption244"248, this was mainly due to the lack of data on energy intake, instead
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most studies adjusted for BMI. As mentioned previously, energy intake is an
important potential confounder, especially as it is a large component of alcoholic
beverages. Regular consumers of alcohol may obtain a substantial proportion of their
total energy intake from alcohol230 and in cases of chronic alcohol abuse, alcohol
may account for as much as 50% of an individuals daily total energy intake231.
Residual confounding by socio-economic status or other factors related to socio¬
economic status might explain the variation in the patterns of association between
PCa and different types of alcohol. Beer consumption is more common in lower
social classes257, whereas consumption ofwine is more associated with higher social
classes. As socio-economic status may influence availability and access to health
care, as well as attitudes and concerns over health in general thereby influencing
PSA screening and stage of presentation3; it is therefore of utmost importance that
socio-economic status is controlled for. With this regard, the stronger positive
associations between wine consumption and localised PCa observed by Schuurman
243
et al (OR = 4.6, 95%CI 2.6-13.4) may suggest a socio-economic status effect
related to increased use ofmedical services (including PSA screening) among men
with a higher socio-economic status.
3.6.4 Conclusions.
Evidence from this literature review suggests that several components of diet, in
particular meat, vegetables and lycopene, may be associated with PCa risk. It is the
aim of this thesis to examine these potential dietary factors within a population
known for its 'unhealthy' diet and relatively high rate of PCa, using a study design
and methodology based on the methodological considerations discussed in chapter 2.
To my knowledge this is the first epidemiological study to examine the effect of diet
on PCa in Scottish men alone. Further details of this aim and the hypotheses to be
tested are discussed in the next chapter.
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This chapter describes the aims and objectives of the thesis and the methodology
used, including subject recruitment, data collection and data analysis.
4.1 Aims and Objectives
4.1.1 Aim
The main aim of this study was to investigate the association between PCa and foods
and nutrients commonly consumed by Scottish men (see Table 4.1) and which
previous literature (as discussed in Chapter 3) suggest are associated with a
protective effect against / increase of risk of PCa.
Table 4.1: List of the specified dietary factors
Nutrients and minerals
• Total energy (El)
• Protein
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4.1.2 Main objectives
1. To assess the dietary intake of the above dietary factors, for all subjects and also
by case / control status.
2. To examine the inter-association between the above dietary factors and also
potential confounding factors (see Table 4.2).
3. To analyse the above dietary factors by case / control status in order to obtain
crude ORs and 95%CIs.
4. To repeat the above objective, adjusting for potential confounders.
5. To test for interaction between the above dietary factors and potential
confounders.
6. To examine the possible variation in the effect of dietary factors on PCa risk
between younger and older subjects, by repeating steps 3 and 4, stratifying by age
group.
Table 4.2: List of potential confounding factors
Potential confounding factors:
• Age
• Family History of PCa and BRCa




N.B. El was also included as a potential confounding factor.
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4.1.3 Hypotheses
It was hypothesed that there would be an association between the below dietary
factors and PCa:
• Protein (hypothesed to increase risk of PCa)
• Total fat and its constituents (hypothesed to increase risk of PCa)
• Calcium (hypothesed to increase risk of PCa)
• Selenium (hypothesed as being protective against PCa)
• Retinol (hypothesed to increase risk of PCa)
• Carotenes (hypothesed as being protective against PCa)
• Vitamin E (hypothesed as being protective against PCa)
• Vitamin C (hypothesed as being protective against PCa)
• Isoflavones (hypothesed as being protective against PCa)
• Alcohol (hypothesed to increase risk of PCa)
• Dairy products (hypothesed to increase risk of PCa)
• Meat products (hypothesed to increase risk of PCa)
• Soy products (hypothesed as being protective against PCa)
• Fruit (hypothesed as being protective against PCa)
• Vegetables (hypothesed as being protective against PCa)
N.B. Due to the lack of information regarding lycopene intake, unfortunately the
hypothesis that lycopene in associated with a specific protective affect against PCa
cannot be tested.
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4.2 The PCANDIET Study
This thesis was based on PCANDIET: A population based epidemiological case-
control study of PCa in relation to inherited susceptibility and diet, and focused
mainly on the dietary side of this study. The PCANDIET study took place between
1998 and 2002 at the Department ofCommunity Health Sciences, University of
Edinburgh and was headed by Professor Freda Alexander. It was funded by Cancer
Research UK (CRUK) and the Food Standards Agency (FSA) (as part of an ongoing
group of projects investigating phyto-oestrogens).
The protocol was for a population based epidemiological case-control study of
prostate cancer. The main aims of the study were:
1. To investigate dietary factors specified in advance as being protective against, or
as increasing risk of, clinically important (or progressive) PCa.
2. To investigate polymorphisms of the androgen receptor (AR) gene as modulator
of risk of clinically important (or progressive) PCa cancer.
3. To examine synergism between inherited susceptibility and dietary constituents.
The specified dietary factors were:
• Phyto-estrogens (hypothesised as being protective)
• Carotenes (hypothesised as being protective)
• Animal and total fat (hypothesised to increase risk)
• Red meat (hypothesised to increase risk)
It should be noted that the PCANDIET study also used blood samples to examine
certain genetic polymorphisms and also to analyse phyto-oestrogen serum
concentrations in order to validate the Scottish Collaborative Group - Food
Frequency Questionnaire's (SCG-FFQ) ability to assess isoflavone intake accurately.
The genetics part of the PCANDIET study was not included in this thesis.
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N.B. Some of the work in this thesis will refer to work done by other collaborators of
PCANDIET. Where the work was undertaken by others, this is explicitly noted in
the text, otherwise the work was conducted by the author.
4.3 Ethical Approval
Ethical approval was obtained for this study from the Multi-centre Research Ethics
committee for Scotland (MREC) and the appropriate Local Research Ethics
Committees (LRECs). In addition, permission to contact potential subjects were
obtained from the respective consultants / GPs and informed consent was obtained
from each subject agreeing to take part in the study.
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4.4 Study subjects
The study was made up of three subject groups (one case and two control groups):
• Cases: Subjects newly diagnosed with clinically important PCa, see below for
more details (proposed n = 400).
• Controls:
• Benign Prostatic Hyperplasia (BPH) controls: Subjects newly diagnosed
with BPH but with no diagnosis of PCa. (proposed n = 200).
• Population controls: Subjects randomly selected from the target population,
who had no diagnosis of PCa. (proposed n= 335).
The recruitment ofBPH controls ensured that a proportion of controls were
histologically confirmed as not having PCa, thereby reducing the likelihood of
selection bias, unlike the population controls for which there is a possiblity for the
presence of undiagnosed asymptomatic PCa. A more detailed discussion can be
found in Chapter 6, section 2.
At the start of the PCANDIET study, power calculations were undertaken to
calculate the sample size required to give 80% power to detect ORs of 2.0 for
comparison between dichotomous genetic polymorphism categories in addition to
comparisons of highest versus lowest dietary intake categories. The formula for these
power calculations is found in Bland, 1995271. The sample of size of 935 was found
to be suitable for the above comparisons.
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4.5 Subject recruitment
N.B. Please see appendix for copies of subject correspondence letters etc.
4.5.1 Recruitment of cases
Identification of potential cases
All cases of clinically important PCa (defined as grade > Tla and Gleason Score > 4)
newly diagnosed between April 1998 and December 2001 at hospitals within the
Lothian, Borders and Glasgow Health Boards, whilst resident in Greater Glasgow,
Lothian and Borders and aged 50 - 74 years were eligible.
Monthly computer downloads of newly diagnosed cases from each hospital
(including details of name, age and address and treating consultant and GP), were
collected and checked to confirm diagnosis was 1st diagnosis of PCa, before being
assigned an individual ID number and added to the PCANDIET database. Once on
the database these potential cases were checked for eligibility (age and residence),
any cases found to be ineligible due to age or residence were given a status of
INELIGIBLE and were omitted from further recruitment stages.
The following recruitment procedure was then performed for each potential case.
Please see Figure 4.1 for an overview of the subject recruitment strategy.
Approach of treating consultant
The treating consultant of each eligible potential case was approached by letter in
order to obtain permission to approach the potential case and also to confirm that the
potential case was diagnosed with PCa after 1st April 1998 and was mentally capable
of completing the FFQ. The name and address of the GP, in addition to the potential
case's address was also asked to be confirmed.
If the treating consultant indicated diagnosis was before 1st April 1998 or that the
potential case was mentally incapable of completing the FFQ, the potential case was
given the status of INELIGIBLE. If the treating consultant did not wish the otherwise
eligible potential case to be approached, the potential case was given the status of
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CONSULTANT REFUSAL. In both these cases, the potential case was omitted from
further recruitment stages.
Approach of potential case
Having received permission from the treating consultant, each eligible potential case
was approached by letter in order to invite them to take part in the study. The letter
and enclosures included an outline of the study and what it would entail. Permission
was also asked to check their medical records and also to inform their GP of their
participation in the study.
If the potential case did not wish to take part, they were given the status ofCASE
REFUSAL and were omitted from the study. Otherwise they were given the status of
CASE CONSENT and were recruited to the study.
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4.5.2 Recruitment of BPH Controls
Identification of potential BPH controls
All cases of benign prostatic hyperplasia (BPH) newly diagnosed between April
1998 and December 2001 at the Western General Hospital, Edinburgh and Borders
General Hospital, Melrose, whilst resident in Greater Glasgow, Lothians and Borders
and aged 50 - 74 years were eligible. Monthly downloads of newly diagnosed BPH
cases from each hospital were collected and checked to confirm diagnosis (i.e. no
evidence of PCa), before being assigned an individual ID number and added to the
PCANDIET database. Once on the database these potential BPH controls were
checked for eligibility (age and residence), any controls found to be ineligible due to
age or residence were given a status of INELIGIBLE and were omitted from further
recruitment stages.
The following recruitment procedure was then performed for each potential BPH
control. Please see Figure 4.1 for an overview of the recruitment strategy.
Approach of treating consultant
The treating consultant of each eligible potential BPH control was approached by
letter in order to obtain permission to approach the potential BPH control and also to
confirm that the potential BPH control was diagnosed with BPH after Jan 1998 and
was mentally capable of completing the FFQ.
If the treating consultant indicated diagnosis before Jan 1998 or that the potential
BPH control was mentally incapable of completing the FFQ, the potential BPH
control was given the status of INELIGIBLE. If the treating consultant did not wish
the otherwise eligible potential BPH control to be approached, the potential BPH
control was given the status ofCONSULTANT REFUSAL. In both these cases, the
potential BPH control was omitted from further recruitment stages.
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Approach of potential BPH Control
Having received permission from the treating consultant, each eligible potential BPH
control was approached by letter in order to invite them to take part in the study. The
letter and enclosures included an outline of the study and what it would entail.
Permission was also asked to inform their GP of their participation in the study.
If the potential BPH control did not wish to take part, they were given the status of
CONTROL REFUSAL and were omitted from the study. Otherwise they were given
the status ofCONTROL CONSENT and were recruited into the study.
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4.5.3 Recruitment ofPopulation controls
Random selection of population controls by age distribution
Population controls were age-frequency matched to cases (five-year age groups) and
by health board region. Table 4.3 shows the five-year age distribution of population
controls requested.
Table 4.3: Distribution of population controls requested




<55 0 7 6
55-59 2 11 13
60-64 6 31 33
65-69 12 60 70
70-74 2 38 43
Total 22 147 165
Identification and recruitment of potential population controls
Due to varying conditions imposed for ethical approval for control selection and
recruitment across the Health Boards, different recruitment procedures were used.
Borders Health Board
Borders Health Board gave access to their Health Board lists in order to select
potential controls. The request for twenty-two potential primary controls and four
replacement controls for each control (in case the primary control was ineligible or
did not wish to take part in the study), with a given birth month/year, was sent to the
data department at Borders Health Board with instructions to use the same control
selection methodology as used in a previous study (Scottish and Newcastle
Epidemiological Study ofHodgkin's Disease).
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Once the download of the potential primary and replacement controls (including
details of name, date of birth, address and GP) were received, the potential primary
controls were assigned an individual ID number and added to the PCANDIET
database. Once on the database the potential controls' eligibility (age and residence in
the Borders region) was confirmed, any primary controls found to be ineligible due
to age or residence were given a status of INELIGIBLE and were omitted from
further recruitment stages. Ineligible primary controls were replaced with a
respective replacement control.
The following recruitment procedure was then performed for each potential Borders
population control. Please see Figure 4.1 for an overview of the subject recruitment
strategy.
Approach of Borders general practitioners
The named GP of each eligible potential Borders population control was approached
by letter in order to obtain permission to approach the potential population control
and also to confirm that the potential control was eligible to take part in the study
(i.e. no previous diagnosis of PCa and mentally capable of completing the FFQ). The
GP was also asked if the control was currently receiving therapy by finasteride or
any other drug for BPH and to confirm the potential control's address.
If the GP indicated a previous diagnosis of PCa or that a potential population control
was mentally incapable of completing the FFQ, the potential population control was
given the status of INELIGIBLE. If the GP did not wish an otherwise eligible
potential population control to be approached, the potential population control was
given the status of GP REFUSAL. In both these cases, the potential population
control was omitted from further recruitment stages, and a respective replacement
control was selected.
Approach of potential Borders population control
Having received permission from the GP, each eligible potential Borders population
control was approached by letter in order to invite them to take part in the study. The
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letter and enclosures included an outline of the study and what it would entail. The
control was also asked to confirm that they had never been given a diagnosis of PCa.
If the potential control did not wish to take part, they were given the status of
CONTROL REFUSAL and were omitted from the study. As in the previous steps, a
respective replacement control was then selected. Otherwise they were given the
status of CONTROL CONSENT and were recruited to the study.
Lothian Health Board
Like Borders Health Board, Lothian Health gave us access to their Health Board lists
in order to select potential controls. However, in order to protect patient identities
under the Data Protection Act 1998, Lothian Health undertook to contact the selected
potential Lothian population controls and their GPs, as outlined in Steps 1 and 2
above, themselves. The request for 165 population controls with a given birth
month/year was sent to the data department at Lothian Health Board, with
instructions to select at random potential controls who were born within the given
birth month/year and who resided within the Lothian area. Once contacted by
Lothian Health Board (after receiving permission from their GP), potential Lothian
population controls would then send their reply to the PCANDIET Team.
If the potential Lothian population control did not wish to take part, they were given
the status of CONTROL REFUSAL and were omitted from the study, otherwise they
were given the status ofCONTROL CONSENT and were recruited into the study.
Recruitment updates were exchanged at fortnightly meetings.
Greater Glasgow Health Board
Unlike the other Health Boards, Greater Glasgow Health Board did not allow access
to their health board lists. Instead, GP patient lists from individual GP practices
allowing access to their patient lists were used as a sampling frame to select Glasgow
population controls with the birth month/year as requested.
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Selection of Greater Glasgow general practitioners
Using the Greater Glasgow GP practice list received from Information Services at
Greater Glasgow Health Board, 115 Glasgow GP practices were selected at random,
weighted according to the number ofmen aged 50-74 in each practice. The number
of GP practices was chosen so as to allow for an average of two controls to be
selected from each consenting GP practice and a refusal / non-response rate of
approximately 40%. The first GP listed for each selected GP practice was chosen as
primary contact.
Approach of Greater Glasgow general practitioner
The 115 selected GP practices were approached in three batches (West Glasgow
(n=22), South Glasgow (n=48), North and East Glasgow (n=45)) by letter in order to
ask permission to randomly select potential Glasgow population controls from their
practice lists. If the GP practice agreed, they were also asked if they would be
prepared to collect a blood sample from the controls agreeing to participate in the
study. The name and telephone number of the appropriate contact (usually the
practice manager) was also asked for.
Ifpermission to access their patient lists was given, each GP practice was assigned
Glasgow population control IDs with respective birth month/years and the GP
practice was given the status of GP CONSENT. If the GP practice did not wish to
participate or did not respond to the reminder letter (see Reminder Letters section
below), the GP practice was given the status of GP REFUSAL or GP NON-
RESPONSE respectively and were not contacted again.
Selection of potential Greater Glasgow control
Each consenting GP practice was visited, during which the required number of
primary controls and their five replacements were selected at random according to
the required birth month/year(s) using the procedure as described in the appendix
(See Appendix - recruitment). The name, address and date ofbirth of each potential
control were noted on the control selection form, and then given to the GP in order to
confirm eligibility and to give permission to contact the control.
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Approach of potential Greater Glasgow population control
Once each completed and signed control selection form was returned by the GP
practice, the first potential Glasgow population control on each form was assigned an
ID number and his details were entered into the PCANDIET database. If the GP
indicated the potential control to be ineligible or did not wish him to be contacted,
the potential population control was given the status of INELIGIBLE or GP
REFUSAL respectively and was omitted from further recruitment stages. The next
potential Glasgow population control was then selected from the respective control
selection form. If the GP gave his permission to approach the potential control, the
control was approached by letter in order to invite them to take part in the study.
If the potential Glasgow population control did not wish to take part, they were given
the status ofCONTROL REFUSAL and were omitted from the study. As in the
previous steps, the next replacement control from the respective control selection
form was then selected. Otherwise they were given the status ofCONTROL
CONSENT and were recruited into the study.
4.5.4 Mailing of the Scottish Collaborative Group - Food Frequency
Questionnaire (SCG-FFQ)
Recruited subjects were sent an SCG-FFQ with an attached information sheet
regarding completion guidelines and portion sizes and a cover letter (see appendix:
FFQ and FFQ information sheet). A free phone number was also given for
population controls to telephone if they had any queries about the FFQ and it's
completion. If a subject still had difficulty in completing the FFQ, a research nurse
would then be sent round to help them in person.
4.5.5 Case-note review
For those recruited cases that gave consent to check hospital records, research nurses
visited the hospital where the appropriate case-notes were kept in order to review
each cases' case-notes regarding the PCa diagnosis, prognosis and treatment.
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4.5.6 Permission to give blood sample
Once the completed FFQ had been returned, subjects were also asked to give a blood
sample for serum phyto-oestrogen and DNA analysis. This was not part of the
present thesis, although the serum phyto-oestrogen data was used to validate the
SCG-FFQ.
4.5.7 Reminder letters
Subjects who had still not replied to any of the recruitment / data collection steps
after four weeks were re-sent the required letter and enclosures, along with a
covering letter reminding them to reply. If after another four weeks the subject had
still not replied, depending on the stage of recruitment reached, the subject was either
deemed as a NON-RESPONDER and a replacement was selected or LOST TO
FOLLOW-UP, their statuses were changed accordingly.
4.6 Subject response analysis
Subject response rates (proportion of subjects agreeing to participate within the total
number of eligible subjects contacted) were examined across status, Flealth Board,
Carstairs Deprivation Index and age group, in order to investigate the possibility of
selection bias related to subject status and other characteristics being introduced into
the study.
The overall response rate was observed to be 67%, please see Table 4.4. The
response rate was also observed to differ significantly (p < 0.001) across status, with
a higher number of cases agreeing to participate compared to controls. Subjects from
the Borders Health Board were far more likely to participate than those from the
Greater Glasgow Health Board, as were younger subjects and those with lower levels
of deprivation.
N.B. The number of responding subjects differs from the study size used in the
analysis (916) due to the inclusion of subjects who were later found to be ineligible
(21 subjects) and those who failed to complete an SCG-FFQ.
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Table 4.4: Subject response rates
All
subjects


































































































Chi-square test p < 0.0001 p< 0.0001 p = 0.025 p = 0.038
















Chi-square test p = 0.016 p = 0.265 p = 0.002 p = 0.873
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4.7 Subject data processing and management
4.7.1 Assignment of ID numb ers
Subjects were assigned ID numbers in order to protect the subjects' identity and also
to ensure that the laboratory technicians were blinded to the status of each subject.
The ID number consisted of three digits for cases, four digits for BPH controls and
five digits for the population controls, the ID number range is summarised in Table
4.5.
For cases and BPH controls, ID numbers were assigned consecutively according to
the order in which they were identified from the hospital files. For the population
controls, the first four digits denoted the control number, whereas the fifth digit
identified the control choice (primary or replacement control).
Table 4.5: ID distribution by status
Status ID Range
Cases: 1 to 980
BPH Controls: 7000 to 7615
Population Controls:
Borders: 20000 to 20201
Lothian: 10000 to 11970
Glasgow: 30000 to 31774
4.7.2 Subject recruitment spreadsheets
Recruitment and subject details were stored and managed in Microsoft Excel
spreadsheets that made up the PCANDIET database. Each subject group had their
own spreadsheet. The spreadsheets contained the information as listed in Table 4.6
In addition to storing recruitment information, the spreadsheets were used to mail-
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merge recruitment and data collection correspondence in conjunction with Microsoft
Word and also to create recruitment updates for the monthly team meetings.
Once all the recruitment and data collection stage was completed, time was taken to
clean the recruitment data, checking dates and recruitment status and correcting
incorrect date sequences.
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Control choice number (population controls only)
3. Status Recruitment status
4. Recruited Subject recruited (yes/no/ineligible)
5. Case Note Review Case note review done (cases only)
6. DT Target Date consultant / GP contacted, (not used for Lothian
population controls).
7. DT Cons/ GP Resp Date Consultant / GP responded.
8. DT Subject Resp Date Subject responded.
9. Last Name Subject's last name.
10. First Name Subject's first name.
11. DOB Subject's date of birth.
12. DODIAG Subject's date of diagnosis (Cases and BPH controls only).
13. Ref Date Reference date for calculation of age.
14. Age Subject's age (at time of recruitment)
15. Treating Consultant Subject's treating consultant (Cases and BPH controls only).
16. Treating Hospital Subject's treating hospital (Cases and BPH controls only).
17. ConsAddress_1, _2, _3 Consultant's address and postcode (Cases and BPH
controls only).
18. Unit No Unit Number.
19. Address_1, _2, _3 Subject's address and postcode.
20. FFQ Sent Date FFQ sent.
21. FFQ Recvd Date FFQ received.
22. GP Subject's GP (not Lothian controls).
23. GPAddress _1, _2, _3 GP's address and postcode (not Lothian controls).
24. Blood App Date of approach for consent to give blood sample.
25. Blood Cons Date of consent to give blood sample
26. GP No GP not willing to take blood (population controls only).
27. ID_B ID + control choice (population controls only)
28. Blood WGH Date of blood sample received at WGH Laboratories,
Edinburgh
29. Blood Cardiff Date of blood sample received at Cardiff laboratories (Cases
and population controls only).
30. Comments Additional subject details.
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4.8 FFQ Data collection and collation
4.8.1 The Scottish Collaborative Group food frequency questionnaire
The FFQ used in this study was the validated Scottish Collaborative Group Food
Frequency Questionnaire (SCG-FFQ), Version 6.31, previously known as the
Aberdeen Food Frequency Questionnaire, see Appendix: FFQ. This FFQ, modified
by Geraldine McNeil and colleagues at the University of Aberdeen, has been based
on a FFQ that has been extensively used in Scottish populations50 and has been
validated against, 4-day weighed diet records259; and now also against serum phyto-
oestrogen concentrations.
The SCG-FFQ consisted of a list of 150 foods, divided into 20 food groups (as
described in Table 4.7). Subjects were asked to describe the amount and frequency of
each food on the list they had eaten in the last 2-3 months. For those foods that were
never or rarely eaten (< once a month), subjects were asked to circle 'R' (rarely /
never). For foods that were eaten once a month or more, subjects were asked the
amount of food eaten in one day (1 measure - 5+ measures), and the number of days
in a week the food was usually eaten (once a month to 7 days per week). An FFQ
information sheet, which included a colour picture showing examples of the size of
measures, was enclosed with the FFQ. Subjects were also given the opportunity to
add other foods that they ate regularly. The FFQ also contained questions on the
type and amount of vitamins, minerals and food supplements taken, recent dietary
change and special diets / dietary restrictions, general information questions (age at
completion ofFFQ, height, weight, smoking status) and family history ofPCa / BrCa
and other prostate / breast problems.
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Table 4.7: FFQ food groups and other sections
FFQ Section Food Group / Other questions
1. a - d Bread
2. a - f Breakfast Cereals
3. a - d Milk
4. a - e Cream and Yogurt
5. a - e Cheese
6. a - c Eggs
7. a - n Meats
8. a-I Fish
9. a - i Potatoes, Rice and Pasta
10. a - s Savoury Foods, Soups and Sauces
11. a-q Vegetables
12. a-j Fruit
13. a -f Puddings
14. a-h Chocolates, Sweets, Nuts and Crisps
15. a - g Biscuits
16. a - e Cakes
17. a-g Sugar and Spreads
18. a - g Beverages and Soft Drinks
19. a - i Alcoholic Drinks
20. a - d Other Foods
Other Sections
21. a - b Vitamin, Mineral and Food Supplements
22. a - g Dietary Restrictions
23. a - b Special Diets
24. a - g General Information
24. h - s Family History Information
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4.8.2 Processing of the SCG-FFQ
Data from the SCG-FFQ was extracted using the scanning software package
TELEForm (version 5.2, Cardiff Software, Inc., San Marcos, CA), set up by Sherry
Patheal (database manager) and Alastair Murray (computing assistant).
A data entry clerk was employed to process, review and scan the FFQs. She was
supervised by the author, who was also responsible for cleaning and processing the
FFQ data ready for the nutrient calculation and in house analysis. The FFQ
processing procedure was as follows:
FFQ receiving process and storage
Completed FFQs were grouped according the subject status and allocated a storage
file, the number of which was written on the front of the FFQ. Each storage file held
ten FFQs and was grouped together in sets of three storage folders.
Pre-scan review process
Before the scanning, the pre-scan review was done using the FFQ Review checklist
(Table 4.8) to insure that the FFQ was complete and ready to scan. Once the FFQ
had been reviewed, and if necessary referred to and returned by the supervisor
(author), it was deemed ready to scan.
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1. ID number ID was written in the top right hand corner of each FFQ
page.
2. Removal of staples The staples holding the FFQ together were removed to





Each page of the FFQ was reviewed, where required the
response was enhanced so that Teleform would identify
the response, i.e. circles which were too light (pale pen or
pencil) or too small, or if tick marks were used instead.
The FFQ was referred to the supervisor if there was any
question regarding the readability, if a frequency question
had more than one response or if whole sections had not
been completed by the subject.
Questions 17e and 17g were open-ended questions
relating to the spreads, fats and oils consumed. Codes
were entered onto the FFQ according to the type of
spread / fat / oil (see appendix: Data collection for code
sheets).
Section 20 allowed subjects to record foods that were not
included in the FFQ and that they regularly ate, if the
subject had reported any 'other foods', the FFQ was
referred to the supervisor.
6. Comments Any FFQ on which the subject had written comments
were referred to the supervisor.
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SCG-FFQ referral
Those FFQs referred to the supervisor (author) were dealt with according to the
procedures summarised below:
Data Check Referrals
For Frequency questions in which there was more than one response, the lowest
response was recorded.
For FFQs with incomplete sections that were deemed to have been skipped by
mistake, a copy of the incomplete page was sent to the subject to fill in. Once
returned, the section was added to the original FFQ.
Other Foods
Where the subject had reported 'other foods', a list of other foods devised by
Geraldine McNeill and colleagues at the University of Aberdeen was used to add
these foods to existing food group questions. If there was no suitable alternative, a
note was made for reference in the analysis stage.
Comments
Any comments made by the subject were noted for future reference and acted upon if
thought to be important.
Scanning process
FFQs noted as ready to scan, were scanned using a multi-page scanner and the
software scanning package TELEForm. Once the FFQ had been scanned into the
computer, it was then verified using the TELEForm Verifier. This process involved
verifying and checking that the FFQ data had been scanned and read correctly,
particularly that open answer questions were read and identified correctly and that
the chosen value for multiple response answers was correctly identified. The FFQ
data was then automatically saved and exported to an SPSS file. Once the FFQ had
been scanned and verified, the FFQ was returned to its respective folder.
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4.8.3 FFQ data preparation
The FFQ data was cleaned and processed to create FFQ datasets for food group /
family history analysis and for the individual calculation of nutrient intakes. This
process was done in batches of 100 - 250 FFQs.
Each batch was checked for odd ID numbers, date / weight / height values, missing
variables and duplicate study numbers. Data for several FFQs picked at random were
checked with the hard copy of the FFQ. The data file was then processed using an
SPSS Macro devised by Sherry Patheal, database manager in which:
1. If the bread type (Qu. 1) was blank, a default value of all three bread types
was assigned.
2. If a day-variable (number of days eaten per week) value was blank, a default
value of 'B' was assigned as the day-value.
3. If a measure-variable (number ofmeasures eaten in a day) value was blank,
but the day-variable value was neither blank or 'R' (rarely or never), a default
value of' 1' was assigned as the measure-value.
4. If an food exclusion variable (Qu. 22) had a value of 'yes', but the subject
had reported eating this food, a flag was created.
The fixed ascii file (DAT file) created was sent to Dr David Grubb at the Rowett
Research Institute, Aberdeen for the nutrient intake calculations. The SPSS 'inhouse'
file was processed and saved for food-group and family history analyses.
4.8.4 Nutrient intake calculations
The FFQ data were processed using software based on the Oracle Relational
Database Management System (Version 7), which has been developed and routinely
used at the University of Aberdeen. Intake estimates of 39 specific nutrients and
minerals, in particular the isoflavones daidzein and genistein, were calculated using
the UK National Nutrient Databank, based on McCance and Widdowson's The
Composition of Foods (5th edition)60 and related supplements61"69, and also the new
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validated Isoflavone Food Table71'260, constructed by Margaret Ritchie at the
University of St Andrews. A list of the specific nutrients is shown on Table 4.9.
4.8.5 Food group variables
FFQ food items for several a priori food groups (see Table 4.10) were used to
calculate food group intake data, using the procedure below.
The consumption of each individual food item was computed using the formula:
Food item intake = (number ofmeasures) x (number ofdays)
(N.B. the day responses 'Rarely' and 'Monthly' were recoded to 0 and 0.5
respectively.)
Food group intake was then computed using:
Food group intake = sum offood item intakes within thefood group
Grilled meat score
The grilled meat score was calculated using the formula:
Grilled meat score = [qu. 7m] x [qu. 7n]
Where: qu.7m = number ofmeasures grilled meat per week and qu.7n = meat
doneness (1 = lightly browned, 2 = medium browned, 3 = well browned).
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Table 4.10: List of food groups
Food group FFQ food items (FFQ question number)
Dairy products





Total meat Meats (qu.7: a -1)
Red meat Meats (qu.7: a,b,c,d,e,g,h,i)
Processed meat Meats (qu.7: b,c,l,,j,k,l)
Fish Fish (qu.8)
Grilled meat Meats (qu.7: m)
Grilled meat score Meats ([qu.7: m] x [qu.7n])
Fruit & Vegetables





Savoury foods, soups & sauces (qu.10: e & g)
Alcohol type
Drinkers Vs non-drinkers Alcoholic drinks (qu.19:a)
Beer & lager Alcoholic drinks (qu.19:b,c,d)
Wine Alcoholic drinks (qu.19:e)
Spirits Alcoholic drinks (qu.19:g)
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4.8.6 Alcohol intake variables
The consumption of each alcohol type was calculated using the FFQ alcohol items in
which consumption of several types of alcohol was reported as the number of units
per week across nine categories ranging from 0 units to 40+ units. These categories
were recoded into five smaller ones for ease of analysis, as shown in Table 4.11. A
category for no overall alcohol consumption, in addition to one for no consumption
of each individual type, was also included. The top five original categories were
originally recoded into two categories (10-19 & 20+), however these were combined
into one large category due the small number of subjects reporting high consumption
of each alcohol type.
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As beer / lager was measured by three items (low alcohol beer / lager, beer and
lager), overall beer consumption was calculated by recoding the three beer items to
the appropriate category median (see Table 4.12), these recoded beer items were then
added together and recoded using the categories as shown in Table 4.10.
Table 4.12: Recoding of beer items for the calculation of overall beer consumption










4.8.7 Smoking status variable
The smoking status variable was coded using Qu. 24 f in the general information
section of the FFQ, as shown in Table 4.13.
Table 4.13: Smoking status coding
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4.8.8 Family history of PCa and BrCa variable
The family history variable was coded using the FFQ family history questions in
which subjects were asked whether any male or female relatives had been diagnosed
with prostate or breast cancer respectively as shown in Table 4.14.
Table 4.14: Family history of PCa / BrCa coding
FFQ family history response Family history code (FHIST)
No family history of either PCa or BrCa reported 0
Family history of PCa reported 1
Family history of BrCa reported 2
Family history of both PCa and BrCa reported 3
N.B. It should be noted that the family history variable was based on the responses
given in the FFQ and here not followed up for confirmation. Therefore, it is very
likely that this variable is prone to recall bias.
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4.8.9 Further FFQ data preparation
Calculation of additional anthropometric variables
Additional anthropometric characteristics including: Body Mass Index (BMI), Basal
Metabolic Rate (BMR) and the energy intake:BMR ratio (EI:BMR) were calculated
using the below formulas:
Body Mass Index (BMI)261
2BMI = weight(kg/height(m)
Estimated Basal Metabolic Mass (BMR):
Based on formula according to Schofield262
• Men aged 30 to 60 years:
BMR = (0.048 x weight(kg)) — (0.011 x height(m)) +3.670
• Men aged over 60 years:
BMR = (0.038 x weight^)) + (4.068 x height(m)) -3.491
El : BMR Ratio (EI:BMR)
Based on formula according to Goldberg et al
EI.BMR = EI/BMR
Low Energy Reporters (LERs)264
In order to control for the possible effect of under reporting, Low Energy Reporter
status, i.e. those subjects who reported consuming less total energy than their
estimated metabolic requirements were computed, using the cut-off point defined by
Black et al264:
Subject is an LER when EI:BMR <1.10
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Computation of energy-adjusted nutrient and food group variables
In order to control for the potential confounding effect of total energy intake, the
residual method, as determined by Willet and Stampfer80, was used. This method
estimates individual dietary intake when EI is constant. The procedure was as
follows:
For each dietary intake variable:
1. Check the distribution of energy intake
Check the distribution of El to identify any outliers and that the distribution is normally distributed.
2. Check the distribution of dietary intake
For each nutrient / food group check that the distribution is normally distributed. If it is not normally distributed
then the data can be transformed.
3. Simple linear regression
Perform simple linear regression with dietary intake variable as response (Y variable) and El as x variable:
Y = a + bx Where a is the intercept and b the slope.
4. Record the residuals
Save the residuals from step 3. Record the intercept (a) and the slope (b).
5. Calculate mean El
Calculate the mean El (x) i.e. mean of x.
6. Calculate expected nutrient intake, when El is constant (i.e. equal to its mean)
Calculate the expected dietary intake (y variable) using the formula:
y = a + (b x x) Where values for a and b are from step 3. and x is mean El (from step 5.).
Record the value for y for each dietary intake variable.
7. Calculate the energy adjusted dietary intake variable
To obtain the energy adjusted dietary intake value, add y to the residuals recorded in step 4.
8. For previously transformed variables
If the dietary intake in step 2 has been transformed these are to now be reversed. For example if the log
transformation of a dietary intake variable has been used then the values obtained in step 7 are to be anti-
logged.
9. Analyse the energy adjusted variables
Look at the mean, standard deviation, minimum and maximum of the energy adjusted variable.
Compare the mean of the energy adjusted variable to that of the original variable. The mean should be similar.
The standard deviation should be lower for the energy adjusted variable.
There should be no negative values in the energy adjusted variable. If negative values are present go back to
steps 1. and 2. to check for outliers and to ensure that the skewness of the data is between -1 and 1.
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4.9 Deprivation category data
The Carstairs deprivation index (DEPCAT)265, based on the 1991 Census data, was
assigned to each subject at the postcode sector level. The index contained seven
categories ranging from very low deprivation (DEPCAT = 1) to very high
deprivation (DEPCAT = 7).
N.B. DEPCAT data was missing for several subjects, due to postcode changes and
the exclusion of very small postcode sectors from the DEPCAT calculation.
4.10 Histo-pathological and case-note review
Pathology specimens from all cases were reviewed by Dr Ken Grigor at University
ofEdinburgh for which the stage and grade of each PCa case was classified and the
eligibility confirmed.
The case-notes were reviewed by the research nurses, supervised Professor Freda
Alexander, in order to confirm stage and grade classification and to elucidate any
other information regarding diagnosis and prognosis that may be important.
N.B. Stage and grading data was not available for the present analysis.
4.11 The PCANDIETAccess Database
Once all the data for PCANDIET was collected and cleaned, it was collated together
within one large Microsoft Access database. Each set of data was contained on a
separate table, see Figure 4.2 for an overview of the PCANDIET database tables and
relationships. The tables were linked together by a key variable (ID number).
Although this database was primarily used to store the data in a convenient form, the
query function was used to collate data for analysis when needed.
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Figure 4.2: PCANDIET database relationship summary
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4.12 Data analysis
4.12.1 List of dietary and confounding variables
To test the hypotheses as stated in the aims and objectives section of this chapter, the













12. Carotenes (as carotenoid equivalents)
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The following potential confounding variables were also included in the analysis:
1. Age
2. Family history of PCa and BrCa
3. Carstairs deprivation index (DEPCAT)
4. Smoking
5. EI:BMR ratio
6. BMI (N.B. BMI was not included in the final model as it was shown not to be
associated with any dietary factor nor PCa risk)
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4.12.2 Statistical analysis
The statistical analyses were conducted using the statistical packages SPSS (version
11, SPSS Inc. USA ) and STATA (Intercooled Stata, version 7.0, USA).
The analysis was divided into two main parts, the analysis of nutrient intake and the
analysis of selected food groups, the analysis for both these parts followed the same
method as follows:
Descriptive analysis
The distributions of each dietary and potential confounding variable were examined.
Any extreme values / outliers were investigated with the view of omitting from
subsequent analyses using continuous data. Any variable showing a skewed
distribution was normalised using log transformation.
A correlation analysis, using Spearman's Rank Correlation was also performed on
dietary and potential confounding variables in order to examine any associations
between these variables.
The distributions of each dietary and potential confounding variable were then
examined by:
• BPH Vs population controls (in order to confirm that dietary intake did not
vary significantly between these two control groups, thereby allowing for the
two control groups to be combined into one control group).
• Cases Vs BPH and population controls
• Potential confounding variables (using categorical variables)
Differences in dietary intake and confounding variables were tested for significance
using both parametric (t-tests: for tests between two groups, and ANOVA: for tests
between more than two groups) and non-parametric tests (Mann-Whitney U: for tests
between two groups, and Kruskal-Wallis: for tests between more than two groups).
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Data categorisation
Continuous dietary and confounding variables were grouped into four categories
using quartiles (based on the distributions within the combined control group) as the
cut-offpoints. Categories that had too few subjects in them were combined with the
next lowest category.
Odds ratio (OR) analysis
Crude ORs
The association of case / control status with each dietary and confounding variable
was examined using 2x4 tables. Each nutrient intake category was compared with the
reference category (lowest category) in order to obtain crude ORs and 95%
confidence intervals (95%CIs). The score test for a linear trend of the odds ratios was
also conducted to examine any potential dose-response effects.
Mantel-Haeszel Test for Interaction
In order to test for any interaction between dietary variables and confounding
variables, ORs and 95%CIs were estimated for each dietary variable stratified by
each confounding variable using the Mantel-Haeszel method, so as to examine the
OR within each individual confounding variable category. Interaction was examined
using the Mantel-Haeszel test for homogeneity ofORs.
Log Likelihood Ratio test
The log likelihood ratio test was used to examine the effect of each dietary variable
on PCa risk, with and without adjusting for confounding factors. The effect of each
confounding variable was also examined.
Multiple logistic regression
Multiple logistic regression models were used to study the effect of each dietary
variable adjusting for the confounding variables as listed previously. Adjusted ORs
were calculated with 95%CIs.
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N.B. Energy-adjusted dietary variables, calculated using the residual method, were
included in the model instead of the original dietary variables, in order to control for
EI.
Analysis omitting LERs
A descriptive analysis for all dietary and confounding variables by LER status was
conducted to examine any variation in dietary intake and confounding between LERs
and non-LERs.
The descriptive, crude OR and logistic multiple regression analysis was then
repeated omitting LERs in order to examine whether potential misclassification due
to under-reporting had effected the estimations of risk.
Analysis stratified by age group
As age is a known risk factor for PCa and that dietary intake has been observed to
change with age, it is possible that there may be an interaction between age group
and dietary intake, as has been noted by previous studies observing a variation in the
effect of dietary factors on PCa between older and younger subjects98. The analysis
was therefore repeated stratified by two age groups: younger (< 65 yrs) and older
(>65 yrs).
Methodology page 167
5 . Chapter 5: Resu Its
Prostate Cancer & Diet
5.1 Dataset
The dataset used for analysis contained 916 subjects (after four subjects whose FFQs
were found to be reviewed incorrectly and thirteen age ineligible subjects were
omitted). Data were complete for all nutrient variables and for age. However data for
weight and/or height, on which the variables BMI, EI / BMR ratio and LER status
were based on, were missing for twenty nine subjects, and data for smoking status
and the Carstairs deprivation index were missing for fifteen and seventeen subjects
respectively.
5.2 Subject characteristics
The 916 subjects consisted of 433 cases and 483 controls, see Table 5.1. The
majority of continuous general characteristics, including the potential confounding
variables (see methods chapter for list of confounding variables) were normally
distributed, see Figure 5.1. An exception was age which was skewed towards the
older age groups, where the incidence of PCa increases. The distributions of
categorical general characteristics are also shown in Figure 5.1. The majority of
subjects reported no family history of either PCa or BrCa (74.8%) and were either
non- or ex-smokers (81.4%). They also tended to be low to moderately deprived
(Carstairs deprivation index 3 and 4), with relatively few subjects being highly
deprived (Carstairs deprivation index 6 and 7).
Table 5.1: Study subjects
Subject Group Number of eligible subjects (%)
Cases 433 (47)
Controls
• BPH controls 178 (20)
• Population controls 305 (33)
Total 916 (100)
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Figure 5.1: Distributions of general characteristics and potential confounders
Fig 5.1a: Age Fig 5.1b: Height
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El / BMR Ratio
Results: Subjects page 169
Prostate Cancer & Diet
Fig 5.1, cont.: Distributions of general characteristics and potential confounders
Fig 5.1f: Family history Fig 5.1g: Smoking status
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No family history Family history BrCa
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Smoker
1.00 2.00 3.00 4.00 5.00
Carstairs deprivation index
Fig 5.1 i: Low energy responder (LER)
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5.2.1 Distribution of general characteristics by case-control status
A summary of the distribution of general characteristics by subject status is shown in
Tables 5.2 and 5.3. BPH and population controls were combined together, as no
significant differences were observed between the BPH and population controls with
the exception of age and the Carstairs deprivation index, see Tables 5.4 and 5.5.
Cases were significantly older than controls, the significant difference is probably
due to the inclusion ofBPH controls which were not frequency matched to cases
unlike the population controls. The EI / BMR ratio was also significantly higher
within the cases, suggesting either that cases consumed more food than necessary
(thereby suggesting that over consumption is association with increased risk of PCa)
or that controls were underreporting. As BMI did not differ significantly between
cases and controls the latter seems more likely, this was confirmed by the proportion
of LERs being significantly higher within the control group, see Table 5.3. Family
history of PCa and/or BrCa was also observed to be significantly higher within the
cases (Table 5.3).





































































BMI = Body mass index
El / BMR ratio = Energy intake : basal metabolic rate ratio
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Table 5.3: Distribution of general characteristics by status (categorical variables)
Confounding Variable Frequencies (n)
Cases (%] Controls Total Subjects




No Family History of
Prostate or Breast Cancer
298 (69) 387 (80) 685 (75)
Family History of Prostate
Cancer
60(14) 38 (8) 98 (11)
Family History of Breast
Cancer
58(13) 48(10) 106(12)
Family History of Prostate
and Breast Cancer
17(4) 10(2) 27 (3)
Total 433(100) 483 (100) 916(100)
Missing Values 0 0











Smoker 76(18) 79(17) 155 (17)
Total 425 (100) 476 (100) 901 (100)
Missing Values 8 7











Total 421 (100) 466 (100) 887
Missing Values 12 17

















4 75(18) 93 (20) 168
5 54 (13) 69(15) 123
6 31 (7) 33 (7) 64
7 37 (9) 35 (7) 72
Total 427 (100) 472(100) 899
Missing Values 6 11
Chi-square test (p value) = 0.87
17
N.B percentages may not add up to 100% due to rounding.
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Table 5.4: Distribution of general characteristics between population and BPH controls
(continuous variables)
Continuous Population controls BPH Controls Test for difference between
Variables (n=305) (n=178) population and BPH
controls
Mean Median Mean Median T-test Mann-Whitney
(s.d.) (l-QR) (s.d.) (l-QR) (p-value) U Test
(p-value)
Age (years) 66.7 67.4 64.8 65.0 0.001 <0.001
(4.9) (63.8-69.9) (6.0) (60.7-69.6)
Height (m) 1.75 1.75 1.74 1.73 0.14 0.14
(0.07) (1.70-1.80) (0.07) (1.68-1.78)
Weight (m) 79.2 77.6 78.9 78.0 0.75 0.82
(12.3) (71.2-85.7) (11.9) (71.2-86.6)
BMI 26.0 25.6 26.2 26.0 0.35 0.50
(3.5) (23.7-27.7) (3.7) (23.6-28.7)
El / BMR 1.52 1.46 1.51 1.42 0.75 0.86
ratio (0.52) (0.48) (1.20-1.76)
BMI = Body mass index
El : BMR ratio = Energy intake : basal metabolic rate ratio
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Table 5.5: Distribution of general characteristics between population and BPH controls
(categorical variables)












No Family History of
Prostate or Breast Cancer
250 (82) 137 (77) 387 (80)
Family History of Prostate
Cancer
18(6) 20 (11) 38 (8)
Family History of Breast
Cancer
30(10) 18(10) 48(10)
Family History of Prostate
and Breast Cancer
7(2) 3(2) 10(2)
Total 305(100) 178(100) 483(100)
Missing Values 0 0
Chi-square test (p value) = 0.20
0
Smoking Non Smoker 135 (45) 94 (53) 229 (48)
Ex Smoker 106 (36) 62 (35) 168 (35)
Smoker 58 (19) 21 (12) 79(17)
Total 299(100) 177 (100) 476(100)
Missing Values 6 1
Chi-square test (p value) = 0.07
7
LER Yes 62 (21) 33 (19) 95 (20)
No 233 (79) 138(81) 371 (80)
Total 295(100) 171 (100) 466(100)
Missing Values 10 7

















4 55 (19) 38 (22) 93 (20)
5 35 (12) 34(19) 69(15)
6 26 (9) 7(4) 33 (7)
7 34 (11) 1 (1) 35 (7)
Total 296(100) 176 472 (100)
Missing Values 9 2
Chi-square test (p value) <0.001
11
N.B. percentages may not add up to 100% due to rounding
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5.3 Nutrient analysis
The following section reports the results of the nutrient analysis part of the study.
5.3.7 Nutrient intake distribution
Distributions for the majority of nutrient intakes were shown to have some degree of
skewedness towards lower intake, in particular alcohol, retinol, and the antioxidants
(carotenes, vitamin E, vitamin C and the isoflavones) see Fig 5.2. Only EI and
protein intake neared normality. Due to the nutrient intake being generally skewed,
the nutrient intake variables were normalised by log transformation for the use in
parametric tests, in addition to the use of non-parametric tests.
5.3.2 Outliers
Analysis of the nutrient intake distributions revealed outliers for many of the nutrient
intakes. Several subjects were reported as having very high intakes of total energy
and fats. These subjects also had very high EI/BMR ratios therefore suggesting that
they were high-energy responders (HERs) (i.e. over-reported dietary intake). Due to
this and the presence of LERs, the EI/BMR ratio was included in the final model in
order to control for both over and under reporting.
Several subjects were reported to have very high intakes of antioxidants, in particular
isoflavones and carotenes and selenium. The majority of these outliers were cases
who had changed their diet after diagnosis to include food items known to contain
high levels of antioxidants and isoflavones, i.e. soy products for isoflavones and
tomatoes for lycopene (carotenes). This information was gained from notes written
on the completed FFQs. Unfortunately there was no adequate FFQ question
regarding change in diet over last three months (i.e. since diagnosis), which could
have been used to control for this effect. The results for these nutrients should
therefore be interpreted with caution.
For the present analysis no outliers where omitted, as the repeated checking ofFFQs
showed that subjects with very high intakes of these nutrients had indeed reported to
consume high quantities of the respective food items. Also as categorical variables
for nutrient intake were used in the odds ratio analysis, instead of the original
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continuous variables, the potential effect that these outliers may have on the observed
ORs would be reduced.
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Figure 5.2: Distribution of nutrient intake
Fig 5.2a: El Fig 5.2b: Protein
Std. Dev = 3352.60
Mean = 10343.2
N = 916.00
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Fig 5.2e: Mono-unsaturated fat Fig 5.2f: Poly-unsaturated fat
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Fig 5.2, cont: Distribution of nutrient intake
Fig 5.2g Cholesterol Fig 5.2h: Alcohol
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Mean = 380.4
N = 916.00
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Fig 5.2n: Vitamin E
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Fig 5.2, cont: Distribution of nutrient intake
Fig 5.2m: Vitamin C
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5.3.3 Nutrient Intake: by control status (BPH Vs population controls)
In order to confirm that there were no major significant differences between the
population and BPH controls, thereby justifying the combining of these two control
groups into one control group, the distribution of nutrient intakes between population
and BPH controls were examined, see Table 5.6.
No significant differences between population and BPH controls were reported, with
the exception of vitamin E and alcohol (Mann-Whitney U test only), thereby
confirming that there were no major significant differences between population and
BPH controls.
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Total Energy (kj) 10113 9657 10151 9731 0.63 0.88
(3423) (7705-11956) (3227) (8047-11375)
Protein (g) 96.46 93.10 96.14 91.20 0.68 0.99
(35.14) (72.80-117.0) (31.38) (76.66-110.5)
Total Fat (g) 90.12 83.90 91.17 86.05 0.52 0.60
(36.48) (63.3-110.2) (34.28) (67.30-108.6)
Saturated Fat (g) 36.46 33.20 37.04 35.00 0.46 0.57
(16.17) (24.85-46.7) (15.27) (26.48-44.80)
MUFA (g) 31.37 29.50 31.74 30.15 0.54 0.69
(12.90) (22.4-38.55) (12.41) (23.10-37.58)
PUFA (g) 14.31 13.10 14.52 13.65 0.39 0.29
(6.85) (9.55-18.00) (5.91) (10.30-17.63)
Cholesterol (mg) 369.1 336.0 350.5 317.5 0.66 0.43
(185.7) (240.5-457.5) (150.1) (248.8-446.0)
Alcohol (g) 15.5 11.4 12.5 7.8 0.19 0.03
(15.2) (3.7-24.5) (13.2) (2.4-17.8)
Calcium (mg) 1096 1031 1110 1070 0.22 0.54
(435) (789-1340) (367) (847-1284)
Selenium (Fg) 77 73 80 74 0.27 0.42
(33) (56-93) (34) (57-95)
Retinol (Fg) 721 579 666 567 0.76 0.96
(604) (343-884) (501) (395-813)
Carotenoids (Fg) 2850 2234 2559 1992 0.82 0.60
(2417) (1237-3480) (1837) (1376-3386)
Vitamin E (Fg) 8.11 6.99 8.74 7.76 0.02 0.02
(4.82) (4.53-10.24) (4.27) (5.46-11.00)
Vitamin C (mg) 103.5 87.5 106.8 95.1 0.24 0.38
(61.3) (61.9-135.1) (61.2) (65.7-134.5)
Isoflavones (Fg) 1747 991 1988 1226 0.05 0.06




s.d. = Standard Deviation
l-QR = Inter-quartile Range
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
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5.3.4 Distribution of nutrient intake: by case-control status
Controls were observed to have lower intakes of all nutrients compared to cases,
however these differences were observed to be significant for total energy, protein,
total fat and its constituents (excluding poly-unsaturated fat), alcohol and calcium
(Mann-Whitney U test only) only, see Table 5.7. Antioxidant intakes were observed
to have no significant differences between cases and controls.
Please see Appendix: Table 8.1 for the distribution of all nutrients by case-control
status.
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Table 5.7: Descriptive Report of nutrient intake by status
Daily Nutrient Cases Controls Test for difference
Intake (n=437) (Population and BPH controls) between Cases and
(n=483) Controls
Mean Median Mean Median T-test * Mann-
(s.d.) (l-QR) (s.d.) (l-QR) (p-value) Whitney
U Test
(p-value)
Total Energy (kJ) 10584 10165 10127 9684 0.02 0.02
(3344) (8369-12370) (3349) (7874-11757)
Protein (g) 100.69 96.10 96.34 92.10 0.02 0.03
(33.07) (78.15-118.85) (33.77) (74.70-112.70)
Total Fat (g) 95.95 91.30 90.51 84.90 0.01 0.01
(35.77) (72.75-116.30) (35.66) (65.30-109.60)
Saturated Fat (g) 39.36 37.00 36.67 34.00 0.01 0.01
(16.71) (27.55-48.15) (15.83) (25.30-46.30)
MUFA (g) 33.32 31.20 31.50 29.90 0.01 0.01
(12.34) (25.50-40.60) (12.71) (22.80-38.30)
PUFA (g) 14.83 13.90 14.39 13.30 0.14 0.14
(6.29) (10.50-17.90) (6.51) (9.70-17.80)
Cholesterol (mg) 401 368 362 326 0.001 <0.001
(194) (277-486) (173) (242-450)
Alcohol (g) 13.2 7.9 14.4 9.9 0.03 0.06
(15.1) (1.8-20.3) (14.6) (3.4-21.6)
Calcium (mg) 1143 1110 1101 1039 0.08 0.04
(400) (859-1373) (411) (812-1321)
Selenium (Fg) 83 75 78 73 0.15 0.25
(45) (58-98) (33) (56-94)
Retinol (Fg) 759 582 701 571 0.13 0.15
(647) (390-910) (568) (348-838)
Carotene (Fg) 2690 2143 2742 2187 0.49 0.75
(2156) (1185-3614) (2224) (1308-3447)
Vitamin E (Fg) 8.70 7.31 8.34 7.27 0.16 0.30
(4.86) (5.35-10.97) (4.63) (4.89-10.56)
Vitamin C (mg) 110.4 97.2 104.7 90.5 0.25 0.19
(67.1) (65.2-136.5) (61.2) (62.5-134.7)
Isoflavones (Fg) 1975.9 1143.2 1835.7 1050.9 0.16 0.10




s.d. = Standard Deviation
l-QR = Inter-quartile Range
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
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5.3.5 Correlation between individual nutrient intakes
As expected, crude correlation coefficients showed that the majority of nutrients
were highly positively correlated with each other, see Appendix: Table 8.2.
Therefore, the correlation analysis was repeated using El-adjusted nutrient intakes.
Most nutrients remained associated with each other, though these correlations tended
to be weaker, see Table 5.8. Total fat and its constituents continued to be strongly
positively associated with each other, with the exception ofPUFA and saturated fat /
cholesterol for which significant negative associations were observed. Retinol was
also highly positively associated with fats. Significant inverse associations were
observed between fats and most antioxidants, especially total fat, saturated fat and
cholesterol, whereas PUFA was shown to be positively associated with antioxidants,
in particular vitamin E and selenium, as was selenium and protein. Antioxidants also
continued to be associated with each other. Whereas alcohol was observed to be
inversely associated with most nutrients, especially total fat and its constituents and
calcium.
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5.3.6 Nutrient intake by confounding variables
The association between nutrient intake and confounding variables were examined
using Spearman's rank correlation, see Table 5.9. The EI: BMR ratio was
significantly positively correlated with all nutrients, and also age. Significant inverse
correlations were observed between age and alcohol, and also family history,
Carstairs deprivation index and BMI. Family history of PCa / BrCa was significantly
positively correlated with total energy, protein, PUFA, selenium and vitamin E
intake, but with no other confounding variables. Smoking status was significantly
positively correlated with cholesterol and alcohol and significantly inversely
correlated with PUFA, carotene, isoflavones and vitamins E and C. Whilst BMI was
significantly positively correlated with protein, PUFA, cholesterol, selenium,
carotene and vitamin C intakes.
To examine the association between nutrient intake and confounding variables
further, mean nutrient intake (with 95%CIs) were compared across confounding
variable categories. The associations that were observed to be significant are shown
in Figures 5.3 to 5.9. As expected, intake for all nutrients increased significantly
across total energy and the ETBMR ratio categories (Figures 5.4 and 5.8). Most
nutrients also varied significantly across the Carstairs deprivation index (Figure 5.6).
In general, no clear linear trends were observed, with most nutrient intakes,
especially fat and its constituents, remaining relatively homogeneous across most of
the deprivation index categories except categories 5 and 6 for which intake tended to
be relatively higher and lower respectively. However, intakes for calcium, retinol,
carotene and vitamin C were shown to decrease with increasing deprivation, whereas
cholesterol was shown to increase.
Nutrient intake also varied across smoking status, with cholesterol, alcohol and
retinol intake being higher in ex-smokers and smokers, whilst for carotene, vitamins
E and C, isoflavones and PUFA, intake was higher in non smokers (Figure 5.7).
However, only alcohol and retinol varied significantly across age categories (Figure
5.3), which was surprising as there is general evidence that dietary intake decreases
in old age105. In addition, only PUFA, selenium and vitamin E varied significantly
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across family history categories (Figure 5.5), with intake increasing with increasing
family history categories, and only carotene intake varied significantly across BMI
categories (Figure 5.9).
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Figure 5.3: Nutrient intake across age categories
Fig 5.3a: Alcohol Fig 5.3b: Retinol
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Figure 5.4: Nutrient intake across El categories
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Fig 5.4, Cont. Nutrient intake across El categories
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Fig 5.4, cont.: Nutrient intake across El categories
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Figure 5.5: Nutrient intake across family history categories
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Figure 5.6: Nutrient intake across Carstairs deprivation index
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Fig 5.6, Cont.: Nutrient intake across Carstairs deprivation index
Fig 5.6c: Total fat Fig 5.6d: Saturated fat
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Fig 5.6, Cont.: Nutrient intake across Carstairs deprivation index
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Figure 5.7: Nutrient intake across smoking status
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Figure 5.7, cont.: Nutrient intake across smoking status
Fig 5.7c: Alcohol Fig 5.7d: Retinol
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Smoker Smoker
Fig 5.7e: Carotenes Fig 5.7f: Vitamin E
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Figure 5.8: Nutrient intake across EI:BMR ratio categories
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Fig 5.8, Cont.: Nutrient intake across EI:BMR ratio categories
Fig 5.8g: Cholesterol Fig 5.8h: Alcohol
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Fig 5.8, Cont.: Nutrient intake across EI:BMR ratio categories
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5.3.7 Odds Ratio analysis
Crude ORs
The majority of nutrients were observed to have positive crude ORs (OR > 1.3)
between the reference (lowest) and highest intake categories, with the exception of
carotenes and vitamin C for which no association was observed, and alcohol which
was observed to have an inverse, though non-significant, association with PCa risk,
see Table 5.10. Several of these positive associations were shown to be significant,
including: EI (OR 1.56, 95%CI 1.08-2.27), protein (OR 1.46, 95%CI 1.01-2.11),
total fat (OR 1.86, 95%CI 1.27-2.74), saturated fat (OR 1.56, 95%CI 1.07-2.27),
MUFA (OR 1.85, 95%CI 1.26-2.73), cholesterol (OR 2.00, 95% 1.36-2.95), calcium
(OR 1.52, 95%CI 1.05-2.22) and retinol (OR 1.47, 95%CI 1.01-2.13).
Crude ORs for other non a priori nutrients are found in Appendix: Table 8.3.
Significant crude ORs between the reference (lowest) and highest categories were
also observed for the majority of potential confounding variables, including: age (OR
1.97, 95%CI 1.36-2.83) and EI: BMR ratio (OR 1.75, 95%CI 1.19-2.56), and also for
family history of PCa (OR 2.05, 95%CI 1.32-3.17), family history ofBrCa (OR
1.56, 95%CI 1.03-2.37), ex-smoker (OR 1.36, 95%CI 1.01-1.81). See Appendix:
Table 8.4
Score test for trends
In addition, a dose response effect was found for total energy, protein, total fat and
its constituents (excluding PUFA) and calcium, with the crude ORs of these nutrients
being observed to increase significantly with higher intake categories, see Table
5.10.
Score tests for other nutrients are found in Appendix: Table 8.3.
Test for interaction
ORs (and 95% CIs) for nutrient intakes stratified by each confounding variable
category were computed using the Mantel Haenszel method, in order to examine the
ORs within each individual confounding variable category and to test for interaction.
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The results showed that there was no evidence for interaction between the nutrient
variables and confounding variables, with the exception of vitamin C with total
energy and EI/BMR ratio, and PUFA with the Carstairs deprivation index.
Log likelihood ratio test
The Log Likelihood test was used to examine the effect of each nutrient variable on
PCa risk, whilst adjusting for the confounding variables. Only cholesterol was
observed to have a significant effect on PCa risk.
Adjusted ORs
The controlling for confounding variables, including the use of energy adjusted
nutrient intakes (using the residual method), had a great effect on the observed
associations with PCa risk, see Table 5.10. Whereas before the controlling for
confounding variables, significant positive crude associations were observed for
protein, fat and its constituents, calcium and retinol, only cholesterol continued to
have a significant adjusted OR (OR 1.57, 95%CI 1.04-2.37). Whereas the borderline
significant inverse association between alcohol intake and PCa risk became stronger
when adjusted for (OR 0.66, 95%CI 0.44-0.99). In addition, several nutrients were
observed to become inversely, though non-significantly associated with PCa,
including PUFA, calcium, selenium, carotene and vitamin E. A borderline significant
dose response effect was observed for cholesterol only (p = 0.054).
Adjusted ORs for other nutrients are found in Appendix: Table 8.3.
Results: Nutrient analysis page 200
Prostate Cancer & Diet




Crude OR Adjusted ORa
OR (95% CI) OR (95% CI)









1.21 (0.82-1.77) 1.02 (0.59-1.76)
1.22 (0.83-1.78) 1.03 (0.53-2.01)
1.56 (1.08-2.27) 0.96 (0.41-2.25)
Score test for linear trend: p = 0.022b, 0.996 0









1.10 (0.76-1.61) 0.99 (0.67-1.46)
1.16 (0.79-1.69) 0.91 (0.61-1.36)
1.46 (1.01-2.11) 1.00 (0.67-1.48)
Score test for linear trend: p = 0.042 b, 0.964°









1.55 (1.05-2.29) 1.11 (0.75-1.64)
1.53 (1.04-2.27) 1.11 (0.75-1.65)
1.86 (1.27-2.74) 1.10 (0.74-1.65)
Score test for linear trend: p = 0.003 b, 0.949 °









1.21 (0.82-1.78) 1.03 (0.69-1.54)
1.56 (1.07-2.27) 1.03 (0.69-1.54)
1.56 (1.07-2.27) 1.15 (0.77-1.72)










1.56 (1.06-2.30) 1.17 (0.79-1.75)
1.53 (1.04-2.27) 1.21 (0.81-1.81)
1.85 (1.26-2.73) 1.25 (0.83-1.87)










1.26 (0.87-1.84) 0.88 (0.60-1.30)
1.40 (0.97-2.03) 1.01 (0.69-1.49)
1.24 (0.85-1.81) 0.86 (0.57-1.28)
Score test for linear trend: p = 0.221 b, 0.782 °









1.29 (0.86-1.92) 0.95 (0.63-1.43)
1.83 (1.24-2.70) 1.26 (0.85-1.88)
2.00 (1.36-2.95) 1.57 (1.04-2.37)
Score test for linear trend: p = 0.0001 b, 0.054°
Cont.
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Table 5.10, Cont.: Crude and adjusted ORs for nutrient intake





OR (95% CI) OR (95% CI)
Alcohol (g) 0-3.4 129 122 1.00 . 1.00 -
3.4-9.9 112 120 0.88 (0.62-1.26) 0.80 (0.55-1.17)
9.9-21.6 102 122 0.79 (0.55-1.14) 0.72 (0.49-1.07)
>21.6 90 119 0.72 (0.49-1.04) 0.66 (0.44-0.99)
Score test for linear trend: p = 0.060b, 0.196°
Calcium (mg) 0-812 84 121 1.00 - 1.00 -
812 - 1039 104 121 1.24 (0.84-1.82) 1.15 (0.77-1.71)
1039- 1321 118 121 1.40 (0.96-2.05) 1.33 (0.90-1.97)
> 1321 127 120 1.52 (1.05-2.22) 0.81 (0.54-1.23)
Score test for linear trend: p = 0.022b, 0.091°
Selenium (Mg) 0-56 102 121 1.00 - 1.00 -
56-73 103 122 1.00 (0.69-1.45) 0.92 (0.62-1.35)
73-94 105 122 1.02 (0.70-1.48) 0.67 (0.45-0.99)
>94 123 118 1.24 (0.86-1.78) 0.88 (0.59-1.29)
Score test for linear trend: p = 0.257", 0.222°
Retinol (Mg) 0-348 86 121 1.00 . 1.00 -
348 - 571 124 121 1.44 (0.99-2.10) 1.11 (0.75-1.65)
571 - 838 98 121 1.14 (0.78-1.67) 0.94 (0.63-1.40)
>838 125 120 1.47 (1.01-2.13) 1.21 (0.82-1.80)
Score test for linear trend: p = 0.141 0.587°
Carotene (Mg) 0-1308 117 121 1.00 - 1.00 -
1308-2187 103 121 0.88 (0.61-1.27) 0.73 (0.49-1.07)
2187-3447 95 121 0.81 (0.56-1.18) 0.77 (0.52-1.13)
> 3447 118 120 1.02 (0.71-1.46) 0.76 (0.51-1.14)
Score test for linear trend: p = 0.9720.367°
Vitamin E (Mg) 0 - 4.89 82 121 1.00 - 1.00 -
4.89-7.27 131 121 1.60 (1.10-2.33) 0.92 (0.62-1.37)
7.27-10.56 103 121 1.26 (0.85-1.85) 1.07 (0.72-1.57)
> 10.56 117 120 1.44 (0.98-2.11) 0.86 (0.57-1.28)
Score test for linear trend: p =0.2060.714°
Cont.
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Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)









0.89 (0.61-1.30) 1.13 (0.76-1.69)
1.22 (0.85-1.76) 1.12 (0.75-1.67)
1.10 (0.76-1.58) 1.18 (0.79-1.78)










1.05 (0.72-1.54) 1.12 (0.76-1.67)
1.18 (0.81-1.71) 1.11 (0.75-1.65)
1.34 (0.93-1.93) 1.18 (0.79-1.75)
Score test for linear trend: p = 0.094b, 0.874 °
N.B.
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
El = Energy Intake
a
= Adjusted for Age, El (residual method), Family History of PCa and BrCa, Deprivation Index, Smoking and
EI/BMR Ratio.
b
= Crude ORs, c= adjusted ORs.
Results: Nutrient analysis page 203
Prostate Cancer & Diet
5.3.8 Low energy responders (LERs) analysis
As reported in the subjects characteristics section, 157 subjects (17%) were classified
as LERs (see Table 5.3) with significantly more controls reported as LERs than
cases. In order to examine further the effect this may have on the results and also to
eliminate any possible effect this potential bias may have, the above analysis was
repeated.
Nutrient intake by LER status
As expected, intake for all nutrients was observed to be significantly lower in the
LERs than non-LERs, see Table 5.11.
Nutrient intake: by status, omitting LERs
The omission of LERs had a great effect on the significance of the variation of
nutrient intakes by status. Although intakes for most nutrient were still higher within
the cases, apart from alcohol and carotene for which intakes were lower in the cases,
these differences were significant for cholesterol, alcohol and retinol intake only (the
latter two with the T-Test only) see Table 5.12.
Results: Nutrient analysis page 204
Prostate Cancer & Diet
Table 5.11: Distribution of nutrient variables by LER status
Nutrient Daily Intake
Variables















Total Energy (kj) 11159 10464 6402 6488 <0.001 <0.001
(3071) (9045-12884) (1114) (5798-7042)
Protein (g) 105.72 100.30 63.01 62.30 <0.001 <0.001
(31.52) (84.10-120.50) (15.16) (52.25-72.20)
Total Fat (g) 101.15 95.80 54.04 53.50 <0.001 <0.001
(33.47) (78.10-118.90) (14.87) (43.30-65.30)
Saturated Fat (g) 41.36 39.10 21.42 20.60 <0.001 <0.001
(15.55) (30.20-49.70) (7.21) (16.35-26.35)
MUFA (g) 35.16 33.30 18.85 19.00 <0.001 <0.001
(11.78) (26.80-41.30) (5.42) (14.75-22.85)
PUFA (g) 15.79 14.70 8.85 8.30 <0.001 <0.001
(6.25) (11.30-18.70) (3.30) (6.55-10.55)
Cholesterol (mg) 412 383 229 220 <0.001 <0.001
(183) (292-497) (92) (163-292)
Alcohol (g) 14.5 9.7 10.8 6.1 0.004 0.002
(15.2) (3.2-21.6) (12.6) (1.7-15.6)
Calcium (mg) 1200 1151 736 722 <0.001 <0.001
(388) (926-1402) (244) (568-862)
Selenium (Fg) 86 79 53 50 <0.001 <0.001
(39) (63-101) (27) (38-60)
Iodine (Fg) 196 180 119 107 <0.001 <0.001
(85) (140-232) (57) (85-144)
Retinol (Fg) 779 618 482 311 <0.001 <0.001
(619) (427-920) (477) (207-529)
Carotene (Fg) 2893 2290 1871 1556 <0.001 <0.001
(2242) (1364-3763) (1692) (768-2502)
Vitamin E (Fg) 9.20 7.83 5.18 4.26 <0.001 <0.001
(4.77) (5.72-11.66) (2.78) (3.27-6.23)
Vitamin C (mg) 115.9 101.5 66.3 60.4 <0.001 <0.001
(65.6) (71.6-143.4) (33.5) (42.7-84.6)
Isoflavone (Fg) 2107.04 1236.80 910.58 602.10 <0.001 <0.001




s.d. = Standard Deviation
l-QR = Inter-Quartile Range
MUFA = Mono Unsaturated Fat
PUFA = Poly Unsaturated Fat
Carotene = Carotene Equivalent
Vitamin E = "-Tocopherol Equivalent
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Total Energy (kJ) 11283 10729 11039 10249 0.20 0.16
(3074) (9183-12896) (3067) (8914-12867)
Protein (g) 106.88 101.80 104.61 98.95 0.28 0.23
(31.22) (85.00-122.10) (31.81) (83.80-118.98)
Total Fat (g) 102.88 97.30 99.50 95.00 0.09 0.09
(33.50) (79.60-119.60) (33.40) (76.25-116.35)
Saturated Fat (g) 42.34 40.20 40.43 38.10 0.05 0.10
(15.97) (31.20-50.10) (15.09) (29.63-49.58)
MUFA (g) 35.71 33.50 34.64 33.10 0.09 0.08
(11.53) (27.70-41.90) (12.00) (25.90-40.53)
PUFA (g) 15.84 14.90 15.73 14.35 0.70 0.52
(6.12) (11.70-18.50) (6.38) (10.90-18.77)
Cholesterol (mg) 428 404 396 362 0.005 0.004
(192) (313-506) (172) (278-482)
Alcohol (g) 13.9 8.2 15.0 10.3 0.02 0.09
(15.5) (2.4-20.8) (14.9) (3.6-23.8)
Calcium (mg) 1207 1162 1194 1139 0.40 0.43
(381) (936-1420) (394) (917-1396)
Selenium (Fg) 88 81 84 79 0.68 0.76
(45) (63-102) (32) (62-100)
Retinol (Fg) 821 622 739 615 0.03 0.07
(665) (460-1000) (569) (403-867)
Carotene (Fg) 2856 2284 2928 2295 0.56 0.85
(2195) (1339-3847) (2288) (1383-3732)
Vitamin E (Fg) 9.31 7.79 9.10 7.84 0.69 0.71
(4.90) (5.75-11.91) (4.65) (5.69-11.05)
Vitamin C (mg) 116.7 105.6 115.1 98.9 0.93 0.88
(69.0) (70.1-142.4) (62.3) (73.0-144.1)
Isoflavone (Fg) 2159.65 1340.80 2056.74 1181.20 0.34 0.18




s.d. = Standard Deviation
l-QR = Inter-Quartile Range
MUFA = Mono Unsaturated Fat
PUFA = Poly Unsaturated Fat
Carotene = Carotene Equivalent
Vitamin E = "-Tocopherol Equivalent
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5.3.9 Odds Ratio analysis, omitting LERs
Crude ORs
As with the observed ORs for all subjects, the majority of nutrients were observed to
have positive crude ORs (OR > 1.3) between the reference (lowest) and highest
intake categories, with the exception ofPUFA, selenium and carotene for which no
association was observed, and also alcohol and vitamin C which were observed to
have an inverse, though non significant, association with PCa risk, see Table 5.13.
However, although far fewer of these positive associations were shown to be
significant than for all subjects, those which were significant had far stronger crude
ORs, for example total fat (crude OR 2.16, 95%CI 1.26-3.72), MUFA (crude OR
2.15, 95%CI 1.25-3.70), cholesterol (crude OR 1.90, 95%CI 1.18-3.04) and retinol
(crude OR 1.78, 95%CI 1.13-2.81).
Score test for trends
A dose response effect was found for total fat, MUFA, cholesterol and retinol, with
the crude ORs of these nutrients being observed to increase significantly with higher
intake categories, see Table 5.13.
Adjusted ORs
As with the observed ORs for all subjects, the controlling for confounding variables,
including the use of energy adjusted nutrient intakes (using the Residual Method),
had a great effect on the observed associations with PCa risk, see Table 5.13. No
ORs remained significant when adjusted for, with many nutrients that had previously
reported positive associations with PCa risk, being observed to either have little or no
association (e.g. total fat and MUFA) or having an inverse, though non-significant,
association with PCa risk, (e.g. calcium and vitamin E ). This same pattern towards
an inverse association was seen for nutrients that had previously shown no
association with PCa risk, (e.g. PUFA, selenium and carotene). Whereas the inverse,
though non-significant, association between alcohol intake and PCa risk continued to
be observed. A borderline significant dose response effect was observed for calcium
only (p = 0.048).
Results: Nutrient analysis page 207
Prostate Cancer & Diet




Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)









1.08 (0.62-1.88) 1.00 (0.52-1.95)
1.05 (0.61-1.82) 1.00 (0.47-2.13)
1.35 (0.78-2.33) 0.92 (0.37-2.32)
Score test for linear trend: p = 0.180b, 0.994 c









0.99 (0.60-1.63) 1.02 (0.66-1.57)
0.99 (0.61-1.62) 0.74 (0.48-1.15)
1.24 (0.76-2.00) 0.97 (0.63-1.50)
Score test for linear trend: p = 0.254b, 0.436 c









1.92 (1.10-3.35) 1.05 (0.68-1.63)
1.79 (1.04-3.09) 1.00 (0.65-1.55)
2.16 (1.26-3.72) 0.99 (0.63-1.55)
Score test for linear trend: p = 0.026b, 0.993 0









1.28 (0.77-2.13) 1.10 (0.70-1.71)
1.53 (0.94-2.51) 0.98 (0.63-1.53)
1.53 (0.94-2.50) 1.13 (0.72-1.78)










1.94 (1.12-3.38) 1.29 (0.83-2.00)
1.79 (1.04-3.09) 1.30 (0.83-2.03)
2.15 (1.25-3.70) 1.16 (0.73-1.84)










1.22 (0.76-1.97) 0.86 (0.56-1.31)
1.33 (0.84-2.11) 0.90 (0.59-1.38)
1.14 (0.72-1.82) 0.78 (0.50-1.22)
Score test for linear trend: p = 0.676b, 0.740 0









1.17 (0.71-1.93) 0.90 (0.57-1.42)
1.67 (1.04-2.70) 1.23 (0.79-1.92)
1.90 (1.18-3.04) 1.56 (0.98-2.48)
Score test for linear trend: p = 0.001b, 0.075 c
Cont.
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Table 5.13, cont.: Crude and adjusted ORs for nutrient intake, omiting LERs





OR (95% CI) OR (95% CI)
Alcohol (g) 0-3.4 105 91 1.00 _ 1.00 -
3.4 - 9.9 95 96 0.86 (0.57-1.28) 0.89 (0.59-1.36)
9.9-21.6 88 97 0.79 (0.53-1.18) 0.66 (0.43-1.01)
> 21.6 83 104 0.69 (0.46-1.04) 0.74 (0.47-1.17)
Score test for linear trend: p = 0.066b, 0.233 c
Calcium (mg) 0-812 44 56 1.00 - 1.00 -
812-1039 91 95 1.22 (0.75-1.99) 1.14 (0.74-1.78)
1039- 1321 112 118 1.21 (0.75-1.94) 1.40 (0.90-2.17)
> 1321 124 119 1.33 (0.83-2.12) 0.76 (0.48-1.21)
Score test for linear trend: p = 0.2930.048°
Selenium (9g) 0-56 60 60 1.00 - 1.00 -
56-73 93 99 0.94 (0.59-1.48) 0.95 (0.62-1.45)
73-94 97 114 0.85 (0.54-1.33) 0.63 (0.41-0.99)
> 94 121 115 1.05 (0.68-1.63) 0.85 (0.55-1.32)
Score test for linear trend: p = 0.795b, 0.187°
Retinol (hg) 0-348 48 72 1.00 - 1.00 -
348 - 571 108 101 1.60 (1.01-2.54) 1.13 (0.73-1.75)
571 - 838 94 113 1.25 (0.79-1.97) 0.90 (0.58-1.42)
>838 121 102 1.78 (1.13-2.81) 1.43 (0.91-2.25)
Score test for linear trend: p = 0.059b, 0.187°
Carotene (M^g) 0-1308 88 88 1.00 - 1.00 -
1308-2187 85 91 0.93 (0.61-1.42) 0.75 (0.49-1.14)
2187-3447 85 98 0.87 (0.57-1.31) 0.85 (0.55-1.31)
> 3447 113 111 1.02 (0.69-1.51) 0.85 (0.54-1.33)
Score test for linear trend: p = 0.970b, 0.606°
Vitamin E (hg) 0-4.89 46 61 1.00 - 1.00 -
4.89-7.27 114 108 1.40 (0.88-2.23) 0.81 (0.52-1.24)
7.27-10.56 96 108 1.18 (0.73-1.89) 0.87 (0.57-1.34)
> 10.56 115 111 1.37 (0.86-2.19) 0.75 (0.48-1.16)
Score test for linear trend: p = 0.416b, 0.606°
Cont.
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Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)









0.59 (0.37-0.93) 1.22 (0.79-1.88)
0.89 (0.58-1.35) 1.13 (0.72-1.75)
0.77 (0.51-1.18) 1.07 (0.68-1.68)
Score test for linear trend: p = 0.737b, 0.838 c









0.97 (0.62-1.51) 1.06 (0.68-1.65)
1.15 (0.74-1.76) 1.15 (0.74-1.77)
1.26 (0.83-1.93) 1.22 (0.79-1.88)
Score test for linear trend: p = 0.171b, 0.827 0
N.B.
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
El = Energy Intake
a
= Adjusted for Age, El (residual method), Family History of PCa and BrCa, Deprivation Index, Smoking and
EI/BMR Ratio.
b
= Crude ORs,c = adjusted ORs.
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5.3.10 Nutrient analysis: stratified by age group
Although no interaction was observed between age and nutrient intake, and that only
a handful of nutrients were observed to vary significantly across age categories, the
nutrient analysis by age group was still conducted. As, in addition to the significant
positive association between age and PCa risk (OR 1.97, 95%CI 1.36-2.83), closer
examination of the distribution of nutrient intake across the four age categories
showed that in general, nutrient intake within the younger two categories was higher
than the older two categories. Furthermore, tests for interaction between age group
and nutrient intakes observed an interaction with several nutrients, including alcohol
and selenium intake.
As shown in Table 5.14, 310 of subjects were in the younger age group (< 65yrs),
with the remaining 606 subjects in the older age group (> 65 yrs), the distribution of
cases and controls varied significantly between age groups (chi square test, p <
0.001), with more controls within the younger age group and more cases within the
older age group. This significant variation was due to a larger number of younger
BPH controls than older BPH controls being included in the study which, unlike the
population controls, were not age-frequency matched to cases.








Younger age group (- 65 yrs) 119(27.5) 191 (39.5) 310(33.8)
Older age group (> 65 yrs) 314(72.5) 292 (60.5) 606 (66.2)
Total 433 (100) 483 (100) 916 (100)
Nutrient intake by age group
Intake ofmost nutrients was higher in the younger age group, with intake in the
younger age group being significantly higher for EI, protein, total fat, MUFA, PUFA,
cholesterol, alcohol, selenium and vitamin E (T-Test only, except for alcohol), see
Table 5.15.
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s.d. = Standard Deviation
l-QR = Inter-Quartile Range
MUFA = Mono Unsaturated Fat
PUFA = Poly Unsaturated Fat
Carotene = Carotene Equivalent
Vitamin E = "-Tocopherol Equivalent
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5.3.11 Odds Ratio analysis, stra tified by age group
Crude ORs
The effect of nutrient intake on PCa risk was observed to vary greatly between the
age groups, see Table 5.16. For the younger age group, positive associations with
PCa risk were observed for the majority of nutrients, with the exception of alcohol,
carotene, vitamin C and isoflavones for which no association was observed. Within
those nutrients observing a positive association, significant crude ORs for the highest
intake category compared to the reference category were observed for EI (crude OR
2.03, 95%CI 1.07-3.86), protein (crude OR 2.10, 95%CI 1.09-4.05), MUFA (crude
OR 1.91, 95%CI 1.00-3.68), Cholesterol (crude OR 2.01, 95%CI 1.05-3.82),
selenium (crude OR 2.07, 95%CI 1.08-3.97) and retinol (crude OR 2.18, 95%CI
1.12-4.24).
Flowever, for the older age group, although a positive association with PCa risk was
also observed for the majority of nutrients, an inverse, though non-significant,
association was observed for alcohol, whilst no association was observed between
PCa risk and selenium, carotene and vitamin C. Within those nutrients for which a
positive association was observed, significant crude ORs for the highest intake
category compared to the reference category were observed for total fat (crude OR
1.88, 95%CI 1.16-3.04), saturated fat (crude OR 1.63, 95%CI 1.02-2.62), MUFA
(crude OR 1.83, 95%CI 1.13-2.96) and cholesterol (crude OR 1.99, 95%CI 1.22-
3.23).
Score test for trends
Within the younger age group, a dose response effect was found for protein,
cholesterol, selenium and retinol, with the crude ORs of these nutrients being
observed to increase significantly with higher intake categories, see Table 5.16.
Whereas for the older age group, a dose response effect was found for total fat,
saturated fat, MUFA, cholesterol and alcohol, with the crude ORs of these nutrients
being observed to increase significantly with higher intake categories, except for
alcohol which showed an inverse dose response effect, with the crude ORs being
observed to decrease significantly with higher intake categories.
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Adjusted ORs
The controlling for confounding variables, including the use of energy adjusted
nutrient intakes (using the residual method), had a great effect on the observed ORs
for nutrients in both age groups, see Table 5.16.
Within the younger age group, although most of nutrients remained positively
associated with PCa risk, in particular protein whose OR was found to be significant
(adjusted OR 2.34, 95% CI 1.13-4.87), several nutrients were observed to become
inversely associated with PCa risk, including calcium, carotene, vitamin E and
isoflavones, although none of these inverse associations were found to be significant.
Whereas alcohol continued to show no association with PCa risk.
Within the older age group, a large number of nutrients previously shown to be either
positively or non-associated with PCa risk, were observed to become inversely
associated with PCa risk, including protein, PUFA, calcium, selenium and carotene,
ofwhich the OR for selenium was found to be significant (adjusted OR 0.61, 95%CI
0.37-0.99). In addition, the inverse association between alcohol and PCa risk became
significant (adjusted OR 0.54, 95%CI 0.32-0.89). No significant dose response
effects were observed for either age group.
Results: Nutrient analysis page 214
Prostate Cancer & Diet





Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)
Older
(> 65 vears)
Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)




1.00 - 1.00 -
1.70 (0.83-3.45) 2.37 (0.95-5.93)
1.20 (0.60-2.38) 2.25 (0.68-7.49)
2.03 (1.07-3.86) 4.88 (0.93-25.50)
Score test for linear trend: p = 0.062b, 0.163°
1.00 - 1.00 -
0.97 (0.61-1.54) 0.56 (0.26-1.17)
1.18 (0.74-1.88) 0.62 (0.26-1.50)
1.39 (0.87-2.21) 0.44 (0.15-1.29)
Score test for linear trend: p = 0.105b,0.338°





1.00 - 1.00 -
1.53 (0.76-3.05) 1.72 (0.82-3.61)
1.52 (0.74-3.14) 1.89 (0.91-3.90)
2.10 (1.09-4.05) 2.34 (1.13-4.87)
Score test for linear trend: p = 0.030b, 0.159°
1.00 - 1.00 -
0.95 (0.60-1.50) 0.79 (0.49-1.28)
0.98 (0.62-1.55) 0.67 (0.41-1.09)
1.28 (0.81-2.02) 0.66 (0.41-1.08)
Score test for linear trend: p = 0.286b, 0.283°




1.00 - 1.00 -
1.52 (0.77-3.01) 1.24 (0.63-2.44)
0.94 (0.46-1.92) 1.17 (0.58-2.36)
1.87 (0.97-3.63) 1.32 (0.64-2.74)
Score test for linear trend: p = 0.143b, 0.890°
1.00 - 1.00 -
1.55 (0.96-2.49) 1.05 (0.64-1.73)
1.84 (1.14-2.97) 1.05 (0.64-1.72)
1.88 (1.16-3.04) 0.98 (0.60-1.60)
Score test for linear trend: p = 0.008b, 0.989°
Saturated Fat 0 - 25.3
(9) 25.3 - 34.0
34.0 - 46.3
> 46.3
1.00 - 1.00 -
0.70 (0.34-1.41) 0.92 (0.46-1.82)
1.21 (0.64-2.30) 0.81 (0.41-1.63)
1.39 (0.74-2.62) 1.34 (0.63-2.85)
Score test for linear trend: p = 0.143b, 0.529°
1.00 - 1.00 -
1.46 (0.91-2.36) 1.12 (0.68-1.85)
1.72 (1.07-2.75) 1.13 (0.68-1.87)
1.63 (1.02-2.62) 1.03 (0.63-1.68)





1.00 - 1.00 -
1.54 (0.76-3.06) 1.04 (0.51-2.09)
0.83 (0.41-1.69) 1.41 (0.70-2.84)
1.91 (1.00-3.68) 1.21 (0.57-2.57)
Score test for linear trend: p = 0.145b, 0.706°
1.00 - 1.00 -
1.53 (0.95-2.46) 1.20 (0.73-1.97)
1.97 (1.21-3.21) 1.07 (0.65-1.77)
1.83 (1.13-2.96) 1.25 (0.77-2.04)





1.00 - 1.00 -
1.79 (0.89-3.60) 1.50 (0.75-3.02)
1.42 (0.72-2.81) 0.88 (0.44-1.75)
1.31 (0.67-2.55) 0.90 (0.44-1.83)
Score test for linear trend: p = 0.661b, 0.459°
1.00 - 1.00 -
1.08 (0.68-1.69) 0.65 (0.40-1.05)
1.41 (0.90-2.22) 1.02 (0.63-1.65)
1.29 (0.81-2.06) 0.78 (0.48-1.28)
Score test for linear trend: p = 0.157b, 0.170°
Cholesterol 0 - 242
(mg) 242 - 326
326 - 450
> 450
1.00 - 1.00 -
0.63 (0.30-1.33) 1.02 (0.51-2.03)
1.21 (0.63-2.36) 0.75 (0.35-1.59)
2.01 (1.05-3.82) 1.99 (0.97-4.08)
Score test for linear trend: p = 0.006b, 0.089°
1.00 - 1.00 -
1.65 (1.01-2.71) 0.96 (0.57-1.61)
2.19 (1.34-3.57) 1.44 (0.89-2.35)
1.99 (1.22-3.23) 1.34 (0.81-2.21)
Score test for linear trend: p = 0.004b, 0.189°
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Crude OR Adjusted OR "
OR (95% CI) OR (95% CI)
Older
(> 65 vears)
Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)




1.00 - 1.00 -
0.57 (0.27-1.19) 0.78 (0.37-1.65)
1.14 (0.58-2.25) 1.19 (0.57-2.48)
1.10 (0.58-2.10) 1.02 (0.50-2.09)
Score test for linear trend: p = 0.307b, 0.697°
1.00 - 1.00
1.09 (0.71-1.66) 0.79 (0.50-1.25)
0.71 (0.46-1.10) 0.58 (0.36-0.94)
0.63 (0.39-1.03) 0.54 (0.32-0.89)





1.00 - 1.00 -
1.09 (0.55-2.19) 1.04 (0.52-2.10)
1.46 (0.75-2.82) 1.05 (0.53-2.06)
1.54 (0.83-2.86) 0.86 (0.44-1.70)
Score test for linear trend: p = 0.125b, 0.959°
1.00 - 1.00
1.19 (0.74-1.90) 1.12 (0.68-1.84)
1.29 (0.81-2.06) 1.40 (0.85-2.31)
1.50 (0.93-2.43) 0.76 (0.45-1.29)
Score test for linear trend: p = 0.088b, 0.128°




1.00 - 1.00 -
1.33 (0.65-2.75) 1.25 (0.63-2.48)
1.83 (0.94-3.56) 0.85 (0.41-1.79)
2.07 (1.08-3.97) 1.83 (0.93-9.63)
Score test for linear trend: p = 0.016b, 0.183°
1.00 - 1.00
0.80 (0.51-1.26) 0.76 (0.49-1.23)
0.76 (0.48-1.20) 0.56 (0.34-0.92)
0.96 (0.61-1.53) 0.61 (0.37-0.99)
Score test for linear trend: p = 0.851b,0.078°
0-348
Retinol (M9) 348 . 571
571 - 838
> 838
1.00 - 1.00 -
1.48 (0.75-2.96) 0.63 (0.30-1.35)
0.99 (0.49-1.99) 1.26 (0.61-2.59)
2.18 (1.12-4.24) 1.61 (0.80-3.23)
Score test for linear trend: p = 0.048b, 0.106°
1.00 - 1.00
1.39 (0.88-2.19) 1.42 (0.89-2.30)
1.22 (0.76-1.96) 0.84 (0.51-1.37)
1.22 (0.77-1.93) 1.00 (0.62-1.63)





1.00 - 1.00 -
0.69 (0.35-1.36) 0.60 (0.30-1.21)
0.82 (0.41-1.61) 0.78 (0.40-1.56)
1.03 (0.55-1.95) 0.77 (0.38-1.55)
Score test for linear trend: p = 0.716b, 0.533°
1.00 - 1.00
1.03 (0.66-1.61) 0.84 (0.53-1.36)
0.82 (0.53-1.29) 0.81 (0.50-1.31)
1.07 (0.69-1.67) 0.85 (0.52-1.40)
Score test for linear trend: p = 0.974b, 0.790°
0 - 4.89
Vitamin E (Mg) 4 gg _ ? 2J
7.27-10.56
> 10.56
1.00 - 1.00 -
2.06 (1.04-4.09) 1.08 (0.53-2.19)
1.07 (0.53-2.15) 0.97 (0.49-1.91)
1.56 (0.80-3.04) 0.65 (0.31-1.35)
Score test for linear trend: p = 0.571b,0.597°
1.00 - 1.00
1.39 (0.88-2.20) 0.86 (0.53-1.39)
1.36 (0.84-2.18) 1.07 (0.66-1.73)
1.41 (0.88-2.25) 0.94 (0.58-1.53)
Score test for linear trend: p = 0.213b,0.876°
Cont.
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Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)
Older
(> 65 vears)
Crude OR Adjusted OR "







1.00 - 1.00 -
0.89 (0.47-1.70) 1.20 (0.61-2.37)
1.06 (0.55-2.05) 1.23 (0.58-2.58)
1.19 (0.63-2.23) 0.92 (0.43-1.96)
Score test for linear trend: p = 0.508b, 0.839°
1.00 - 1.00
0.88 (0.55-1.41) 1.13 (0.69-1.86)
1.20 (0.77-1.88) 1.03 (0.63-1.68)
1.02 (0.65-1.62) 1.29 (0.78-2.14)
Score test for linear trend: p = 0.593b, 0.688°
0-581.1
Isoflavones




1.00 - 1.00 -
1.12 (0.57-2.23) 1.00 (0.50-1.98)
1.30 (0.68-2.47) 1.44 (0.71-2.93)
1.15 (0.62-2.15) 0.84 (0.40-1.76)
Score test for linear trend: p = 0.590b, 0.682c
1.00 - 1.00
0.95 (0.60-1.51) 1.24 (0.76-2.04)
1.08 (0.68-1.72) 0.99 (0.61-1.61)
1.44 (0.90-2.29) 1.41 (0.87-2.30)
Score test for linear trend: p = 0.091b, 0.213°
N.B.
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
El = Energy Intake
a
= Adjusted for El (residual method), Family History of PCa and BrCa, Deprivation Index, Smoking and EI/BMR
ratio
b
= crude ORs,0 = adjusted ORs.
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5.4 Food groups analysis
The following section reports the results for the food group analysis part of the study
and includes the analysis of alcohol type.
5.4.1 Food group distribution
Distributions of food group consumption were all observed to have varying degrees
of skewedness, with only total meat showing a distribution close to normality, see
Figure 5.10. Due to this, food group variables were normalised by log transformation
for the use in parametric tests, in addition to the use of non-parametric tests. For
alcohol consumption, the majority of subjects reported to consume alcohol (82.9%),
although the distribution of each alcohol type was skewed towards lower / no
consumption.
5.4.2 Outliers
Analysis of the distributions also revealed outliers for many of the food groups.
Several subjects were reported as having very high intakes of dairy products, in
particular one subject whom reported consuming 60 eggs per week. Other subjects
were reported as having very high intakes of soy foods in relation to the low mean
intake, these tended to be subjects who did not eat meat and therefore used soy
products as a meat alternative. The repeated checking of the FFQs showed that the
subjects had indeed reported consuming high levels of these foods. It was therefore
decided not to omit any of these outliers in the present analysis, especially as
categorical variables for food group intake were used in the odds ratio analysis
instead of the original continuous variables, thereby minimising the potential effect
that these outliers would have on the observed ORs.
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Figure 5.10: Distribution of food groups




0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0
Total Dairy
Std. Dev = 8 52
Mean = 12.4
N = 916.00
20.0 30.0 40.0 50.0 60.0 70.0
Milk
Fig 5.10c: Cheese Fig 5.10d: Eggs
Std. Dev = 4.58
Mean = 4.4
N = 916.00
5.0 10 0 15.0 20.0 25 0 30.0 35.0




0.0 10.0 20.0 30.0 40.0 50.0 60.0
Eggs
Fig 5.10e: Total meat Fig 5.10f: Red meat
Std. Dev = 9.09
Mean = 16.4
N = 916.00
°o 7o vo so° ° o o o o o o o o o
Std. Dev = 6.49
Mean = 9.9
N = 916.00
10.0 15.0 20.0 25.0 30.0 35.0 40.0
Total meat Red meat
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Fig 5.10g: Processed meat Fig 5.10h: Fish
Processed Meat Fish
Fig 5.10i: Grilled meat
Grilled meat
Fig 5.10j: Soy foods
0.0 2.5 5.0 7.5 10.0 12.5 15.0
Soy Foods
Fig 5.10k: Whole Fruit Fig 5.101: Vegetables
,r: : .. :
55589
I Std. Dev= 14.57
Mean = 16.9
N = 916.00
Std. Dev = 24.09
Mean = 32.8
N = 916.00
^ % % % % \ %% \ \
Total Vegetables (excluding potatoes)
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Fig 5.10m: Alcohol consumption Fig 5.1 On: Beer
3-9 10-19 20+
Alcohol consumption Beer (units)
Fig 5.10o: Wine Fig 5.1 Op: Spirits
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5.4.3 Food group intake: by case-control status
Controls were observed to have lower intakes of all food groups compared to cases,
with the exception of total vegetables for which intake did not vary between status,
and soy foods for which controls were observed to have a significantly higher intake
than cases, see Table 5.17. These differences were shown to be significant for eggs,
total meat, red meat and processed meat.
In addition, no significant variation across both grilled meat and the grilled meat
score categories was observed, see Table 5.18. However, significantly more controls
than cases reported to consume alcohol, with significantly more controls than cases
consuming high quantities (10+ units per week) of wine. Controls also consumed
higher quantities of both beer and spirits, although these were shown to be non¬
significant, see Table 5.18.
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s.d. = Standard Deviation
l-QR = Inter-Quartile Range
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Table 5.18: Distribution of categorical food group variables, by status
Food Groups Cases Controls
(helpings per week) (Population and BPH
(% within status) controls)
(% within status)
Grilled Meat:










Chi-Square Test (p-value) = 0.61
Grilled Meat Score:












Chi-Square Test (p-value) = 0.48
Cont.
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Table 5.18, cont.: Distribution of categorical food group variables, by status
Alcohol Types Cases Controls










Chi-Square Test (p-value) = 0.015
Beer
No alcohol consumption 88 69
(20.3%) (14.3%)
Alcohol consumption other than beer 113 131
(26.1%) (27.1%)
1-2 units 69 76
(15.9%) (15.7%)
3-9 units 95 127
(21.9%) (26.3%)




Chi-Square Test (p-value) = 0.227
Wine
No alcohol consumption 88 69
(20.3%) (14.3%)
Alcohol consumption other than wine 136 181
(31.4%) (37.5%)
1-2 units 93 107
(21.5%) (22.2%)
3-9 units 95 85
(21.9%) (17.6%)




Chi-Square Test (p-value) = 0.015
Spirits
No alcohol consumption 88 69
(20.3%) (14.3%)
Alcohol consumption other than spirits 99 127
(22.9%) (26.3%)
1-2 units 84 84
(19.4%) (17.4%)
3-9 units 103 116
(23.8%) (24.0%)




Chi-Square Test (p-value) = 0.086
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5.4.4 Correlation between individual food groups
As expected, crude correlations showed that most food groups were associated with
each other, see Appendix: Table 8.5. Therefore the correlation analysis was redone
using El-adjusted food groups.
Certain patterns within and between general food groups continued to be observed,
though they tended to be weaker. Both milk and cheese were strongly positively
correlated with total dairy products but not with each other. Meat products were
strongly positively associated with each other, with the exception of fish, which was
positively associated with vegetables. Eggs were also observed to be positively
associated with most meat products, whilst vegetables were positively associated
with fruit. Within alcohol types, spirits were observed to be positively associated
with beer and to a lesser extent with wine, see Table 5.19.
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5.4.5 Food groups by confounding variables
The correlation between food group consumption and confounding variables were
examined using Spearman's rank correlations, see Table 5.20. As expected, both energy
intake and the EI: BMR ratio were significantly positively correlated with all food
groups, except for soy foods and wine, as was BMI to a lesser extent and with fewer food
groups. Age was significantly inversely correlated with total meat, processed meat and
beer and spirits, whereas family history of PCa / BrCa was positively correlated with
processed meat, total vegetables and wine. For both the Carstairs Deprivation Index and
smoking status a similar pattern was observed. Significant positive correlations were
observed with eggs, most meat products and beer, whereas significant inverse
correlations were observed with fish, soy foods, total vegetables, total fruit and wine, and
also for most dairy products (Carstairs Deprivation Index only).
In order to examine the association between food groups and confounding variables
farther, mean food group consumption was compared across confounding variable
categories. The associations that were observed to be significant are shown in Figures
5.11 to 5.17. As expected, consumption for all food groups increased significantly across
total energy and the EI / BMR ratio categories, with the exception of soy foods (Figures
5.11 and 5.16). Most food groups also varied significantly across the Carstairs
deprivation index (Figure. 5.14), the consumption of total dairy, cheese, fish, soy food,
fruit and vegetables were shown to decrease with increasing deprivation index categories,
whilst the consumption of eggs and other meat products was observed in increase with
increasing deprivation index categories. In addition, consumption of beer and wine also
varied significantly across Carstairs deprivation index categories, no pattern was
observed for beer, however wine consumption was observed to be significantly lower
with the higher deprivation categories.
Consumption for the majority of food groups also varied significantly with smoking
status (Figure 5.16), particularly for eggs and red meat consumption which were observed
to be higher within smokers and ex-smokers, and cheese, fish and soy food for which
consumption was observed to be higher in non-smokers. Grilled meat consumption and
gilled meat score were lower in non-smokers and ex-smokers compared to smokers,
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whereas smoker tended to consume more spirits but less wine than ex-smokers and non-
smokers.
The consumption of certain food groups also varied with BMI category, eggs and meat
products increased significantly across BMI categories, as did grilled meat and beer
consumption, whereas soy food consumption was observed to decrease significantly.
However, only soy food and beer consumption was observed to vary significantly with
age categories (Figure 5.12), whereas only the consumption of total meat, processed meat
and vegetables varied significantly with family history categories (Figure 5.13).
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Figure 5.11: Food group consumption across energy intake categories
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Fig 5.11 h: Fish
Energy intake category Energy intake category
Fig 5.11 i: Total vegetables Fig 5.11j: Total fruit
1.00 2.00
Energy intake category Energy intake category












1.00 2.00 3.00 4.00
Energy intake category Energy intake category
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Fig 5.11m: Beer




Figure 5.12: Food group consumption across age categories
Fig 5.12a: Soy food Fig 5.12b: Beer
3 c
1.00 2.00 3.00 4.00
Age category
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Figure 5.13: Food group consumption across family history categories
Fig 5.13a: Total meat Fig 5.13b: Processed meat
No Family History Family History BrCa
Family History PCa F. Hist. PCa & BrCa
Family History
No Family History Family History BrCa
Family History PCa F. Hist. PCa & BrCa
Family History






No Family History Family History BrCa
Family History PCa F. Hist. PCa & BrCa
Family History
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Figure 5.14: Food group consumption across Carstairs deprivation index
Fig 5.14a: Total dairy Fig 5.14b: Cheese
1.00 2.00 3.00 4.00 5.00
Carstairs deprivation index
00 7.00 00 7.00
Carstairs deprivation index
Fig 5.14c: Eggs Fig 5.14d: Total meat
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
Fig 5.14e: Red meat Fig 5.14g: Processed meat
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
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Fig 5.14i: Soy food
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
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Carstairs deprivation index
Fig 5.14j: Total vegetables Fig 5.14k: Total fruit
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Carstairs deprivation index
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Carstairs deprivation index
Fig 5.141: Beer Fig 5.14m: Wine
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
1.00 2.00 3.00 4.00 5.00 6.00 7.00
Carstairs deprivation index
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Fig 5.15h: Grilled meat
Smoker Smoker
Fig 5.15i: Grilled meat score Fig 5.15j: Wine
o 0
Grilled Meat Score
Non Smoker Ex Smoker Smoker
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Figure 5.16: Food group consumption across El / BMR ratio category


















I p < 0.001 |
EI/BMR ratio category
1.00 2.00 3.00
EI/BMR ratio - categorical variable
T"
-

























z: I p < 0.0011
1.00 2.00
EI/BMR ratio category
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Fig 5.16h: Fish
EI/BMR ratio category EI/BMR ratio category
Fig 5.16i: Total vegetables Fig 5.16j: Total fruit
p < 0.001
3.00 4.00
EI/BMR ratio category EI/BMR ratio category
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Fig 5.16n: Spirits
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O 0
EI/BMR ratio category
Figure 5.17: Food group consumption across BMI category
Fig 5.17a: Eggs Fig 5.17b: Total meat
3.00 4.00
BMI category
Fig 5.17c: Red meat Fig 5.17d: Processed meat
BMI category BMI category
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5.4.6 The association between food groups and nutrient intake
The association between food group consumption and nutrient intakes adjusting for EI
was also examined using Spearman's rank correlations, see Table 5.21. See Appendix:
Table 8.6 for crude correlation coefficients.
As expected meat products, were highly positively associated with protein and, with the
exception of fish, most fats expecially MUFA and cholesterol, whereas fish was highly
positively associated with PUFA and selenium. Dairy products, with the exception of
eggs, were highly positively associated with calcium, whilst eggs with highly correlated
with fats, especially cholesterol and MUFA. Both fruit and vegetables were inversely
associated with fats, with the exception ofPUFA, and highly positively associated with
most antioxidants. Alcohol, as expected, was highly positively associated with all alcohol
types. Soy foods were also weakly positively associated with isoflavones.
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5.4.1 Odds ratio analysis
Crude ORs
All meat products and most dairy products were observed to have positive crude ORs
(OR > 1.3) between the reference (lowest) and highest intake categories, ofwhich
significant ORs were observed for eggs (OR 1.59, 95%CI 1.08-2.35), total meat (OR
1.53, 95%CI 1.05-2.25) and red meat (OR 1.92, 95%CI 1.32-2.79), see Table 5.22.
Inverse crude ORs were observed for soy food and all alcohol types, these were
observed to be significant except for beer, soy food OR 0.57 (95%CI 0.34-0.97);
alcohol consumed OR 0.65 (95%CI 0.46-0.92); wine OR 0.40 (95%CI 0.21-0.75)
and spirits OR 0.53 (95%CI 0.33-0.84). However, no association was observed for
total dairy, milk, fish, total vegetables, total fruit and grilled meat.
Score test for trends
In addition, a dose response effect was found for eggs, total meat, red meat, alcohol
consumed and spirits, with the crude ORs being observed to increase significantly
with higher consumption of eggs, total meat and red meat, and to decrease
significantly with higher intakes of spirits and also for soy food and alcohol
consumers compared non consumers, see Table 5.22.
Test for interaction
ORs (and 95% CIs) for food group intakes stratified by each confounding variable
category were computed using the Mantel Haenszel method, in order to examine the
ORs within each individual confounding variable category and to test for interaction.
The results showed that there was no evidence for interaction between the food group
variables and confounding variables.
Log likelihood ratio test
The Log Likelihood test was used to examine the effect of each food group variable
on PCa risk, whilst adjusting for the confounding variables.
A significant effect on PCa risk, whilst adjusting for confounding variables, was
observed for total meat, red meat, soy foods, alcohol consumed, wine and spirits.
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Adjusted ORs
The controlling of confounding variables, including the use of energy adjusted
nutrient intake (using the residual method), had a great effect on the observed
association with PCa risk, with the exception of alcohol types whose ORs remained
similar to those of the crude ORs, see Table 5.22. Whereas before the controlling for
confounding variables, significant positive crude associations were observed for
eggs, the majority ofmeat products and a significant inverse crude association for
soy products. Only red meat remained significant (OR 1.64, 95%CI 1.09-2.48). In
addition, an inverse association between vegetables and PCa risk was observed to
become significant (OR 0.62, 95%CI 0.41-0.93). Significant dose-response effects
were observed for total vegetables (p = 0.021), alcohol consumption (p = 0.012),
wine (p = 0.003) and spirits (p = 0.045).
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Crude OR Adjusted OR a










0.88 (0.61-1.27) 1.06 (0.71-1.57)
0.85 (0.59-1.23) 0.98 (0.66-1.45)
1.14 (0.79-1.64) 1.02 (0.69-1.52)
Score test for linear trend: p = 0.54b, 0.983°









0.94 (0.63-1.40) 1.09 (0.72-1.65)
1.04 (0.69-1.58) 1.05 (0.70-1.56)
1.15 (0.74-1.78) 1.15 (0.77-1.71)










1.08 (0.75-1.54) 1.08 (0.72-1.60)
0.84 (0.59-1.21) 0.83 (0.56-1.23)
1.20 (0.83-1.74) 0.90 (0.61-1.34)










0.98 (0.68-1.40) 0.97 (0.66-1.44)
1.06 (0.72-1.55) 1.13 (0.76-1.68)
1.59 (1.08-2.35) 1.41 (0.94-2.11)










1.34 (0.93-1.93) 1.13 (0.77-1.68)
1.83 (1.26-2.67) 1.43 (0.96-2.13)
1.53 (1.05-2.25) 1.42 (0.94-2.13)
Score test for linear trend: p = 0.007b, 0.225°









1.56 (1.07-2.28) 1.25 (0.84-1.85)
1.48 (1.03-2.13) 1.13 (0.76-1.69)
1.92 (1.32-2.79) 1.64 (1.09-2.48)
Score test for linear trend: p = 0.001b, 0.109°
Cont.
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Crude OR Adjusted OR "
OR (95% CI) OR (95% CI)










1.03 (0.71-1.50) 1.21 (0.81-1.79)
1.56 (1.09-2.23) 1.26 (0.85-1.87)
1.24 (0.87-1.79) 1.40 (0.94-2.10)










0.93 (0.65-1.34) 0.98 (0.66-1.46)
1.28 (0.90-1.84) 1.19 (0.80-1.77)
0.98 (0.67-1.44) 0.81 (0.54-1.20)












0.73 (0.50-1.06) 0.67 (0.45-0.99)
0.98 (0.69-1.40) 1.01 (0.68-1.50)
0.90 (0.63-1.29) 0.62 (0.41-0.93)
Score test for linear trend: p = 0.91 b, 0.021°










0.71 (0.50-1.03) 0.94 (0.64-1.40)
0.97 (0.67-1.39) 1.00 (0.70-1.51)
0.95 (0.66-1.36) 0.99 (0.65-1.49)






0.57 (0.34-0.97) 0.81 (0.53-1.24)










1.14 (0.83-1.58) 1.11 (0.78-1.57)
1.34 (0.87-2.07) 1.29 (0.80-2.06)
1.05 (0.50-2.21) 1.07 (0.48-2.39)
Score test for linear trend: p = 0.32b, 0.802°
Cont.
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Table 5.22, cont.: Crude and adjusted odds ratios


















2 116 130 1.13 (0.78-1.64) 1.04 (0.70-1.55)
3 124 145 1.08 (0.75-1.56) 1.07 (0.72-1.59)
4+ 79 76 1.31 (0.86-2.00) 1.29 (0.81-2.04)













Score test for linear trend: p = 0.016b, 0.012°
Beer No alcohol consumption 88 69 1.00 - 1.00 -
Alcohol consumption other than beer 113 131 0.68 (0.45-1.01) 0.64 (0.42-0.99)
1-2 69 76 0.71 (0.45-1.12) 0.67 (0.41-1.09)
3-9 95 127 0.59 (0.39-0.89) 0.54 (0.35-0.85)
10+ 68 80 0.67 (0.42-1.05) 0.66 (0.40-1.08)
Score test for linear trend: p = 0.057b, 0.115°
Wine No alcohol consumption 88 69 1.00 - 1.00 -
Alcohol consumption other than wine 136 181 0.59 (0.40-0.87) 0.54 (0.35-0.82)
1-2 93 107 0.68 (0.45-1.04) 0.65 (0.41-1.02)
3-9 95 85 0.88 (0.60-1.35) 0.90 (0.56-1.45)
10+ 21 41 0.40 (0.21-0.75) 0.38 (0.19-0.74)
Score test for linear trend: p = 0.25b, 0.003°
Spirits No alcohol consumption 88 69 1.00 - 1.00 -
Alcohol consumption other than wine 99 127 0.61 (0.40-0.92) 0.59 (0.38-0.92)
1-2 84 84 0.78 (0.51-1.22) 0.73 (0.46-1.17)
3-9 103 116 0.70 (0.46-1.05) 0.67 (0.43-1.04)
10+ 59 87 0.53 (0.33-0.84) 0.48 (0.29-0.79)
Score test for linear trend: p = 0.047b, 0.045°
N.B.
a
= ORs adjusted for: Age, total energy (using residual method), family history of PCa & BrCa, deprivation index,
smoking, EI/BMR ratio,
b
= crude ORs. c = adjusted ORs.
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5.4.8 Low energy responders (LERs) analysis
As reported in the subjects characteristics section, 157 subjects (17%) were classified
as LERs, with significantly more controls reported as LERs than cases, see Table 5.3.
In order to examine further the effect this may have on the results and also to
eliminate any possible effect this potential bias may have, the above analysis was
repeated with LERs omitted.
Food group by LER status
As expected, intake for all food groups were observed to be significantly lower in the
LERs than non-LERs, see Tables 5.23 and 5.24, with the exception of soy food,
grilled meat score and all alcohol types for which the observed differences in
distribution were shown to be non-significant.
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Total Dairy 21.28 19.00 14.83 12.50 <0.0001
(11.66) (13.00-28.13) (9.78) (8.25-19.00)
Milk 13.18 14.00 9.06 7.00 <0.0001
(8.61) (7.00-14.00) (6.92) (6.00-14.00)
Cheese 4.72 3.50 2.96 2.00 <0.0001
(4.79) (1.88-6.00) (3.19) (0.50-4.00)
Eggs 4.13 3.25 2.68 2.00 <0.0001
(3.82) (2.00-5.00) (2.25) (1.00-4.00)
Total Meat 17.69 16.00 10.37 10.00 <0.0001
(9.08) (11.50-21.50) (5.60) (6.00-14.00)
Red Meat 10.71 9.50 6.09 5.50 <0.0001
(6.56) (6.38-14.00) (3.95) (3.00-8.25)
Processed Meat 7.11 6.00 3.88 3.00 <0.0001
(5.18) (3.50-10.00) (3.29) (1.50-5.50)
Fish 6.10 5.00 3.47 3.00 <0.0001
(4.79) (2.88-8.00) (3.06) (1.00-5.00)
Total Vegetables 35.57 30.75 19.86 16.00 <0.0001
(excluding potatoes) (24.64) (18.88-46.00) (14.45) (9.75-26.00)
Total Whole Fruit 18.26 15.00 10.76 9.00 <0.0001
(15.10) (8.50-23.00) (8.73) (4.50-14.25)
Soy Food 0.11 0.00 0.06 0.00 0.25
(0.73) (0.00-0.00) (0.32) (0.00-0.00)
N.B.
s.d. = Standard Deviation
l-QR = Inter-Quartile Range
29 subjects with missing LER status were omitted from the distribution analysis
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Table 5.24: Distribution of categorical food group and alcohol type variables, by LER
status
Food Groups Non LERs LERs
(helpings per week) (% within Non LERs) (% within LERs)
Grilled Meat:










Chi-Square Test (p-value) = 0.021
Grilled Meat Score:












Chi-Square Test (p-value) = 0.07
Cont.
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Table 5.24, cont.: Distribution of categorical food group and alcohol type variables, by
LER status
Alcohol Types Non LERs LERs








Chi-Square Test (p-value) = 0.22
Beer
No alcohol consumption 119 32
(16.3%) (20.4%)
Alcohol consumption other than beer 188 50
(25.8%) (31.8%)
1-2 units 111 28
(15.2%) (17.8%)
3-9 units 188 30
(25.8%) (19.1%)




Chi-Square Test (p-value) = 0.06
Wine
No alcohol consumption 119 32
(16.3%) (20.4%)
Alcohol consumption other than wine 242 61
(33.2%) (38.9%)
1-2 units 168 27
(23.0%) (17.2%)
3-9 units 150 27
(20.5%) (17.2%)




Chi-Square Test (p-value) = 0.26
Spirits
No alcohol consumption 119 32
(16.3%) (20.4%)
Alcohol consumption other than spirits 176 40
(24.1%) (25.5%)
1-2 units 139 26
(19.0%) (16.6%)
3-9 units 176 36
(24.1%) (22.9%)




Chi-Square Test (p-value) = 0.71
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5.4.9 Odds Ratio analysis, omitting LERs
Crude ORs
The omission of LERs had little effect on the crude ORs, with the exception of fish,
vegetables and fruit that became inversely, albeit non-significantly, associated with
PCa risk, and soy foods whose inverse association became non-significant, see Table
5.25. ORs remained significant for total meat OR 1.62 (95%CI 1.03-2.54); red meat
OR 1.89 (95%CI 1.23-2.90); alcohol consumed OR 0.67 (95%CI 0.45-0.99); wine
OR 0.35 (95%CI 0.17-0.71) and spirits OR 0.5 (95%CI 0.30-0.84).
Score test for trends
A dose response effect was found for eggs, total meat, red meat, alcohol consumed
and spirits. The crude ORs were observed to increase significantly with higher intake
categories for eggs, total meat and red meat, and to decrease significantly with higher
intake categories for alcohol consumed and spirits, see Table 5.25.
Adjusted ORs
As with the observed adjusted ORs for all subjects, the controlling for confounding
factors had a great effect on the observed association with PCa risk, with the
exception of the alcohol types for which adjusting for confounding factors had little
effect, see Table 5.25. Of the meat products, only red meat remained significant (OR
1.98, 95%CI 1.24-3.17), whereas the positive association between eggs and PCa risk
and the negative association between vegetables and PCa risk both became
significant (eggs OR 1.67, 95%CI 1.05-2.64, vegetables OR 0.63, 95%CI 0.40-0.99).
Significant dose-response effects were observed for red meat (p = 0.022), alcohol
consumption (p = 0.036) and wine (p = 0.006) only.
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Total Dairy 0-11.0 75 69 1.00 - 1.00 -
11.5- 17.5 86 102 0.78 (0.50-1.20) 0.95 (0.61-1.47)
18.0-26.5 89 106 0.77 (0.50-1.19) 1.00 (0.65-1.55)
>26.5 109 94 1.07 (0.70-1.64) 1.08 (0.70-1.69)
Score test for linear trend: p = 0.62b,0.949°
Milk 0-6.5 45 48 1.00 - 1.00 -
7.0 - 12.0 114 125 0.97 (0.60-1.57) 0.97 (0.61-1.54)
12.5-14.0 111 115 1.03 (0.63-1.67) 1.06 (0.69-1.61)
> 14.0 89 83 1.14 (0.69-1.90) 1.10 (0.71-1.70)
Score test for linear trend: p = 0.48b, 0.948°
Cheese 0-1.0 82 90 1.00 - 1.00 -
1.5-3.0 89 89 1.10 (0.72-1.67) 1.13 (0.73-1.75)
3.5-6.0 94 109 0.95 (0.63-1.42) 0.78 (0.50-1.20)
>6.0 94 83 1.24 (0.82-1.89) 1.14 (0.73-1.78)
Score test for linear trend: p 0.47b, 0.267°
Eggs 0-1.5 68 75 1.00 - 1.00 -
2.0-3.0 99 123 0.89 (0.58-1.35) 1.13 (0.73-1.74)
3.5-5.0 87 98 0.98 (0.63-1.52) 1.17 (0.76-1.80)
> 5.0 105 75 1.54 (0.99-2.41) 1.67 (1.05-2.64)
Score test for linear trend: p = 0.030 b, 0.157°
Total Meat 0-10.0 54 83 1.00 - 1.00 -
10.5-15.0 98 108 1.39 (0.90-2.17) 1.06 (0.69-1.63)
15.5-21.0 110 88 1.92 (1.23-3.01) 1.62 (1.05-2.51)
>21.0 97 92 1.62 (1.03-2.54) 1.43 (0.90-2.27)
Score test for linear trend: p = 0.020b, 0.097°
Red Meat 0-5.5 61 93 1.00 - 1.00 -
6.0-8.5 81 81 1.52 (0.97-2.39) 1.52 (0.99-2.34)
9.0 - 13.0 103 105 1.50 (0.98-2.29) 1.19 (0.77-1.85)
> 13.0 114 92 1.89 (1.23-2.90) 1.98 (1.24-3.17)
Score test for linear trend: p = 0.006 b, 0.022°
Cont.
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Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)










1.13 (0.73-1.75) 1.18 (0.77-1.82)
1.59 (1.05-2.40) 1.40 (0.91-2.14)
1.28 (0.85-1.92) 1.41 (0.89-2.22)
Score test for linear trend: p = 0.11b, 0.382°









0.74 (0.48-1.14) 0.88 (0.57-1.35)
1.04 (0.68-1.57) 1.06 (0.69-1.65)
0.78 (0.50-1.20) 0.68 (0.43-1.06)












0.53 (0.34-0.84) 0.74 (0.48-1.15)
0.83 (0.55-1.26) 1.05 (0.68-1.61)
0.73 (0.48-1.11) 0.63 (0.40-0.99)
Score test for linear trend: p = 0.52b, 0.075°










0.58 (0.37-0.91) 0.96 (0.62-1.49)
0.84 (0.55-1.28) 1.08 (0.69-1.68)
0.76 (0.50-1.15) 0.99 (0.62-1.57)






0.58 (0.33-1.01) 0.84 (0.55-1.28)










0.97 (0.67-1.40) 0.96 (0.65-1.42)
1.13 (0.70-1.82) 1.05 (0.63-1.75)
1.12 (0.49-2.54) 1.00 (0.43-2.35)
Score test for linear trend: p = 0.60b, 0.983°
Cont.
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Grilled Meat Score 0 77 80 1.00 - 1.00 -
1 19 10 1.97 (0.86-4.55) 1.71 (0.71-4.10)
2 93 106 0.91 (0.60-1.39) 0.85 (0.54-1.32)
3 191 113 0.93 (0.61-1.40) 0.99 (0.63-1.53)
4+ 69 62 1.16 (0.73-1.84) 1.08 (0.66-1.78)













Score test for linear trend: p = 0.042b, 0.036°
Beer No alcohol consumption 70 49 1.00 - 1.00 -
Alcohol consumption other than beer 92 96 0.67 (0.42-1.07) 0.66 (0.40-1.07)
1-2 54 57 0.66 (0.39-1.12) 0.64 (0.37-1.12)
3-9 80 108 0.52 (0.32-0.83) 0.54 (0.33-0.90)
10+ 63 61 0.72 (0.43-1.20) 0.75 (0.43-1.30)
Score test for linear trend: p = 0.09b, 0.190°
Wine No alcohol consumption 70 49 1.00 - 1.00 -
Alcohol consumption other than wine 110 132 0.58 (0.37-0.91) 0.56 (0.35-0.91)
1-2 78 90 0.61 (0.38-0.98) 0.62 (0.37-1.03)
3-9 84 66 0.89 (0.55-1.45) 0.98 (0.58-1.66)
10+ 17 34 0.35 (0.17-0.71) 0.37 (0.17-0.76)
Score test for linear trend: p = 0.21b, 0.006°
Spirits No alcohol consumption 70 49 1.00 - 1.00 -
Alcohol consumption other than spirits 85 91 0.65 (0.41-1.05) 0.68 (0.41-1.12)
1-2 68 71 0.67 (0.41-1.10) 0.66 (0.39-1.12)
3-9 86 90 0.67 (0.42-1.07) 0.68 (0.41-1.12)
10+ 50 70 0.50 (0.30-0.84) 0.49 (0.28-0.85)
Score test for linear trend: p = 0.027b, 0.161°
N.B.
a
= ORs adjusted for: Age, total energy (using residual method), family history of PCa & BrCa, deprivation index,
smoking, EI/BMR ratio.
b
= crude ORs,c = adjusted ORs.
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5.4.10 Food group analysis: Stratified by age group
As shown in Table 5.14, 310 of subjects were in the younger age group (< 65yrs),
with the remaining 606 subjects in the older age group (> 65 yrs). The distribution of
cases and controls varied significantly between age groups (p < 0.001), with more
controls within the younger age group and more cases within the older age group.
Food group consumption by age group
No significant differences were observed for consumption ofmost food groups
between age groups, with the exception of total meat, processed meat and alcohol
types for which consumption was significantly higher in the younger age group, see
Tables 5.26 and 5.27.
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Total Dairy 20.41 17.50 19.90 17.75 0.94
(12.61) (11.00-27.63) (11.12) (11.38-26.00)
Milk 13.00 14.00 12.07 10.00 0.19
(9.08) (7.00-14.00) (8.22) (7.00-14.00)
Cheese 4.64 3.00 4.32 3.00 0.46
(5.46) (1.00-6.00) (4.06) (1.00-6.00)
Eggs 4.13 3.00 3.79 3.00 0.74
(4.60) (2.00-5.50) (3.18) (2.00-5.00)
Total Meat 17.41 15.50 15.91 14.50 0.046
(9.99) (10.50-23.00) (8.56) (10.00-20.00)
Red Meat 9.96 9.00 9.89 9.00 0.91
(6.70) (5.00-14.13) (6.39) (5.50-13.00)
Processed Meat 7.25 6.00 6.21 5.25 0.01
(5.45) (3.00-10.63) (4.83) (3.00-8.00)
Fish 5.76 4.50 5.51 4.50 0.34
(4.64) (2.50-8.00) (4.63) (2.00-7.50)
Total Vegetables 33.57 26.50 32.43 28.00 0.57
(excluding potatoes) (24.69) (16.50-47.00) (23.78) (15.88-41.00)
Total Whole Fruit 16.32 12.75 17.20 14.50 0.13
(15.25) (6.50-21.00) (14.21) (7.88-22.00)
Soy Food 0.09 0.00 0.11 0.00 0.22
(0.38) (0.00-0.00) (0.77) (0.00-0.00)
N.B.
s.d. = Standard Deviation
l-QR = Inter-Quartile Range
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Table 5.27: Distribution of categorical food group and alcohol type variables, by age
group
Food Group Younger Age Group Older Age Group
(helpings per week)
(% within Age Group) (% within Age Group)
Grilled Meat:










Chi-Square Test (p-value) = 0.666
Grilled Meat Score:












Chi-Square Test (p-value) = 0.828
Cont.
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Table 5.27, cont.: Distribution of categorical food group and alcohol type variables, by
age group
Alcohol Type Younger Age Group Older Age Group
(units per week)








Chi-Square Test (p-value) <0.001
Beer
No alcohol consumption 34 123
(11.0%) (20.3%)
Alcohol consumption other 64 180
than beer (20.6%) (29.7%)
1-2 units 57 88
(18.4%) (14.5%)
3-9 units 82 140
(26.5%) (23.1%)




Chi-Square Test (p-value) < 0.001
Wine
No alcohol consumption 34 123
(11.0%) (20.3%)
Alcohol consumption other 125 192
than wine (40.3%) (31.7%)
1-2 units 55 145
(17.7%) (23.9%)
3-9 units 71 109
(22.9%) (18.0%)




Chi-Square Test (p-value) < 0.001
Spirits
No alcohol consumption 34 123
(11.0%) (20.3%)
Alcohol consumption other 88 138
than spirits (28.4%) (22.8%)
1-2 units 53 115
(17.1%) (19.0%)
3-9 units 71 148
(22.9%) (24.4%)




Chi-Square Test (p-value) < 0.001
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Crude ORs, by age group
The effect of food group consumption on PCa risk was observed to vary between age
groups, see Table 5.28. For the younger age group, positive associations with PCa
risk were observed for all dairy and meat products, with the exception of fish and
grilled meat for which no association was observed. Of these only total meat (OR
2.45, 95%CI 1.22-4.90) and red meat (OR 3.04, 95%CI 1.56-5.90) was significant.
Whereas the majority of alcohol types were observed to inversely associated with
PCa risk, however none of these associations were observed to be significant.
However, within the older age group, no association was observed for dairy products,
as well as fruit and vegetables, with the exception of eggs which were observed to be
significantly associated with PCa risk (OR 1.66, 95%CI 1.01-2.73), see Table 5.28.
Most meat products were observed to be positively associated with PCa risk,
although none were shown to be significant. Whereas all alcohol types were
inversely associated with PCa risk, with both wine and spirits showing significant
associations (OR 0.26, 95%CI 0.11-0.61, and OR 0.53, 95%CI 0.30-0.94,
respectively), as was soy foods (OR 0.50, 95%CI 0.25-0.98).
Score test for trends
Within the younger group, a dose response effect was found for total meat and red
meat only, with the crude ORs of these food groups being observed to increase
significantly with higher intake categories, see Table 5.28. Whereas for the older age
group, a dose response effect was found for eggs, processed meat, soy food and beer,
with crude ORs being observed to increase significantly with higher intake categories
of eggs and processed meat, and decrease significantly with higher intake categories
of soy food and beer.
Adjusted ORs
The controlling of confounding variables, including the use of energy adjusted
nutrient intakes (using the residual method), had a small effect on the observed ORs
for food group consumption in both age groups, see Table 5.28.
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Within the younger age group, controlling for confounding factors had little effect on
the association between food group consumption and PCa risk, with the exception of
total meat, whose positive association with PCa risk became non-significant, and
vegetables and beer for which a non-significant inverse association with PCa risk
were now observed. Red meat remained significantly positively associated with PCa
risk (OR 3.73, 95%CI 1.70-8.15).
Within the older age group, again controlling for confounding factors had little effect
on the association between food group consumption and PCa risk, with the exception
of eggs and soy foods (whose associations with PCa risk became non-significant),
red meat (for which no association was observed) and vegetables which became
significantly inversely associated with PCa risk (OR 0.60, 95%CI 0.36-0.99).
Significant dose-response effects were observed for red meat (p = 0.007) within the
younger age group only, and for alcohol consumption (p = 0.048) and wine (p =
0.002) within the older age group only.
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Crude OR Adjusted OR a
Older
(> 65 vears)
Crude OR Adjusted OR a






1.24 (0.65-2.37) 0.81 (0.39-1.69)
0.65 (0.32-1.32) 1.02 (0.50-2.07)
1.82 (0.96-3.47) 1.32 (0.67-2.60)
Score test for linear trend: p = 0.21b, 0.611°
1.00 - 1.00
0.74 (0.47-1.16) 1.10 (0.68-1.80)
0.91 (0.58-1.43) 0.91 (0.56-1.49)
0.90 (0.57-1.42) 0.87 (0.52-1.45)
Score test for linear trend: p = 0.89b, 0.786°





0.60 (0.29-1.25) 1.12 (0.51-2.45)
0.90 (0.43-1.88) 0.86 (0.42-1.79)
1.31 (0.62-2.77) 1.55 (0.77-3.08)
Score test for linear trend: p = 0.12b, 0.372°
1.00 - 1.00
1.13 (0.69-1.83) 1.11 (0.67-1.84)
1.12 (0.68-1.86) 1.13 (0.69-1.85)
1.09 (0.63-1.88) 0.96 (0.58-1.59)






0.76 (0.39-1.45) 0.72 (0.36-1.46)
0.96 (0.50-1.83) 0.78 (0.38-1.60)
1.47 (0.78-2.77) 1.21 (0.60-2.45)
Score test for linear trend: p = 0.20b, 0.478°
1.00 - 1.00
1.23 (0.79-1.94) 1.31 (0.79-2.17)
0.76 (0.49-1.19) 0.86 (0.53-1.41)
1.08 (0.68-1.72) 0.78 (0.48-1.27)






0.93 (0.49-1.78) 1.17 (0.58-2.37)
1.02 (0.51-2.03) 1.15 (0.54-2.42)
1.57 (0.82-3.01) 1.40 (0.68-2.86)
Score test for linear trend: p = 0.15b, 0.839°
1.00 - 1.00
0.97 (0.62-1.51) 0.94 (0.57-1.53)
1.03 (0.65-1.64) 1.13 (0.70-1.83)
1.66 (1.01-2.73) 1.41 (0.84-2.36)






2.20 (1.07-4.50) 1.56 (0.74-3.26)
2.73 (1.32-5.63) 2.12 (1.03-4.34)
2.45 (1.22-4.90) 1.83 (0.89-3.77)
Score test for linear trend: p = 0.011b, 0.194°
1.00 - 1.00
1.09 (0.71-1.67) 1.03 (0.63-1.68)
1.57 (1.00-2.47) 1.24 (0.75-2.05)
1.37 (0.85-2.21) 1.30 (0.78-2.18)
Score test for linear trend: p = 0.07b, 0.677°





2.15 (1.06-4.38) 1.48 (0.73-3.00)
2.37 (1.20-4.76) 2.23 (1.08-4.61)
3.04 (1.56-5.90) 3.73 (1.70-8.15)
Score test for linear trend: p = 0.001b, 0.007°
1.00 - 1.00
1.28 (0.81-2.02) 1.06 (0.64-1.74)
1.13 (0.73-1.74) 0.79 (0.48-1.31)
1.55 (0.97-2.48) 1.13 (0.68-1.88)
Score test for linear trend: p = 0.12b, 0.520°
Cont.
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Crude OR Adjusted OR a
OR (95% CI) OR (95% CI)
Older
(> 65 vears)
Crude OR Adjusted ORa
OR (95% CI) OR (95% CI)






1.27 (0.63-2.53) 1.20 (0.57-2.50)
1.76 (0.91-3.42) 1.23 (0.59-2.53)
1.22 (0.66-2.26) 1.00 (0.49-2.05)
Score test for linear trend: p = 0.41b, 0.906c
1.00 - 1.00
0.94 (0.60-1.46) 1.26 (0.78-2.05)
1.46 (0.95-2.25) 1.37 (0.84-2.23)
1.45 (0.91-2.32) 1.65 (0.99-2.75)






0.68 (0.35-1.31) 1.10 (0.52-2.32)
1.17 (0.61-2.24) 1.14 (0.56-2.29)
0.99 (0.50-1.94) 0.91 (0.44-1.89)
Score test for linear trend: p = 0.58b, 0.930c
1.00 - 1.00
1.14 (0.73-1.78) 0.96 (0.59-1.56)
1.35 (0.89-2.09) 1.26 (0.76-2.07)
1.02 (0.63-1.63) 0.78 (0.48-1.27)







0.59 (0.30-1.16) 0.81 (0.40-1.65)
1.34 (0.68-2.61) 1.50 (0.75-3.03)
0.92 (0.50-1.72) 0.73 (0.34-1.56)
Score test for linear trend: p = 0.64b, 0.197°
1.00 - 1.00
0.86 (0.54-1.37) 0.61 (0.37-0.99)
0.85 (0.55-1.30) 0.84 (0.51-1.38)
0.94 (0.60-1.47) 0.60 (0.36-0.99)







0.65 (0.34-1.23) 0.79 (0.40-1.56)
0.59 (0.31-1.12) 0.59 (0.27-1.30)
0.74 (0.40-1.40) 0.73 (0.34-1.53)
Score test for linear trend: p = 0.28b, 0.624°
1.00 - 1.00
0.73 (0.46-1.17) 0.98 (0.59-1.62)
1.18 (0.75-1.84) 1.28 (0.78-2.12)
1.03 (0.66-1.62) 1.21 (0.73-2.02)




0.79 (0.34-1.82) 0.92 (0.43-1.95)
Score test for linear trend: p = 0.57b, 0.823°
1.00 - 1.00
0.50 (0.25-0.98) 0.71 (0.41-1.21)






1.35 (0.74-2.46) 1.24 (0.65-2.38)
1.90 (0.87-4.12) 1.54 (0.65-3.68)
1.19 (0.35-4.02) 1.22 (0.31-4.79)
Score test for linear trend: p = 0.22b, 0.668°
1.00 - 1.00
1.08 (0.73-1.60) 1.14 (0.75-1.75)
1.17 (0.69-2.00) 1.22 (0.68-2.21)
1.11 (0.42-2.91) 1.32 (0.46-3.74)
Score test for linear trend: p = 0.59b, 0.953°
Cont.
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Table 5.28, cont.: Crude and adjusted odds ratios by age group
Age Group
Food group type




Crude OR Adjusted OR' Crude OR Adjusted OR a
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Grilled Meat score 0 1.00 - 1.00 - 1.00 - 1.00 -
1 2.14 (0.61-7.59) 1.85 (0.46-7.41) 1.55 (0.67-3.55) 2.38 (0.90-6.28)
2 1.17 (0.59-2.34) 1.08 (0.51-2.27) 1.13 (0.72-1.78) 1.14 (0.70-1.86)
3 1.44 (0.74-2.82) 1.38 (0.67-2.86) 0.97 (0.62-1.51) 1.00 (0.61-1.63)
4+ 1.74 (0.83-3.66) 1.40 (0.61-3.22) 1.20 (0.72-2.03) 1.37 (0.76-2.44)












Score test for linear trend: p = 0.27b, 0.150° Score test for linear trend: p = 0.10b, 0.048°
Beer No alcohol
consumption
1.00 - 1.00 - 1.00 - 1.00 -
Alcohol consumption
other than beer 0.41 (0.17-1.00) 0.32 (0.12-0.85) 0.81 (0.51-1.29) 0.76 (0.46-1.26)
1-2 0.82 (0.35-1.93) 0.55 (0.21-1.43) 0.74 (0.43-1.29) 0.64 (0.35-1.18)
3-9 0.58 (0.26-1.33) 0.38 (0.15-0.95) 0.65 (0.40-1.06) 0.57 (0.33-0.98)
10+ 0.98 (0.43-2.23) 0.73 (0.29-1.83) 0.59 (0.33-1.05) 0.55 (0.29-1.04)
Score test for linear trend: p = 0.37b, 0.075° Score test for linear trend: p = 0.036b, 0.184°
Wine No alcohol
consumption
1.00 - 1.00 - 1.00 - 1.00 -
Alcohol consumption
other than wine
0.63 (0.29-1.37) 0.41 (0.17-0.99) 0.64 (0.40-1.01) 0.59 (0.36-0.98)
1-2 0.42 (0.17-1.06) 0.31 (0.11-0.86) 0.82 (0.51-1.34) 0.72 (0.42-1.22)
3-9 0.92 (0.40-2.10) 0.68 (0.27-1.73) 0.97 (0.57-1.64) 0.96 (0.54-1.73)
10+ 0.88 (0.31-2.52) 0.64 (0.20-2.05) 0.26 (0.11-0.61) 0.21 (0.08-0.52)
Score test for linear trend: p = 0.64b, 0.105° Score test for linear trend: p = 0.17b, 0.002°
Spirits No alcohol
consumption
1.00 - 1.00 - 1.00 - 1.00 -
Alcohol consumption
other than spirits
0.71 (0.32-1.58) 0.55 (0.22-1.35) 0.63 (0.38-1.03) 0.57 (0.33-0.97)
1-2 0.58 (0.24-1.41) 0.39 (0.15-1.07) 0.95 (0.57-1.60) 0.86 (0.49-1.50)
3-9 0.69 (0.30-1.59) 0.51 (0.20-1.27) 0.75 (0.46-1.21) 0.69 (0.41-1.17)
10+ 0.68 (0.29-1.58) 0.41 (0.15-1.07) 0.53 (0.30-0.94) 0.49 (0.26-0.91)
Score test for linear trend: p = 0.51b, 0.577° Score test for linear trend: p = O ro tr Ob CO
N.B.
a
= ORs adjusted for: Age, total energy, family history of PCa & BrCa, deprivation index, smoking, EI/BMR ratio.
b
= crude ORs,0 = adjusted ORs,
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5.5 Logistic Regression Analysis - the final model
In order to investigate the overall effect of important dietary factors observed to be
significantly associated with PCa risk, the variables for these dietary factors were









• Family history ofPCa and BRCa
• Carstairs Deprivation Index
• Smoking
• EI:BMR ratio
Of the six important dietary factors observed to significantly effect PCa risk, only
alcohol and red meat consumption continued to have significant inverse (OR 0.63,
95%CI 0.41-0.96) and positive (OR 1.66, 95%CI 1.03-2.70) associations with PCa
risk, respectively, see Table 5.29. It should also be noted that the ORs for these
dietary factors remained at the same magnitude as when adjusted for confounding
variables only. Selenium also continued to have an inverse association with PCa risk,
however this association was only shown to be significant for the second highest
category. Whereas, the positive association between cholesterol intake and PCa risk,
with a magnitude similar to that when only confounding factors were adjusted for,
was observed to be non-significant, as was the inverse association observed with
vegetable consumption.
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Table 5.29: Adjusted ORs for important dietary factors ■ Full model
Adjusted OR a
OR (95%CI)




















































usted for age, El (residual method), family history of PCa and BrCa, Carstairs Deprivation Index, Smoking
:BMR ratio.
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5.6 Adjusted ORs, using the multivariate analysis model
Given the strong intercorrelation between EI and most nutrients and food groups, in
particular fats and high fat food groups such as meat, it is possible that adjusting for
EI using the residual method may have caused the effect of nutrient intake to be over
controlled for. This possibility is discussed in further detail in section 6.2 of the
Discussion Chapter. Adjusted ORs were therefore recalculated using the multi¬
variate model method of adjusting for EI (i.e. putting EI into the final model along
with the other confounders). For nutrient intake, an increase in both magnitude and
significance was observed in ORs for total fat (OR 2.17, 95%CI 0.99-4.80), MUFA
(OR 2.38, 95%CI1.11-5.11), cholesterol (OR 2.19, 95%CI 1.27-3.78) and alcohol
(OR 0.62, 95%CI 0.41-0.94). See Table 5.30. Whereas for food groups, a slight
increase in both magnitude and significance was observed in ORs for red meat (OR
1,79, 95%CI 1.14-2.82) and soy foods (OR 0.52, 95%CI 0.30-0.91). See Table 5.31.
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Table 5.30: Adjusted ORs for nutrient intake, using the multiple regression model
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Table 5.30, Cont.: Adjusted ORs for nutrient intake, using the multiple regression model



























































































MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
El = Energy Intake
a
= Adjusted for Age, El (multiple regression model method), Family History of PCa and BrCa, Deprivation Index,
Smoking and EI/BMR Ratio.
Results: Food group analysis page 273
Prostate Cancer & Diet
Table 5.31: Adjusted ORs for food group intake, using the multiple regression model
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Table 5.31, Cont.: Adjusted ORs for food group intake, using the multiple regression








Fish 0-2.0 107 125 1.00 -
2.5-4.5 105 132 0.97 (0.65-1.44)
5.0-8.0 133 121 1.20 (0.80-1.79)











27.0-42.5 117 120 0.87 (0.58-1.30)
>42.5 107 120 0.71 (0.46-1.09)
Total Whole Fruit 0-7.5 120 121 1.00 -
8.0-13.5 88 125 0.60 (0.40-0.90)
14.0-21.5 113 118 0.91 (0.61-1.35)
>21.5 112 119 0.88 (0.58-1.35)
Soy Food 0 410 440 1.00 -
> 1 23 43 0.52 (0.30-0.91)
N.B.
Adjusted ORs for grilled meat, grilled meat score, alcohol consumption and wine / beer / spirit consumption were
omitted from the table as the original adjusted ORs were calculated using the multiple regression model method,
(due to the categorical nature of the data).
a
= ORs adjusted for: Age, total energy (using residual method), family history of PCa & BrCa, deprivation index,
smoking, EI/BMR ratio.
b
= crude ORs. c = adjusted ORs.
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6.1 Discussion of results
The findings of this study suggest that several nutrients and food groups may be
important factors associated with PCa risk. The findings for each individual a priori
nutrient and food group will be discussed in turn according to whether the
hypotheses were accepted or rejected, a summary of the hypotheses can be found in
the aims and objectives section of the Methodology Chapter. The discussion of these
findings in relation to previous studies are presented in Section 6.3.
6.1.1 Accepted Hypotheses
The hypotheses for the following a priori nutrients were accepted due to strong and
consistent significant associations with PCa risk being observed throughout the-
analysis, thereby inferring that these nutrients are important factors associated with
PCa risk.
Cholesterol
Out of all the components of fat, cholesterol was the only one in which a consistent
significant association was observed, thereby allowing for the hypothesis that high
cholesterol intake is associated with an increased risk of PCa to be accepted. Subjects
whose cholesterol intake was greater than 450mg/day were shown to be 50% more
likely to be diagnosed with PCa than those whose intake was less than 242mg/day.
Average cholesterol intake was 350mg/day, similar to that reported in Scottish men
age 16-64 yrs53.
A significant adjusted OR for the highest cholesterol intake category was observed,
adjusted OR 1.57 (95%CI 1.04-2.37), the omission of LERs had little effect on this
association. This significant positive association with PCa was confirmed by the log
likelihood ratio test showing cholesterol intake to have a significant effect on PCa
and also the observed significant positive dose-response effect. However, when other
important significant dietary factors were adjusted for, this association became
borderline non-significant. This could be explained by the presence of red meat
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consumption in the model, a dietary factor observed to be both strongly associated
with PCa risk and highly correlated with cholesterol, see next paragraph. Further
analysis stratifying by age group showed significant crude ORs continuing to be
observed in both age groups, ORs 2.01 (95%CI 1.05-3.82) and 1.99 (95%CI 1.22-
3.23) for younger and older age groups respectively. However, adjusting for
confounding factors caused these associations to become non-significant, even
though the magnitude of the association remained similar, especially in the younger
age group.
Close examination of the association between cholesterol and other dietary and
confounding factors showed that cholesterol intake was strongly positively correlated
with protein, retinol and meat products, the Carstairs deprivation index and smoking
status, in addition to energy intake, the EI / BMR ratio and total fat and its other
constituents. These associations were expected as meat products are an important
source of cholesterol, in addition to other fats, protein and retinol; hence the
association with these nutrients. The association with Carstairs deprivation index and
smoking status and cholesterol was also expected as high consumption ofmeat
products and fried foods are far more prevalent within lower social classes44, as is the
prevalence of smokers.
Red Meat
Out of all the meat food groups, red meat consumption was the only one in which a
consistent significant positive association with PCa risk was observed, thereby
allowing for the hypothesis that high red meat consumption is associated with an
increased risk of PCa to be accepted. Subjects whose red meat consumption was
greater than thirteen servings a week were shown to be over 60% more likely to be
diagnosed with PCa than those who consumed less than five and a half servings of
red meat per week. Furthermore, the risk was even greater in younger men where
younger subjects whose red meat consumption was in the highest category being
nearly four times as likely to be diagnosed with PCa. The average consumption of
red meat was nine servings a week.
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A significant adjusted OR for the highest red meat consumption category was
observed, adjusted OR 1.64 (95%CI 1.09-2.48). The omission of LERs had little
effect on this association, as did adjusting for other important significant dietary
factors. This positive association was confirmed by the log likelihood ratio test
showing red meat consumption to have a significant effect on PCa and also by the
observed significant positive dose-response effect. Further analysis stratifying by age
group showed the significant adjusted ORs to become stronger within the younger
age group, adjusted OR 3.73 (95%CI 1.70-8.15).
Close examination of the association between red meat and other dietary and
confounding factors showed that red meat intake was strongly positively correlated
with EI, fats and protein as well as other meat products. These associations were
expected, as red meat is an important source of these nutrients.
Protein
High protein intake was shown to have a significant positive association with PCa
risk for younger subjects, thereby allowing for the hypothesis that protein intake is
associated with an increased risk ofPCa to be accepted within the younger age
group. Younger subjects whose protein intake was greater than 112.7g/day were
shown to be over twice as likely to be diagnosed with PCa than those who intake was
less than 74.7g/day. The average intake of protein was 93.3g/day.
For all subjects, a significant crude OR for the highest protein intake category was
observed, OR 1.46 (95%CI 1.01-2.11), as was a significant positive dose-response
effect. However, adjusting for confounding variables made the OR for protein intake
non-significant, as did the omission of LERs. However, further analysis stratifying
by age group observed the association between protein intake and PCa risk to
become stronger within the younger age group, adjusted OR 2.34 (95%CI 1.13-4.87).
Close examination of the association between protein and other dietary and
confounding factors showed that protein intake was strongly positively correlated
with cholesterol, selenium and meat products, in addition to EI and the EI / BMR
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ratio. These associations were expected as meat products are important sources of
protein, in addition to cholesterol, hence the association with this nutrient.
Vegetables
High vegetable consumption was shown to have a significant inverse association
with PCa risk, thereby allowing for the hypothesis that vegetable consumption is
associated with a protective effect against PCa to be accepted. Subjects whose
vegetable consumption was greater than 42.5 portions per week were shown to be
40% less likely to be diagnosed with PCa than those who consumed less then 16.5
portions per week. The average consumption of vegetables was 27.5 portions a week.
A significant adjusted OR for the highest vegetable consumption category was
observed, adjusted OR 0.62 (95%CI 0.41-0.93), the omission of LERs had little
effect on this association. However, when other important significant dietary factors
were adjusted for, this association became non-significant. Further analysis
stratifying by age group showed significant adjusted ORs continuing to be observed
within the older age group, adjusted OR 0.60 (95%Cf 0.36-0.99).
Close examination of the association between vegetable consumption and other
dietary and confounding factors showed that vegetable consumption was strongly
positively correlated with fruit, fish, PUFA, selenium, carotene, vitamin E and
vitamin C, and negatively correlated with fats (with the exception ofPUFA) the
Carstairs deprivation index and smoking. Most of these associations were expected
as vegetables are an important source ofmany of these nutrients, hence the
association. Vegetable consumption is also associated with healthy eating habits
which include high intake of fish and unsaturated fats and which is more prevalent
within higher social classes and amongst non-smokers.
Selenium
High selenium intake was shown to have a significant inverse association with PCa
risk within older subjects, thereby allowing for the hypothesis that selenium intake is
associated with a protective effect against PCa to be accepted within the older age
group. Older subjects whose selenium intake was greater than 94 jug were shown to
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be nearly half less likely to be diagnosed with PCa than those whose selenium intake
was less than 56pg. The average intake of selenium was 74.5|ag per day.
For all subjects, the results suggested an inverse association between selenium intake
and PCa risk. As although the adjusted OR for the highest selenium intake category
was observed to be non-significant (OR 0.88, 95%CI 0.59-1.29), a significant
adjusted OR for the 2nd highest intake was observed (OR 0.67, 95%CI 0.45-0.99),
adjusting for other important significant dietary factors had little effect on this
association. However, further analysis stratifying by age group observed the
association between selenium intake and PCa risk to become both stronger and
significant within the older age group, adjusted OR 0.61 (95%CI 0.37-0.99). It
should also be noted that within the younger age group a significant positive crude
association was observed (OR 2.07, 95%CI 1.08-3.97), however this association
became non-significant when confounding factors were adjusted for.
Close examination of the association between selenium and other nutrients, food
groups and confounding factors showed that selenium intake was strongly positively
correlated with PUFA, protein, fish and vegetables, in addition to EI and the EI:
BMR ratio. These associations were expected, as meat products are an important
source of selenium, as are vegetables, hence the association with these nutrients and
food groups. The co-variation between selenium and protein and red meat could
explain why a positive association with PCa risk was observed within the younger
age group.
Alcohol
Alcohol consumption was consistently observed to be significantly inversely
associated with PCa risk, for both pure alcohol intake, consumption of alcohol versus
no consumption and by alcohol type, thereby causing the hypothesis that alcohol is
associated with an increase in PCa risk to be rejected. Subjects whose pure alcohol
intake was in the highest category (greater than 21,6g/day, the equivalent of 2.5
units) were shown to be at least 30% less likely to be diagnosed with PCa than those
in the lowest intake category (less than 3.4g/day). This reduction in PCa risk was
even stronger for wine and spirit consumption. The average intake of pure alcohol
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was 9.05g/day (just over one unit per day), with 82.9% of subjects reporting to
consume alcohol.
For pure alcohol intake, a significant adjusted OR for the highest alcohol intake
category was observed, adjusted OR 0.66 (95%CI, 0.44-0.99). However the omission
of LERs made this association non-significant, whereas adjusting for other important
significant dietary factors had little effect on this association. Similar associations
were also observed for alcohol consumption (versus non-consumption) (adjusted OR
0.62, 95%CI 0.42-0.90) and for wine and spirit consumption (adjusted ORs 0.38,
95%CI 0.19-0.74 and 0.48, 95%CI 0.29-0.79, respectively), the omission of LERs
had little effect. These inverse associations with PCa were also reinforced by the
presence of a significant dose-response effect for both wine and spirits. Further
analysis stratifying by age group showed significant adjusted ORs continuing to be
observed in the older age group, in particular for pure alcohol intake and wine
consumption whose inverse associations with PCa risk became even stronger
(adjusted ORs 0.54, 95%CI 0.32-0.89 and 0.21, 95%CI 0.08-0.52 respectively). The
association between spirits and PCa risk for the older age group remained similar
(adjusted OR 0.49, 95%CI 0.26-0.91). Within the younger age group, inverse
associations between alcohol and PCa were also observed, however these were found
to be non-significant.
Close examination of the association between alcohol consumption and dietary and
confounding factors showed that pure alcohol intake was weakly inversely correlated
with most nutrients, strong positive associations with alcohol type were also
observed as expected. Age was observed to be significantly inversely associated with
pure alcohol intake, though this association was not strong. No strong correlations
with other dietary and confounding factors were observed for alcohol types either,
with the exception of an inverse association between wine consumption and the
Carstairs Deprivation Index. The lack of strong associations between alcohol
consumption and other nutrients, food groups and confounding variables was
surprising, in particular the lack of association with energy intake. There was
however a general pattern towards 'healthy eating' habits and lower deprivation with
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increased wine consumption and 'unhealthy eating' habits including increased fat and
meat consumption, with increased beer consumption.
6.1.2 Rejected hypotheses
«
Both vitamin C and isoflavone intakes were observed to have no association with
PCa risk, with both crude and adjusted ORs for these nutrients being close to
equilibrium. Therefore, the hypotheses that intake for vitamin C and isoflavones are
associated with a protective effect against PCa were rejected.
Within the food groups, all dairy products (except eggs), fish and fruit were observed
to have no association with PCa risk with both crude and significant ORs for these
food groups being close to equilibrium. Therefore, the hypotheses that intake for
dairy products and fish, and fruit are associated with an increase and decrease in PCa
risk respectively were rejected.
For the remaining nutrients and food groups, although the hypotheses for these were
rejected due to the lack of consistent statistically significant associations with PCa
risk, the ORs observed for these dietary factors suggest that some association may
exist.
High intakes of total fat, saturated fat, MUFA and retinol were observed to have
positive associations with PCa. Significant crude ORs were observed for these
nutrients, as was a significant positive dose-response effect for each fat intake
variable. However, adjusting for confounding variables, in particular the use of the
energy-adjusted fat intakes, made these ORs non-significant.
Within the food groups, high consumption of eggs and total meat were observed to
have positive associations with PCa risk. Significant crude ORs were observed for
these food groups, as were significant positive dose-response effects. However,
adjusting for confounding variables, in particular the use of the energy-adjusted
intakes, made these ORs non-significant. Positive ORs were also observed for
processed meat and the grilled meat score, however these were found to be non¬
significant.
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High intakes ofPUFA, calcium, carotenes and vitamin E were suggested to have a
protective effect against PCa. As although crude ORs for these nutrients were either
observed to be positive, though non-significant, or showed no association, adjusting
for confounding factors revealed an inverse, though non-significant, association with
PCa risk.
Within the food groups, soy products and beer consumption were suggested to have a
protective effect against PCa. Significant crude ORs were observed for soy products,
however adjusting for confounding variables made the OR non-significant. For beer
consumption, inverse, though non-significant, associations were observed for both
crude and adjusted ORs within the highest consumption category. However, both
crude and adjusted ORs for the second highest consumption category observed a
significant inverse association (adjusted OR 0.54, 95%CI 0.35-0.85), suggesting that
moderate beer consumption (3-9 units per week) also had a protective effect against
PCa.
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6.2 Reasons behind the observed associations: Caveats and problems
In interpreting these findings, it is important to consider how much of the observed
association between these dietary factors and PCa risk may have been affected by
other factors before concluding that these associations are a true causal relationship.
These considerations include whether the observed associations were affected by
bias, confounding or could be due to chance.
The design of this study and the methods used in the selection and recruitment of
subjects and data collection allowed for potential bias and confounding to be limited.
The use of hospital records from all the major hospitals to ascertain all new cases of
PCa, and also the use ofhealth board and GP lists as a sampling frame to select
controls at random, ensured that not only were all newly diagnosed cases ofPCa
within the defined population identified, but also that the controls came from this
same population, thereby limiting selection bias. However, many subjects refused to
take part in the study or did not respond to the invitation, leading to an overall
response rate (proportion of subjects agreeing to participate within the total number
of eligible subjects contacted) of 67%, this is slightly lower than the response rate
considered acceptable by Bowling266 (75%). It is possible that bias may have been
introduced into the study as the response rate was shown to differ significantly across
status, with a higher number of cases agreeing to participate compared to controls.
Also, subjects from the Borders Health Board were far more likely to participate than
those from the Greater Glasgow Health Board, as were younger subjects and those
with lower levels of deprivation. It is therefore possible that controls who agreed to
participate were more likely to be a subset of potential controls interested in health
and therefore likely to consume "healthy" diets high in vegetables and low in fats.
This is supported by the lower response rates for controls within high deprivation
categories, where high fat and low vegetable consumption is more prevalent.
The non-participation ofGreater Glasgow controls was reduced as far as possible by
asking the appropriate GP to contact the potential control rather than using direct
contact which may have made the potential control less likely to respond than if it
had been sent by someone he knew and trusted. The contacting of Lothian GPs and
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controls via Lothian Health Board also helped to reduce non-participation for the
same reasons. The use of reminder letters also helped in keeping the non-response
rate low.
The use of a FFQ which was self-completed, in addition to the blinding of data
managers and technicians to the case / control status, allowed for observer bias to be
minimised. However recall bias, in which cases may have recalled their diet
differently to controls, may well have effected the observed associations. This is a
major caveat for all case-control studies in which information on exposure is
collected after the disease of interest has been diagnosed. Certain nutrients, including
(3-carotene, selenium and isoflavones were especially prone to this bias and this
maybe a reason for the lack of statistically significant inverse associations with PCa
for these nutrients. These nutrients have all recently been featured in the media as
being protective against PCa and its progression, thereby causing many older men
especially those diagnosed with PCa to increase their intake of foods such as
tomatoes and soy products which are high in these nutrients. This anecdotal evidence
was confirmed by the presence of notes written on the FFQs by cases advising of a
change in diet to include more of these foods, especially soy milk. To combat this,
the FFQ included a question regarding recent diet changes, which would have
hopefully picked up any post-diagnosis diet changes, however this question was
usually mistaken to be about weight reducing dietary changes rather than for specific
foods. Further potential for misclassification of nutrient intake was reduced by using
an FFQ and food tables that have been validated within the population under study.
The use of the new comprehensive and validated Isoflavone Database71 in particular,
allowed for accurate estimations of isoflavone intake. However, as discussed in
Chapter 2, no dietary assessment method is 100% accurate, although any potential
misclassification of dietary intake is likely to be non-differential, thus leading to a
bias towards an underestimation of risk.
Regarding potential confounding problems, the majority of confounding factors were
controlled for at the analysis stage. Age was also controlled for by age-frequency
matching population controls to cases, although the addition ofBPH controls which
were not age-frequency matched diluted this controlling effect. Age was therefore
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included as a confounding variable in addition to stratifying the analysis by older and
younger age groups. EI was adjusted for by using energy-adjusted dietary intakes,
therefore allowing for the study of the association for each dietary variable outwith
the effect ofEI. This is especially important as EI was observed to have a significant
positive association with PCa risk. However, it is possible that adjusting for EI using
the Residual Method may cause dietary factors to be over controlled for, particularly
for nutrients and food groups containing large amounts of energy such as fats. This
point is discussed in more detail in Section 6.3.1. Indeed, when the adjusted ORs
were recalculated using the multi-variate model method of adjusting for EI, the
association was observed to increase in both magnitude and significance for a
number of dietary factors including: total fat, MUFA, cholesterol, alcohol, red meat
and soy foods. However, as the residual method of adjusting for EI is considered the
'Gold Standard', emphasis is still given to the findings using the residual method of
EI adjustment.
Although this study examined and controlled for several potential confounding
factors, the residual confounding of unknown factors for which data was not
collected for must not be ruled out.
In order to protect against the subject misclassification, all cases were pathologically
confirmed as having PCa. In addition, the use ofBPH controls ensured that at least a
large proportion of controls were confirmed as not having asymptomatic PCa. The
use ofBPH controls could introduce selection bias ifBPH is associated with PCa
267
risk, however, to date no evidence for this association has been observed .
However, this study was limited in that information relating to the mode of detection
ofPCa, in particular PSA screening, was not available, nor was information
regarding the stage and grade of PCa. It is highly likely that a proportion of cases
were detected through PSA testing of asymptomatic men. This may lead to bias if
any associations between diet and PCa risk are related to the mode of detection, for
example, it could be assumed that men who have a PSA test are more likely to be
health conscious and consume a healthier diet high in vegetables and low in meat and
fat. The lack of PCa stage and grade information could also produce bias leading to
an underestimation of risk if the risk patterns of less aggressive and/or incidental PCa
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cases detected by PSA testing were more similar to those risk patterns of the
controls.
It is possible that several of the observed significant findings could be due to chance
as a result ofmultiple testing. The use of 20+ dietary factors increased the likelihood
of at least one spurious result to be observed as significant at the 0.05 level.
However, the use of only a priori dietary factors for which evidence of an association
with PCa had been reported in previous studies, and also that p-values far below the
0.05 level were observed for the majority of significant ORs (p-values not shown) in
addition to further analyses (such as the log likelihood ratio test) confirming the
significant association, meant that the presence of a spurious result was unlikely.
In conclusion, the combined strength of the design and methodologies as discussed
above produced a study that was robust enough to detect any true associations
between dietary factors and PCa risk. However, care must still be taken in the
interpretation of the results due to residual confounding, responder bias and potential
misclassification caused by the lack of information regarding PCa stage / grade and
detection method and also from the diet assessment method used.
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6.3 Discussion of dietary factors in relation to previous studies
In general, the findings of this study are similar to those of the studies reviewed in
Chapter 3. These findings, in their own right, also add to the overall evidence in the
field of nutritional cancer epidemiology by providing estimations ofPCa risk for
dietary factors using a robust methodology in a high risk population not studied
before. This next section will discuss those dietary factors reported to have a
significant association with PCa risk in further detail, including a comparison with
other studies.
6.3.1 Fat
The observed lack of significant associations between fat intake and PCa risk (with
the exception of cholesterol) when confounding factors, in particular EI, were
adjusted for, were similar to the findings of the majority ofprevious studies that have
examined this association such as Andersson et al131 whose large Swedish case-
control study reported no significant association between PCa risk and total fat,
saturated fat, MUFA and PUFA and Schuurman et al93 whose nested case-control
study (taken from a large cohort of 58,279 Dutch men) also reported no significant
association between PCa risk and fat and its components. By contrast, the observed
significant positive effect of cholesterol on PCa risk, has not been reported in any
previous studies investigating cholesterol. However, to date only two case-control
•131*135
studies have reported on the association between PCa and cholesterol intake ' .
It should also be noted that (as with other previous studies which reported crude
relative risks, such as Andersson et al131) total fat, saturated fat and MUFA were
shown to have a crude significant positive effect on PCa risk. These associations
continued to be statistically significant for total fat, MUFA and cholesterol, when EI
was adjusted for by including EI in the multivariate models rather than by using the
Residual Method. As fat intake was highly correlated with EI (rho = 0.92, p < 0.001),
due mainly to the high proportion ofEI coming from fat, it could be conceivable that
the use the Residual Method to calculate energy-adjusted intakes may cause fat
intake to be over controlled for. If this is indeed the case, the use of the Energy
Density Method or multivariate analysis to control for EI as a proxy for total food
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intake would be more appropriate. It could also be suggested that although fat and its
components (apart from cholesterol) has been shown not have a direct effect on PCa
risk, within the public health context high fat intake could still be considered as an
important risk factor. As the total gross effect of fat intake (including the associated
risk from EI) on PCa risk will lead a significant increased risk ofPCa in those men
consuming high amounts of fat.
It should also be noted that attributable risk estimates suggest that approximately 20-
25 % of PCa incidence among Caucasian-Americans and African-Americans, and 5-
1 o*268
10% among Asian-Americans maybe due to high levels of saturated fat intake ' .
6.3.2 Protein and red meat
The observed significant positive associations between protein and red meat
consumption and PCa risk when confounding factors were adjusted for are similar to
the findings of several ofprevious studies, such as Chan et al171 and Hayes et al128
whose large case-control studies reported significant positive associations with both
168total meat and red meat consumption, and also Le Marchand et al whose large
cohort study reported a significant positive association with beef consumption. Only
one case-control study examined the association ofmeat products stratifying for age
group161, however direct comparisons were difficult to make as the age cut-off used
was different (< 70 years) and red meat consumption was not reported.
The observed lack of association between PCa risk and retinol intake and meat
doneness, a proxy for heterocyclic amine and polycyclic aromatic hydrocarbon
intake, suggests that the fat component ofmeat (in particular cholesterol and possibly
saturated fat) is the underlying factor behind the association with meat consumption.
This is further emphasised by the attenuation of the association between cholesterol
consumption and PCa risk when red meat and protein consumpion, along with other
important dietary factors, were adjusted for.
6.3.3 Vegetables and associated nutrients
The observed significant inverse association between vegetable consumption and
PCa risk, in particular when confounding factors were adjusted for, are also similar
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to the findings from previous studies that have examined this relationship, such as
7H7 708
Cohen et al and Kolonel et al whose large case-control studies reported
significant inverse associations with vegetable intake, in particular cruciferous
vegetables and carrots. No previous studies have examined vegetable intake stratified
by age-group, making it impossible to compare the continuing significant inverse
association with vegetable consumption within the older age group.
The only plant-based nutrient to be significantly associated with PCa risk was
selenium, this association was only shown to be significant within the older age
group. The lack of previous studies investigating selenium intake makes comparisons
difficult, however findings of a significant inverse relationship from several studies
investigating serum and toenail concentrations of selenium in addition to the NTPC
1188trial are confirmed by this study.
Selenium and possibly carotenes (for which an inverse, though non-significant,
association was observed), maybe the underlying factors behind vegetable
consumption. However the protective effect of high vegetable consumption could
also just be a proxy for a general healthy diet and lifestyle.
The inverse association reported between soyfoods and PCa risk, although non¬
significant when adjusted for confounding factors, is an important finding and
suggests a protective effect against PCa that has been reported by several previous
studies such as Kolonel et al208, Lee et al214 and Jacobsen et al212 all ofwhich were
large studies conducted in populations known for their high consumption of soy
foods. The lack of a statistically significant association in this study may be due to
the low consumption of soy foods reported in the study population (only 7% of
subjects reported to consume soy foods). The association between soy food
consumption and PCa risk may also have been underestimated due to responder bias
caused by cases changing their post diagnosis diet to include phyto-oestrogen rich
soy foods.
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6.3.4 Alcohol consumption
The observed significant inverse association between alcohol consumption and PCa
risk, is not supported by the majority of previous studies examining alcohol intake,
thereby adding to the inconclusive evidence of the effect of alcohol consumption on
PCa. This is not surprising given the considerable variation in study design, study
population and methodologies as discussed in Chapter 3. For example this study used
non-drinkers of any alcohol as the reference category for alcohol type consumption,
unlike most previous studies that used non-drinkers of the relevant alcohol type. This
reference category was used due to the observed significant association with overall
alcohol consumption and also the observation that non-drinkers of one alcohol type
were likely to be drinkers of another, thereby making the non-drinkers of the relevant
alcohol type as the reference category ineffective. The cut-points for consumption
categories also differed from those in previous studies. It would be very interesting to
conduct a meta-analysis using the original data from these previous studies in order
to regulate reference categories and other methodological variations.
The reported consistent inverse associations, even when LERs were omitted (thereby
controlling for any misclassification bias from controls underestimating alcohol
consumption) and confounding factors were adjusted for, suggest that alcohol
consumption has a true protective effect against prostate cancer. The large variation
in alcohol consumption within Scottish men caused by the high daily consumption of
alcohol, as discussed in Chapter 2, allowed for the association between PCa and
alcohol consumption to be examined accurately, unlike for many of the previous
studies which were undertaken in populations, such as the US and the Netherlands,
where alcohol consumption is lower. However, the scarcity of data for high alcohol
consumption meant that the highest consumption categories for alcohol type had to
be combined, therefore making it difficult to examine the effect of high consumption
of individual alcohol types on PCa risk.
This reported protective effect is supported by the presence of a potential
biomechanism in which alcohol consumption effects androgen serum levels, which
in turn are linked to prostate growth and development and most possibly PCa
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genesis. Nevertheless it is still possible that the reported findings may have been
affected by other methodological factors, in particular recall bias caused by cases
recalling their alcohol consumption differently to controls.
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6.4 The Public Health con text
The evidence from this study suggests that in order to reduce risk of PCa, and
thereby reducing incidence ofPCa, consumption of red meat and fat should be
reduced and the consumption of vegetables should be increased to at least six
portions per day. If the findings of this study regarding the association between
alcohol consumption and PCa risk are indeed true, the consumption of at least two
and a half units of alcohol per day may also reduce PCa risk. Although the findings
suggest that alcohol consumption both at and above this level is protective against
PCa, it is probably more appropriate to keep to the suggested consumption at the
lower range. This is a moderate level of consumption and is below the recommended
maximum daily amount of three to four units for men. However, the public health
implications of the protective effect of alcohol consumption against PCa risk are
complex. Increased alcohol consumption is associated with an increased risk of
several diseases such as liver disease, stroke and some cancers, thus any
recommendation regarding alcohol consumption will need to be carefully examined
regarding both the potential benefits and risks of increased alcohol consumption.
This has been done successfully with the recommendations for red wine consumption
to protect against heart disease.
These suggestions for reducing PCa risk, with exception of alcohol, are similar to
those of the Eating for Health: A Diet Action Plan for Scotland269, published by the
Scottish Office in 1996, which recognized the detrimental effect on health a poor and
unhealthy diet can have and suggested several recommendations on improving the
Scottish diet. These included:
• The average intake of fruit and vegetables to double to more than 400 grams
a day by 2005.
• The average intake of total fat to reduce from 40.7% to no more then 35% of
food energy by 2005.
• The average intake of saturated fats to reduce from 16.6% to no more than
11% of food energy by 2005.
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These are targets are very challenging, especially given the Scottish population's
270affection for high fat / high meat consumption and their dislike for healthy food . It
is very unlikely that they will be met solely by providing dietary education and
advice or from the increased intake of dietary supplements. The Diet Action Plan for
96Q
Scotland has therefore recommended further key steps to tackle this, such as
shaping consumer tastes to make healthier choices and to improve access to healthy
food in particular in low income areas; ensuring that food producers, manufacturers
and retailers supply, develop and market healthier products and by collaborating with
health services and local authorities on health promotion and education, such as the
'5-a-Day' campaign to increase fruit and vegetable consumption and the new
'Choose Life, Choose Healthy Living' advice line and web-site set up by HEBS. It
also recognizes that dietary improvement is not achievable without tackling poverty
and deprivation that underlines so much of Scotland's poor dietary and nutritional
status.
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6.5 Further study
The findings of this study are of great interest, however each of the dietary factors
observed to be associated with PCa risk, in particular alcohol consumption and
cholesterol, as well as the effect that they may have on advanced PCa and the
interaction with age, require further study. These investigations should not only be in
the form of epidemiological and intervention studies but also in experimental and
animal model studies that will allow us greater understanding of the biological
mechanisms involved. Several biological and methodological issues are discussed in
this thesis and should be considered carefully when undertaking these future
investigations, including the complex nature of diet, study design and diet assessment
methodologies.
A new field of investigation, combining the fields of nutritional and genetic
epidemiology, is that of the interaction between diet and genetics. Diet-gene
interactions are of particular importance as they may explain the inconsistencies
within the findings for dietary factors that cannot be explained by differences
methods alone. It is possible that genetic factors relevant to the metabolism and
function of nutrients and hormones (e.g. the Vitamin D Receptor gene and Androgen
Receptor gene) and to carcinogen activation /elimination (e.g. Glutathione-S-
transferases genes), may influence susceptibility to the effect of dietary factors on
PCa.
Another important area of nutritional epidemiology is the study of effect of diet in
early life. As PCa is a slowly progressing disease, which probably begins decades
prior to diagnosis and may possibly be influenced by exposures during puberty and
adolescence3, the study ofpre-adult diet and its effect on PCa risk is also an
important line of future investigation.
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6.6 Conclusion
The findings of this thesis add to the overall evidence of an association between PCa
risk and diet. These findings are especially important, given that the study was
conducted in a high PCa risk population never studied before and used a robust
methodology that included a validated diet assessment method.
In summary, this thesis supports the hypotheses that high vegetable consumption and
selenium intake (in older men only) are protective against PCa, and that high red
meat consumption, in particular for men aged 50 -65 years, is associated with an
increased risk of PCa. In addition, the findings that high cholesterol intake and
increased alcohol consumption are associated with an increased and reduced risk of
PCa respectively, are relatively novel compared to previous studies and therefore
should be investigated further.
These findings are of particular interest with regards to health promotion amongst
Scottish men. If healthy eating targets (such as the increase of fruit and vegetable
consumption and the reduction in meat and fat consumption) are made, it could lead
to a considerable reduction in PCa incidence and mortality in addition to other
diseases such a heart disease at which these targets are aimed.
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8 . Appendices
8.1 Protocol for selection of controls from Glasgow GP Practice List
The essential principle was that a sampling frame was established in which a pool of
at least ten potential controls was used as a source for random sampling of five
(primary control plus four replacements) potential controls. This pool was a list of all
male patients whose dates of birth fall within the birth month/year of the required
control. The procedure for randomly selecting potential controls from this pool was
as follows:
1. Male patients whose date ofbirth was within the required birth month / year were
selected to the pool of potential controls. Checks were made that there were at
least ten patients for each required primary control. If this requirement was not
met, patients whose date ofbirth was within the birth month/years either side of
the original birth month/year were included in the pool ofpotential controls, until
the requirement was achieved. The number of potential controls within the pool
was counted (N).
2. With the use of a set of random numbers between 0 and 1 (r), the number of
potential controls (N) was multiplied by the next random number on the list
(N x r), the resulting number was rounded up to the nearest integer number (M),
this was then used to select the Mth patient on the list as the primary control. If
this number = 0, the calculation was repeated using the next random number. The
name, address and date of birth of the selected potential control was noted on the
selected controls form and the selected control was removed from the list. This
step was repeated five times in order to select the five potential controls (primary
control plus four replacements) required.
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Appendix p.319
Aberdeen Food Frequency Questionnaire (version 6.3)
Examples of food measures
The photograph shows the measures of amounts of food which are used
in the questionnaire. Clockwise from the top right of the picture, these are:
Orange juice (in glass)
Blackcurrant drink (in glass)
Peas (in spoon)
Peas (on dinner plate)
Chips (on dinner plate)
Stewed beef (on dinner plate)
Pizza (on dinner plate)
Bread (on side plate)
Margarine (on bread)
Jam (on side plate)
Cheese (on side plate)











1 oz (25g) or a match-box sized piece.
1 small bowlful
To help you estimate the amounts of different foods, keep this photograph
beside you as you complete the questionnaire.
Please return the photograph with your completed questionnaire





© Aberdeen FFQ Group, 1999
This questionnaire consists of a list of 150 foods, divided into 20 food groups. We would like you
to describe how much of each food on the list you have eaten in the last 2-3 months.
If you didn't eat a food, or ate it less than once a month, please circle 'R' (rarely or never).
For foods you ate on average once a month or more often, we would like to know two things:
- the amount of the food you usually ate on a day you had the food
- the number of days in a week you usually ate the food
Please try to indicate foods you eat at home and foods you eat at work or in restaurants or cafes.
The amount of each food should be described in measures such as tablespoon, slice etc.
The measures are pictured on a colour photograph enclosed with this questionnaire.
Please use black or blue pen.
Example:
If in the last 2-3 months you ate 4 slices of bread most days, an apple most weekdays, half a plate of
chips once a week, 3 scoops of ice-cream once or twice a month, but never had carrots, you should circle
the measures and numbers of days a week like this:
Measure Measures per day Number of days per week
! Bread 1 slice 1 2 3 (4) 5+ R M 1 2 3 4 5 6©
Apple 1 medium fruit (02 3 4 5+ R M 1 2 3 CD©
Chips % plate 103 4 5+ R CM©5 3 4 5 6 7
Ice-cream 1 scoop 1 2 0)4 5+ R (M) 1 2 3 4 5 6 7
Carrots 1 tablespoon 1 2 3 4 5+ ® M 1 2 3 4 5 6 7
Please note:
- 5+ means five or more measures per day
- R means rarely or never. If you circle R you do not have to circle a number of measures a day
- M means you ate the food once or twice a month
Any foods which you usually eat which are not in the list can be added in section 20 at the end.
Please remember that we need you to give a response to every question on this form.




Which of the following kinds of bread do you usually eat? Please tick one or more types:
i) White ii) Brown Hi) Wholemeal
Measure Measures per day Number of days per week
a) Bread (including
toast & sandwiches)
1 medium slice 1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Bread roll 1 roll 1 2 3 4 5+ R M 1 2 3 4 5 6 7
1 c) Croissants, butteries 1 roll 1 2 3 4 5+ R M 1 2 3 4 5 6 7
i d) Other breads
(pitta, naan, etc.)
1 pitta or Vz naan 1 2 3 4 5+ R M 1 2 3 4 5 6 7
2. Breakfast Cereals
i Measure Measures per day Number of days per week
a) Cornflakes, Special K,
Rice Krispies etc.
Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Bran Flakes, Sultana
Bran, All Bran etc.
Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
C) Shredded Wheat,
Weetabix etc.
1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Coco Pops, Frosties,
Sugar Puffs, Crunchy
Cornflakes etc.
Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
e) Muesli (all types) Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
f) Porridge and Ready
Brek
Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
3. Milk (including milk on cereals and in drinks, but not milk in cooked foods)
Measure Measures per day Number of days per week
a) Full fat milk % pint 1 2 3 4 5+ RM1234567
b) Semi-skimmed milk % pint 1 2 3 4 5+ RM1234567
c) Skimmed milk 1/4 pint 1 2 3 4 5+ RM1234567
d) Dried milk or creamer 1 teaspoon 1 2 3 4 5+ RM1234567
Please check that you have circled a response on every line before going to the next page.
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4. Cream and Yogurt
a) Low fat yogurt
(plain or fruit)
b) Full fat yogurt
(e.g. Greek)






1 pot (5 fl oz)
1 pot (5 fl oz)
1 pot (5 fl oz)
1 pot (5 fl oz)
1 tablespoon
Measures per day
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+








a) Full fat hard cheese 1oz(25g)ora
(e.g. Cheddar, Gruyere, matchbox-sized
Wensleydale, Gouda) piece
b) Medium fat cheese 1oz(25g)ora
(e.g. Edam, Brie, Feta, matchbox-sized
Camembert, cheese piece
spreads)
c) Full fat cream cheese 1 tablespoon
(e.g. Philadelphia, or 1oz (25g)
Danish Blue, Boursin
Lymeswold)
d) Low fat cheese (e.g. 1 tablespoon
low fat cream cheese, or 1 oz (25g)
reduced fat hard cheese)
e) Cottage cheese 1 tablespoon
(all types)
Measures per day
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+

















1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+




Please check that you have circled a response on every line before going to the next page.
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7. Meats (excluding meat substitutes e.g. Quorn or soya)
Measure
a) Mince or meat 2 tablespoons
sauce e.g. bolognese
b) Sausages (beef, pork 1 sausage
and frankfurters)
c) Burgers (all types) 1 burger
d) Beef (roast, grilled,
casseroled or fried)
2 tablespoons, 2
slices or 1 steak
I e) Pork or lamb (roast, 2 tablespoons,
grilled, casseroled or 2 slices or 1 chop
fried)
f) Chicken or turkey
(roast, grilled,
casseroled or fried)
g) Bacon or gammon
h) Liver, liver sausage
or liver pate





i) Haggis, black pudding 2 tablespoons
j) Meat or chicken pies, 1 pie or 1 roll
pasties, sausage roll
k) Cold meats (e.g. ham, 1 slice
corned beef, chicken roll)
I) Salami or continental 1 slice
sausage
Measure per day
1 2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+













m) How many times a week do you have fried or grilled red meat (steaks, chops, bacon, sausages
or burgers)?
Zero 1-2 3-4 5+
n) Do you normally have these meats:





b) Fried white fish (e.g. Ismail fillet
haddock, cod or plaice)
c) Grilled, poached or Ismail fillet
baked white fish
Measures per day
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+




d) Smoked white fish Ismail fillet 1 2 3 4 5+ RM1234567
Please check that you have circled a response on every line before going to the next page.
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Measure Measures per day Number of days per week
e) Fried oily fish (e.g.
salmon, herrings, or
mackerel)
Ismail fillet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
f) Grilled, poached, baked
or pickled oily fish
Ismail fillet 1 2 3 4 5+ R M 1 2 3 4 5 6 7




1 2 3 4 5+ R M 1 2 3 4 5 6 7
h) Fish cakes, fish pie 1 cake or
2 tablespoons
1 2 3 4 5+ R M 1 2 3 4 5 6 7
i) Tinned sardines 2 sardines 1 2 3 4 5+ R M 1 2 3 4 5 6 7










1 2 3 4 5+ R M 1 2 3 4 5 6 7
9. Potatoes, Rice and Pasta
Measure Measures per day Number of days per week




1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Mashed potatoes 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) Oven chips 1/4 plate 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Home-cooked chips % plate 1 2 3 4 5+ R M 1 2 3 4 5 6 7
e) Chips from a chip
shop or restaurant
Vi plate 1 2 3 4 5+ R M 1 2 3 4 5 6 7
f) Roast or fried
potatoes
% plate 1 2 3 4 5+ R M 1 2 3 4 5 6 7
g) White rice 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
h) Brown rice 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
i) Pasta (all types) % plate 1 2 3 4 5+ R M 1 2 3 4 5 6 7
10. Savoury foods, Soups and Sauces
Measure Measures per day Number of days per week
a) Pizza 1/2 an 8 inch or
1 slice
1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Quiche or savoury flan 1 medium slice 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) Savoury pancakes 1 pancake 1 2 3 4 5+ R M 1 2 3 4 5 6 7
Please check that you have circled a response on every line before going to the next page.
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Measure Measures per day Number of days per week
id) Baked beans 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
e) Nut roast, nut burgers
or vegetable burgers
1 slice or 1
1 burger
2 3 4 5+ R M 1 2 3 4 5 6 7
f) Quorn products
(all types)
1 tablespoon, 1 1
slice or 1 sausage
2 3 4 5+ R M 1 2 3 4 5 6 7
g) Soya beans, TVP, Tofu
or soya meat substitute
1 tablespoon
or 1 sausage
2 3 4 5+ R M 1 2 3 4 5 6 7
h) Other beans (kidney,
butter, chick peas)
1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
i) Lentils (excluding soup) 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
j) Soups (home-made) Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
k) Soups (tinned) Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
I) Soups (dried or
instant)
Ismail bowl or 1
mug
2 3 4 5+ R M 1 2 3 4 5 6 7
m) Gravy 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
n) Tomato-based sauces
(e.g for pasta)
1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
: o) Other savoury sauces
(white, cheese etc.)
1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
p) Bottled sauces (e.g.
ketchup)
1/4 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
q) Salad cream,
mayonnaise
1 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
r) Oil & vinegar dressing 1 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7




2 3 4 5+ R M 1 2 3 4 5 6 7
11. Vegetables (including fresh, frozen and tinned vegetables)
a) How many servings of vegetables (excluding potatoes) do you have each day? 0 1 2 3 4 5+
I b) Tinned vegetables
(all types)
c) Peas or green beans
d) Carrots







1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+





Please check that you have circled a response on every line before going to the next page.
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• Measure Measures per day Number of days per week
f) Brussels sprouts 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
g) Broccoli
I ay




1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
i) Leeks or courgettes 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
j) Cauliflower or swede
(neeps) or turnip
1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
k) Sweetcorn 1 tablespoon or
1 small piece





1 2 3 4 5+ R M 1 2 3 4 5 6 7
m) Tomatoes 1/4 medium or
2 cherry tomatoes
1 2 3 4 5+ R M 1 2 3 4 5 6 7
n) Sweet peppers % pepper 1 2 3 4 5+ R M 1 2 3 4 5 6 7




1 2 3 4 5+ R M 1 2 3 4 5 6 7
p) Potato salad 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
q) Coleslaw or other
veg. salads in dressing
1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
12. Fruit (including fresh, cooked, frozen and tinned fruits)
a) How many servings of fruit (excluding fruit juice) do you usually have each day? 0 1 2 3 4 5+
Measure Measures per day Number of days per week
b) Tinned fruit (all kinds) 1 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) Apples 1 medium apple 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Bananas Imedium banana 1 2 3 4 5+ R M 1 2 3 4 5 6 7




1 2 3 4 5+ R M 1 2 3 4 5 6 7
f) Pears Imedium pear 1 2 3 4 5+ R M 1 2 3 4 5 6 7
g) Peaches, nectarines Imedium fruit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
h) Kiwi fruit 1 fruit 1 2 3 4 5+ R M 1 2 3 4 5 6 7




1 2 3 4 5+ R M 1 2 3 4 5 6 7
j) All other fruit (grapes, 1 tablespoon or 1 2 3 4 5+ R M 1 2 3 4 5 6 7
strawberries, melon, 1 slice
plums etc.)
Please check that you have circled a response on every line before going to the next page.
■
13. Puddings
Measure Measures per day Number of days per week
a) Milk-based puddings Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
(e.g. rice, semolina)
b) Sponge puddings Ismail bowl 1 2 3 4 5+ R M 1 2 3 4 5 6 7
(steamed, syrup, jam etc)
c) Fruit-based puddings 1 pie, 1 slice or 1 2 3 4 5+ R M 1 2 3 4 5 6 7
(pies, tarts, crumbles) 2 tablespoons
j d) Mousse, blancmange, 2 tablespoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
trifle, meringue or 1 meringue
e) Custard or other 2 tablespoons 1 2 3 4 5+ R M 1 2 3 4 5 6 7
sweet sauces
I f) Ice cream (all kinds) 1 scoop 1 2 3 4 5+ R M 1 2 3 4 5 6 7
14. Chocolates, Sweets, Nuts and Crisps
Measure Measures per day Number of days per week
a) Chocolate bars (e.g. 1baror2oz (50g) 1 2 3 4 5+ R M 1 2 3 4 5 6 7
Mars, Dairy Milk)
b) Chocolate sweets, 1 sweet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
toffees or fudge
c) Boiled sweets, mints 1 sweet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Fruit gums, pastilles, 1 sweet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
jellies or chewy sweets
e) Salted nuts (peanuts, Ismail packet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
cashews etc.) or 1 oz(25g)
f) Unsalted nuts Ismail packet 1 2 3 4 5+ R M 1 2 3 4 5 6 7
or 1 oz (25g)
g) Crisps 1 small bag 1 2 3 4 5+ R M 1 2 3 4 5 6 7
h) Other savoury snacks 1 small bag 1 2 3 4 5+ R M 1 2 3 4 5 6 7
15. Biscuits
Measure Measures per day Number of days per week
a) Plain (e.g. Rich Tea, 1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
digesive)
b) Sweet (e.g. ginger, 1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
custard creams)
c) Shortbread 1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
Ms
19974
Please check that you have circled a response on every line before going to the next page.
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Measure Measures per day Number of days per week
d) Chocolate coated
biscuits
1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
e) Savoury biscuits
(crackers, crispbreads)
1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
f) Oatcakes 1 biscuit 1 2 3 4 5+ R M 1 2 3 4 5 6 7
g) Cereal bars, flapjacks 1 bar 1 2 3 4 5+ R M 1 2 3 4 5 6 7
16. Cakes
Measure Measures per day Number of days per week
a) Plain cakes (sponge
madeira, ginger etc.)
1 medium slice 1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Fruit cakes (all kinds) 1 medium slice 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) Rich cakes (e.g. cream,
chocolate, cheesecake)
1 medium slice 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Pastries or other
iced cakes
1 cake or 1 pastry 1 2 3 4 5+ R M 1 2 3 4 5 6 7
e) Pancakes or scones 1 pancake or
1 scone
1 2 3 4 5+ R M 1 2 3 4 5 6 7
17. Sugar and spreads
Measure Measures per day Number of days per week
a) Table sugar (in drinks &
on cereals or deserts)
1 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) Jam, honey,
marmalade etc.
1 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) Yeast or meat extract
(Marmite, Bovril etc.)
1/4 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) Peanut butter or 1 teaspoon 1 2 3 4 5+ R M 1 2 3 4 5 6 7
chocolate spread
e) What kind of butter or margarine do you usually spread on bread? Please give as much detail as you




f) How much do you normally spread on one slice of bread? (Please tick your answer)
1. none 2. a scrape 3. a thin layer 4. a thick layer
9) What type(s) of fat or oil do you usually use for home frying? Please give as much detail as you can,
including brand name(s) or shop name and variety if possible
Office Use -
I □□
Please check that you have circled a response on every line before going to the next page.
■ E3
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18. Beverages and Soft Drinks
vi) Decaffeinated coffee (instant or brewed)
a) How many cups or mugs of tea or coffee do you usually drink each day?
i) Regular tea (taken with milk)
ii) Regular tea (taken without milk)
iii) Herbal, fruit or deceffeninated tea
iv) Instant coffee (regular)


















f) Low calorie fizzy drinks 1 can
(Cola, lemonade etc.)
g) Regular fizzy drinks lean
Measures per day
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
2 3 4 5+
1 2 3 4 5+








a) Have you had any alcoholic drinks in the last 2-3 months?
If no, please go to section 20.
yes no
If yes, please circle the number of measures you have had in an average week. Please try to allow for
weeks in which you had very few alcoholic drinks and for weeks in which you had more than usual.
For example, if you had a pint of beer each day, you should circle 10-14 measures per week. If you
lad two glasses of wine each weekend you should circle 1-2 measures per week.




b) Low alcohol beer or
lager
| c) Beer (Export) or stout
(e.g. Guinness)
d) Lager or Pilsner-type
beer
e) Wine
f) Sherry, port etc.








h) Alcopops (Hooch etc.) 1 bottle
Number of measures per week
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
0 1-2 3-4 5-9 10-14 15-19 20-29 30-39 40+
() If you have wine, is it usually red or white? mainly red mainly white both red & white
20. Other Foods Data Entered? ^eS
Please use the space below to describe any foods which you have eaten regularly in the last 2-3 months
which you have not already included on the questionnaire.
Food Measure Measures per day Number of days per week
a) 1 2 3 4 5+ R M 1 2 3 4 5 6 7
b) 1 2 3 4 5+ R M 1 2 3 4 5 6 7
c) 1 2 3 4 5+ R M 1 2 3 4 5 6 7
d) 1 2 3 4 5+ R M 1 2 3 4 5 6 7
21. Vitamin, Mineral and Food Supplements
a) Have you taken any vitamin, mineral or food supplements (e.g. bran, iron tablets, fish oil capsules, or
multi-vitamin pills) in the last 2-3 months?
yes no If No, please go to section 22
b) If Yes, please give the type of supplement (e.g. multivitamins, cod liver oil), the amount you take per
week, and as much information as possible on e.g. brand name, strength and ingredients (as given on
the label or packet)
Type Amount per week Brand name, strength and ingredients




Have you excluded any of the following foods from your diet in the last 2-3 months?
a) Red Meat (beef, pork, lamb etc.)
b) Poultry (chicken, turkey etc.)
c) Fish
d) Eggs
e) Milk and milk products
(including cheese and yogurt)
f) Other Dietary Restrictions ?













g) For how long have you excluded these foods?
years months
23. Special Diets
a) Have you been on a weight reducing diet in the last 2-3 months? yes
b) Have you been on any other special diet in the last 2-3 months? yes





a) Your date of birth
b) Your age years
malec) Your sex
d) Your current weight
e) Your height
f) Are you currently a
g) Date of completing the questionnaire:
female
St lb or kg





Please check that you have circled a response on every line before going to the next page.
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h) How many brothers do you have?
i) How old are they (or were they when they died)?
| j) How many uncles (brothers of your mother or father) do you have?
I




| I) How old is your father (or was he when he died)?
| m) Have any of these male relatives had prostate problems
which were or may have been due to a cancer? yes no
If yes: 1) how many were definitely due to a cancer?
i
2) how many others may have been?
n) How many sisters do you have?
o) How old are they (or were they when they died)?
i L
!
| p) How many aunts (sisters of your mother or father) do you have?




r) How old is your mother (or was she when she died)?
s) Have any of these female relatives had breast problems
which were or may have been due to a cancer? yes no
If yes: 1) how many were definitely due to a cancer? *
2) how many others may have been?
Thank-you for your help In completing this questionnaire.
All information provided on this questionnaire will be treated in strictest confidence.
Prostate Cancer & Diet
8.3 Additional nutrient analysis results
Table 8.1: Distribution of all nutrient intakes by status
Nutrient Daily Cases Controls Test for difference
Intake (n=437) (Population and BPH controls) between Cases and
Variables (n=483) Controls
Mann-
Mean Median Mean Median T-test Whitney
(s.d.) (l-QR) (s.d.) (l-QR) (p-value) U Test
(p-value)
Total Energy 10584 10165 10127 9684 0.04 0.02
(kJ) (3344) (8369-12370) (3349) (7874-11757)
Protein (g) 100.69 96.10 96.34 92.10 0.05 0.03
(33.07) (78.15-118.85) (33.77) (74.70-112.70)
Carbohydrate 308.62 295.80 295.10 283.40 0.05 0.02
(g) (103.10) (239.65-368.35) (103.91) (224.20-344.40)
Total Fat (g) 95.95 91.30 90.51 84.90 0.02 0.007
(35.77) (72.75-116.30) (35.66) (65.30-109.60)
Saturated Fat 39.36 37.00 36.67 34.00 0.01 0.01
(g) (16.71) (27.55-48.15) (15.83) (25.30-46.30)
MUFA (g) 33.32 31.20 31.50 29.90 0.03 0.006
(12.34) (25.50-40.60) (12.71) (22.80-38.30)
PUFA (g) 14.83 13.90 14.39 13.30 0.30 0.14
(6.29) (10.50-17.90) (6.51) (9.70-17.80)
Cholesterol (mg) 401 368 362 326 0.002 <0.001
(194) (277-486) (173) (242-450)
Total Sugar (g) 141.96 132.40 131.90 121.70 0.01 0.005
(61.90) (100.35-171.20) (58.17) (92.70-157.50)
Starch (g) 169.68 162.90 165.38 157.10 0.27 0.19
(58.78) (129.55-203.10) (58.65) (123.40-202.70)
Fibre (g) 20.18 18.70 19.78 18.40 0.46 0.51
(8.45) (14.40-24.50) (7.98) (14.20-24.20)
Alcohol (g) 13.2 7.9 14.4 9.9 0.23 0.06
(15.1) (1.8-20.3) (14.6) (3.4-21.6)
Sodium (mg) 3509 3400 3366 3192 0.07 0.04
(1195) (2672-4199) (1174) (2579-3996)
Potassium (mg) 4230 3920 4085 3872 0.12 0.14
(1439) (3283-5055) (1401) (3162-4728)
Calcium (mg) 1143 1110 1101 1039 0.12 0.04
(400) (859-1373) (411) (812-1321)
Magnesium (mg) 386 359 375 361 0.15 0.25
(126) (298-457) (119) (288-441)
Phosphorous 1765 1703 1694 1640 0.05 0.02
(mg) (547) (1391-2061) (564) (1295-1958)
Iron (mg) 14.93 14.51 14.47 13.58 0.17 0.17
(5.17) (11.15-17.60) (4.93) (11.09-17.05)
Copper (mg) 1.58 1.47 1.53 1.43 0.22 0.27
(0.61) (1.17-1.83) (0.57) (1.14-1.78)
Zinc (mg) 12.53 12.09 12.00 11.49 0.06 0.04
(4.27) (9.58-14.82) (4.27) (8.99-14.19)
Chloride (mg) 5372 5218 5160 4862 0.07 0.05
(1811) (4135-6450) (1750) (3992-6052)
Manganese 4.63 4.45 4.57 4.34 0.63 0.46
(mg) (1.89) (3.47-5.47) (1.84) (3.47-5.46)
Selenium (pg) 83 75 78 73 0.06 0.25
(45) (58-98) (33) (56-94)
Cont.
Appendix p.320
Prostate Cancer & Diet
Table 8.1, cont.: Distribution of all nutrient intakes by status
Nutrient Daily Cases Controls Test for difference
Intake (n=437) (Population and BPH controls) between Cases and
Variables (n=483) Controls
Mann-
Mean Median Mean Median T-test Whitney
(s.d.) (l-QR) (s.d.) (l-QR) (p-value) U Test
(p-value)
Iodine (pg) 190 173 176 161 0.02 0.02
(92) (130-229) (80) (121-213)
Retinol (pig) 759 582 701 571 0.15 0.15
(647) (390-910) (568) (348-838)
Carotene (pg) 2690 2143 2742 2187 0.72 0.75
(2156) (1185-3614) (2224) (1308-3447)
Vitamin D (pg) 4.00 3.63 3.94 3.14 0.76 0.09
(2.33) (2.29-5.16) (3.01) (2.21-4.75)
Vitamin E (pg) 8.70 7.31 8.34 7.27 0.25 0.30
(4.86) (5.35-10.97) (4.63) (4.89-10.56)
Vitamin C (mg) 110.4 97.2 104.7 90.5 0.18 0.19
(67.1) (65.2-136.5) (61.2) (62.5-134.7)
Thiamine (mg) 2.19 2.08 2.14 2.00 0.32 0.16
(0.82) (1.63-2.56) (0.92) (1.58-2.48)
Riboflavin (mg) 2.26 2.19 2.15 2.07 0.05 0.02
(0.78) (1.69-2.73) (0.78) (1.62-2.52)
Niacin (mg) 23.67 22.44 23.17 21.99 0.37 0.52
(8.57) (17.47-28.16) (8.38) (17.22-27.65)
Potential Niacin 21.05 20.01 20.15 19.30 0.05 0.03
(mg). (6.89) (16.23-24.71) (6.94) (15.47-23.45)
Vitamin B6 (mg) 2.80 2.61 2.71 2.55 0.15 0.24
(1.03) (2.08-3.37) (0.98) (2.02-3.23)
Vitamin B12 (pg) 7.21 6.56 6.95 5.89 0.32 0.04
(3.62) (4.64-8.96) (4.24) (4.42-8.48)
Folic Acid (pg) 332 307 321 310 0.15 0.35
(118) (244-402) (111) (246-377)
Pantothenic Acid 10.13 7.21 9.97 7.05 0.78 0.31
(mg) (8.86) (5.60-10.45) (8.60) (5.47-10.79)
Biotin (ug) 53.09 51.70 51.61 49.00 0.23 0.05
(18.23) (41.50-60.80) (18.88) (39.30-59.20)
Isoflavone (pg) 1975.87 1143.20 1835.72 1050.90 0.42 0.10
(2455.09) (636.75-2444.50) (2828.21) (581.10-1982.80)
Isoflavone (with 2131.85 1143.20 1922.58 1050.90 0.37 0.11




s.d. = Standard Deviation
l-QR = Inter-Quartile Range
MUFA = Mono Unsaturated Fat
PUFA = Poly Unsaturated Fat
Carotene = Carotene Equivalent
Vitamin E = a-Tocopherol Equivalent
Potential Niacin = Niacin from Tryptophan
Isoflavone = Daidzein and Genistein
Appendix p.321
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Table 8.3: Crude and adjusted ORs for all nutrient intakes

















9684- 11757 106 121 1.22 (0.83-1.78)
>11757 135 120 1.56 (1.08-2.27)













92.1 - 112.7 104 118 1.16 (0.79-1.69) 0.91 (0.61-1.36)
> 112.7 133 120 1.46 (1.01-2.11) 1.00 (0.67-1.48)













283.4 - 344.4 85 121 1.04 (0.70-1.54) 1.35 (0.90-2.02)
> 344.4 139 120 1.71 (1.17-2.49) 1.05 (0.69-1.60)
Score test for linear trendb, p = 0.040










84.9- 109.6 112 121 1.53 (1.04-2.27) 1.11 (0.75-1.65)
> 109.6 135 120 1.86 (1.27-2.74) 1.10 (0.74-1.65)













34.0 - 46.3 127 121 1.56 (1.07-2.27) 1.03 (0.69-1.54)
> 46.3 126 120 1.56 (1.07-2.27) 1.15 (0.77-1.72)











29.9-38.3 110 119 1.53 (1.04-2.27) 1.21 (0.81-1.81)
>38.3 133 119 1.85 (1.26-2.73) 1.25 (0.83-1.87)











13.3-17.8 124 121 1.40 (0.97-2.03) 1.01 (0.69-1.49)
> 17.8 109 120 1.24 (0.85-1.81) 0.86 (0.57-1.28)
Score test for linear trendb, p = 0.221
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Table 8.3, cont.: Crude and adjusted ORs for all nutrient intakes



















326 - 450 129 120 1.83 (1.24-2.70) 1.26 (0.85-1.88)
>450 141 120 2.00 (1.36-2.95) 1.57 (1.04-2.37)













121.7-157.5 106 121 1.28 (0.87-1.87) 1.06 (0.69-1.61)
> 157.5 138 120 1.68 (1.15-2.44) 1.57 (1.05-2.34)











18.4-24.2 109 124 1.03 (0.71-1.49) 1.11 (0.75-1.65)
>24.2 115 117 1.15 (0.80-1.67) 0.78 (0.52-1.18)











9.9-21.6 102 122 0.79 (0.55-1.14) 0.72 (0.49-1.07)
>21.6 90 119 0.72 (0.49-1.04) 0.66 (0.44-0.99)
Score test for linear trendb, p = 0.060










3192 -3996 117 121 1.27 (0.88-1.85) 0.87 (0.59-1.30)
>3996 129 120 1.41 (0.98-2.05) 0.93 (0.63-1.38)











1039- 1321 118 121 1.40 (0.96-2.05) 1.33 (0.90-1.97)
> 1321 127 120 1.52 (1.05-2.22) 0.81 (0.54-1.23)













1640-1958 106 121 1.38 (0.93-2.03) 1.13 (0.76-1.69)
> 1958 135 120 1.77 (1.21-2.59) 1.03 (0.69-1.54)
Score test for linear trendb, p = 0.008
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Table 8.3, cont.: Crude and adjusted ORs for all nutrient intakes






OR (95% CI) OR (95% CI)










11.49-14.19 115 121 1.31 (0.90-1.90) 0.99 (0.67-1.46)
> 14.19 125 120 1.43 (0.99-2.08) 0.90 (0.60-1.32)













4862 - 6052 115 121 1.22 (0.84-1.77) 0.83 (0.55-1.24)
> 4862 132 120 1.42 (0.98-2.04) 0.97 (0.65-1.43)













73-94 105 122 1.02 (0.70-1.48) 0.67 (0.45-0.99)
> 94 123 118 1.24 (0.86-1.78) 0.88 (0.59-1.29)











161 -213 106 120 1.19 (0.81-1.73) 1.20 (0.79-1.81)
>213 134 120 1.50 (1.04-2.17) 1.29 (0.86-1.94)











571 - 838 98 121 1.14 (0.78-1.67) 0.94 (0.63-1.40)
> 838 125 120 1.47 (1.01-2.13) 1.21 (0.82-1.80)













2187-3447 95 121 0.81 (0.56-1.18) 0.77 (0.52-1.13)
> 3447 118 120 1.02 (0.71-1.46) 0.76 (0.51-1.14)













3.14-4.75 126 119 1.30 (0.90-1.87) 1.07 (0.72-1.58)
>4.75 127 120 1.29 (0.90-1.86) 1.02 (0.69-1.52)
Score test for linear trendb, p = 0.036
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Table 8.3, cont.: Crude and adjusted ORs for all nutrient intakes



















7.27-10.56 103 121 1.26 (0.85-1.85) 1.07 (0.72-1.57)
> 10.56 117 120 1.44 (0.98-2.11) 0.86 (0.57-1.28)













90.5- 134.7 126 121 1.22 (0.85-1.76) 1.12 (0.75-1.67)
> 134.7 112 120 1.10 (0.76-1.58) 1.18 (0.79-1.78)













2.07 - 2.52 104 123 1.11 (0.76-1.62) 1.20 (0.81-1.77)
>2.52 133 117 1.50 (1.03-2.16) 1.10 (0.74-1.64)













19.30-23.45 102 121 1.11 (0.76-1.62) 0.90 (0.61-1.34)
> 23.45 137 120 1.50 (1.04-2.17) 1.02 (0.69-1.52)













5.89 - 8.48 130 121 1.31 (0.91-1.89) 1.25 (0.85-1.84)
> 8.48 121 120 1.23 (0.85-1.78) 1.10 (0.74-1.63)
Score test for linear trendb, p = 0.072










49.0 - 59.2 118 122 1.35 (0.92-1.96) 1.12 (0.76-1.66)
>59.2 123 119 1.44 (0.99-2.09) 1.03 (0.69-1.53)
Score test for linear trend b, p = 0.048
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Table 8.3, cont.: Crude and adjusted ORs for all nutrient intakes



















1050.9- 1982.8 112 121 1.18 (0.81-1.71) 1.11 (0.75-1.65)
> 1982.8 126 120 1.34 (0.93-1.93) 1.18 (0.79-1.75)




















> 1982.8 126 121 1.33 (0.92-1.92) 1.18 (0.79-1.75)
Score test for linear trendb, p = 0.100
N.B.
MUFA = Mono unsaturated Fat
PUFA = Poly unsaturated Fat
El = Energy Intake
a
= Adjusted for El (residual method), Family History of PCa and BrCa, Deprivation Index, Smoking and EI/BMR
Ratio.
b
= Crude ORs only.
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Table 8.4: Crude ORs for confounding variables








50-62 88 120 1.00 .
63-66 99 121 1.12 (0.76-1.64)
67-69 73 122 0.82 (0.55-1.22)
70-74 173 120 1.97 (1.36-2.83)
Score test for linear trend, p < 0.001
Family history No family history of PCa or
BrCa







Family history of BrCa 58 48 1.56 (1.03-2.37)
Family history of PCa and
BrCa
17 10 2.21 (0.99-4.91)












3 97 103 0.90 (0.58-1.40)
4 75 93 0.77 (0.49-1.21)
5 54 69 0.75 (0.46-1.23)
6 31 33 0.90 (0.49-1.63)
7 37 35 1.01 (0.57-1.79)
Score test for linear trend, p = 0.724
Smoking Non Smoker 175 229 1.00 -
status
Ex Smoker 174 168 1.36 (1.01-1.81)
Smoker 76 79 1.26 (0.87-1.83)
Score test for linear trend, p = 0.10
El: BMR ratio < 1.17 79 116 1.0 -
1.17- 1.45 106 117 1.33 (0.90-1.96)
1.46-1.78 98 117 1.23 (0.83-1.82)
> 1.78 138 116 1.75 (1.19-2.56)
Score test for linear trend , p = 0.008
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8.4 Subject Corresponda rice
8.4.1 Study Summaries:
SS1: Study summary for health professionals
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
STUDY SUMMARY
AIM
To investigate associations between diet, inherited susceptibility and clinically important prostate cancer.
DESIGN AND HYPOTHESES
An epidemiological case-control study will compare (a) recent diet (b) diet during adolescence and (c)
polymorphic variants of the androgen receptor gene in cases of prostate cancer (stage > T2, Gleason score >4)
and controls. Particular attention will be focused on dietary fat and dietary phyto-estrogens.
SETTING
Greater Glasgow, Lothian and Borders Health Board regions.
SUBJECTS
Men with prostate cancer aged 50-74 years and resident in one of the study areas diagnosed (for the first time)
from 1/04/98 and controls of the same age (i) selected randomly from GP and/or Health Board lists, (ii) with
benign prostate hyperplasia, and (iii) with incidental prostate cancer diagnosed at least 5 years ago.
Men are ineligible ifmentally unable to complete a food frequency questionnaire and ineligible as controls (i), (ii)
if they have had a diagnosis of prostate cancer.
DATA AND PROCEDURES
Epidemiological data will be collected by self-completed food frequency questionnaires (FFQ) which have
previously been validated in Scotland. In addition, a 20ml venepuncture blood sample will be collected from
consenting subjects. Serum will be analysed to quantify phyto-estrogen content. 5-a-reductase activity will also
be measured in serum from controls to test for association with phyto-estrogen content. Polymorphic repeats
lengths of sequences CAG and GGC in the androgen receptor gene will be compared in cases of controls.
For further details, copies of the protocol or discussion, please contact Professor Freda Alexander, Dr Caroline
Bolton-Smith, Dr Fouad Habib or Dr Mike Morton at:
Professor Freda Alexander
Department of Public Health Sciences
University of Edinburgh
Medical School

















St Mellons, Cardiff CF3 OEF
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SS2: Study summary for subjects




The aim of this study is to investigate dietary factors which we believe may, in some instances, increase and in
others, decrease risk of prostate cancer occurring or progressing. In order to do this, we need information from
people with prostate cancer to compare with similar information from people without it.
WHAT DOES IT INVOLVE?
If you are willing to take part, it will involve you completing a simple questionnaire about your diet. This can be
completed at home and generally takes a little under an hour; it can be returned in a prepaid envelope. All
information will be treated confidentially and no individuals will be identified in published results.
WHY SHOULD I HELP?
Ifwe knew why people developed prostate cancer, then attempts could be made to prevent it. To do this, we need
information from people like yourselves.
WHO IS INCLUDED?
Up to 600 men with prostate cancer and the same number without the disease, resident mainly in the Lothians,
Greater Glasgow and the Borders, but including some from the rest of Scotland.
WILL THERE BE ANYTHING ELSE?
People who complete the questionnaire will be asked if they are willing to provide a small sample of blood which
will normally be collected at a routine hospital visit (those with prostate cancer) or at your GP practice. This will
be very useful to us but if you do not wish to do this, then you are under no obligation to do so. We should still
like you to complete the questionnaire.
The same people will be asked for their consent for us to check hospital notes (those with prostate cancer) and GP
notes (others - to check treatment for prostate disease).
WHAT IF I DO NOT WANT TO TAKE PART?
Just let us know and we will not bother you again. This will have no affect on your future health care.
IF I HAVE ANY QUESTIONS WHOM DO I ASK?
The Senior Scientists responsible for this study are:
Professor Freda Alexander Dr Caroline Bolton-Smith
Department of Public Health Sciences Cardiovascular Epidemiology Unit
University of Edinburgh University of Dundee
Medical School Ninewells Hospital & Medical School
Teviot Place Dundee DDI 9SY
Edinburgh EH8 9AG
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SS3: Study summary for cases: Analysis of blood samples
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Disease,
Inherited Susceptibility andDiet
We know little about the causes of prostate tumours but we do know that the disease is under
hormonal control and that risk is much less for men living in countries like China and Japan than
those in countries like Scotland. These two pieces of information suggest that:
Diet with high levels of substances similar to the female hormone estrogen may protect against
prostate tumours. Soy products contain large amounts of these 'phyto-estrogens'.
Inherited factors may influence risk.
Some genes occur naturally in alternative (healthy) forms with different frequencies for Western and
Oriental men. Scientists believe that one or more of these may be an inherited influence on risk of
prostate tumours.
The questionnaire will have asked about your consumption of substances containing phyto-estrogens
but we should like to check the results by measuring phyto-estrogens in your circulation. This is one
reason why a blood sample will assist our research.
The second reason is that we should like to compare the genes mentioned above in men with and
without prostate disease. To do this, genetic material (DNA) will, with your consent, be extracted
and examined for the genes it contains.
We therefore invite you to help us further in our research by donating a sample of blood. We are
collecting such samples from people who have had prostate tumours (like yourself) and from other
men of similar age who have not. If you agree, then a small amount (20ml, which is about 3
teaspoonsful) of blood will be collected from an arm vein. It can be collected when you are having
blood taken at the hospital for routine follow-up checks. It will be posted to Cardiff and the Western
General Hospital in Edinburgh for analysis in specialist laboratories. These laboratories will store the
samples securely and destroy them when the study is completed.
Genetic information from this study will not be made available either to subjects in the study or to any
third party.
When our results are published it will not be possible to identify any individual participant.
Dr Freda Alexander
Department of Public Health Sciences
University ofEdinburgh
Medical School












St Mellons, Cardiff CF3 OEF
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SS4: Study summary for controls: Analysis of blood samples
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
We know little about the causes of prostate cancer but we do know that the disease is under hormonal
control and that risk is much less for men living in countries like China and Japan than those in countries
like Scotland. These two pieces of information suggest that:
Diet with high levels of substances similar to the female hormone estrogen may protect against prostate
cancer. Soy products contain large amounts of these 'phyto-estrogens'.
Inherited factors may influence risk.
Some genes occur naturally in alternative (healthy) forms with different frequencies for Western and
Oriental men. Scientists believe that one or more of these may be an inherited influence or risk on prostate
cancer.
The questionnaire will have asked about your consumption of substances containing phyto-estrogens but
we should like to check the results by measuring phyto-estrogens in your circulation. This is one reason
why a blood sample will assist our research. We should also like to measure certain hormones believed to
influence prostate cancer to see whether their levels are changed by phyto-estrogens.
The second reason why a blood sample would assist us is that we should like to compare the genes
mentioned above in men with and without prostate disease. To do this, genetic material (DNA) will, with
your consent, be extracted and examined for the genes it contains.
We therefore invite you to help us further in our research by donating a sample of blood. We are collecting
such samples from people who have had prostate cancer and from other men of similar age who have not
(like yourself). If you agree, then a small amount (20ml, which is about 3 teaspoonsful) of blood will be
collected from an arm vein. It can be collected when you are having blood taken at the hospital for routine
follow-up checks. It will be posted to the Tenovus laboratory in Cardiff and the Western General Hospital
in Edinburgh for analysis in specialist laboratories. These laboratories will store the samples securely and
destroy them when the study is completed.
Genetic information from this study will not be made available either to subjects in the study or to any third
party.
When our results are published it will not be possible to identify any individual participant.
Professor Freda Alexander
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8.4.2 Case Correspondence








PCANDIET: A Medical Research (Epidemiological) Study ofProstate Cancer,
Inherited Susceptibility andDiet
Re: «FIRST_NAME» «LAST_NAME»: Date of birth: «DOB»: Unit No: «UNIT_NO»
PCANDIET is in a case control study of prostate cancer in adults in the south of Scotland
(see Study Summary). With your permission, we would like to approach the patient named
above. The study would involve the patient completing a food frequency questionnaire and,
with the patients' consent, a blood sample being drawn by my nurse or your phlebotomist.
I would be grateful if you would complete and return the enclosed form stating whether or
not you are willing for us to contact this patient.
This study has the approval of the relevant ethical committee(s).
If you have any other comments or wish to know more of this study, please contact me
personally at this address.
Thanking you for your assistance.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Enc. SSI, CA01R, SAE
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CA01R: Treating consultant reply / consent form
Study No:«STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate Cancer,
Inherited Susceptibility and Diet
Re: «FIRST_NAME» «LAST_NAME»: Date ofbirth: «DOB»
*1 give my permission for you to ask the above to participate in the named study and for you
to view the relevant hospital notes, subject to the consent of the patient.
*1 wish to make the approach to this patient myself.
This patient is ineligible (diagnosed earlier than 1/04/98 or mentally incapable of
completing the questionnaire).
*1 do not wish this patient to be approached (but he is eligible).
Signed Date
Patient's home address:
GP Name and address:
Any personal/family circumstances of relevance:
*Delete whichever is not applicable
Please return this form in the enclosed addressed, prepaid envelope.
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We are conducting a survey in your area to investigate possible causes of prostate cancer and
your Consultant, «TREATINGCONSULTANT», has given permission for us to invite you
to be included in our study.
If you will agree to help us in this research, it would involve you completing a diet
questionnaire which will take 2hour -12 hours. The information will be regarded as strictly
confidential and will be seen only by myself and other members of the research team. We
would also wish to review your confidential medical records at «TREATING_HOSP».
People who complete the food frequency questionnaires will also be asked if they are willing
to provide a blood sample. You are, of course, free to decline this part of the study.
Your decision to participate in this study or not to participate, will have no influence on your
treatment. If you do participate you are, of course, free to change your mind and withdraw at
any time.
This study has been approved by the following ethical committees:
Borders Health Board, Glasgow Royal Infirmary, Lothian Health Board, Stobhill NHS Trust,
Southern General, Glasgow and the West Glasgow Hospitals NHS Trust.
I enclose a form and self addressed, prepaid envelope and I would be very grateful if you
would complete and return this to me.




Encs: SS2, CA02R, SAE
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CA02R: Case reply / consent form
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
Mr «FIRST_NAME» «LAST_NAME»
*1 am willing to take part in the above study. Please send me a diet questionnaire.
*1 am willing*/not willing* for you to inform my GP that I am taking part in this
study (it is a normal courtesy for us to do this).
*1 am willing/not willing for you to check my medical records at «TREATING_HOSP»
*1 am not willing to take part in this study.
SIGNATURE: DATE:
Title: Mr Other
My telephone number is (Home)
My telephone number is (Work)
*Delete whichever is not applicable
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Thank you for agreeing to take part in our study.
I am enclosing a food questionnaire. If you have any difficulty in completing it, please
telephone my assistant, Morag Leitch (Freephone number 0800 783 5281).




Enc. Food frequency questionnaire, information sheet
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PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility andDiet
Re: Name: «FIRST NAME» «LAST NAME»: Date of birth: «DOB»
Your patient has been approached, with the consent of the treating consultant, and has agreed
to take part in this study.
He will be completing a food frequency questionnaire and will possibly be providing a small
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Thank you very much for sending me the completed dietary questionnaire. This will be very
helpful for our research.
As I indicated in the information sheet I sent you initially, we are asking everyone who, like
yourself, has completed the questionnaire if they will help us further by providing a small
blood sample. I am enclosing an information sheet. If you are willing to provide a sample
then it can be collected next time you go to the clinic for a check up.
Please return the form to me to indicate whether or not you wish to take part in this extra part
of the study.
Whatever, your choice, please accept my thanks for your help.
The study will continue for two years and we shall not have any results available until the





Encs. CA05R, SS3, SAE
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CA05R: Case reply / consent for blood sample
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Disease,
Inherited Susceptibility andDiet
Mr «FIRST NAME» «LAST NAME»
*1 am willing to provide a blood sample for research purposes. I have read the information
sheet (SS3). [In this case, we shall send you the necessary bottles].
*1 am not willing to provide a blood sample.
Signed: Date:
My next appointment is:
*Please delete whichever is not applicable.
Please return this form using the prepaid envelope.
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Thank you for returning the form we sent you. I am now writing to send you the bottles and
boxes for the collection of the blood sample.
Please take these to the clinic on your next visit. You will need to show them the copy of the
consent form you have signed.
Without your help and that of the other participants, this study would have not been possible.




Enc. Copy of consent form, blood boxes
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8.4.3 BPH Control Correspondence








PCANDIET: A Medical Research (Epidemiological) Study ofProstate Cancer,
Inherited Susceptibility andDiet
Re: «FIRST_NAME» «LAST_NAME»: Date of birth: «DOB»: Unit No: «UNIT_NO»
PCANDIET is in a case control study of prostate cancer in adults in the south of Scotland
(see Study Summary). With your permission, we would like to approach the patient named
above. The study would involve the patient completing a food frequency questionnaire and,
with the patients' consent, a blood sample being drawn by my nurse or at their GP surgery.
I would be grateful if you would complete and return the enclosed form stating whether or
not you are willing for us to contact this patient.
This study has the approval of the relevant ethical committee(s).
If you have any other comments or wish to know more of this study, please contact me
personally at this address.
Thanking you for your assistance.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Enc. SSI, BPH01R, SAE
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BPH01R: Treating consultant reply / consent form
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
m
Re: «FIRST_NAME» «LAST_NAME» Date of birth: «DOB»
*1 give my permission for you to ask the above to participate in the named study.
*1 wish to make the approach to this patient myself.
This patient is ineligible (diagnosed earlier than 1998 or mentally incapable of completing
the questionnaire).
*1 do not wish this patient to be approached (but he is eligible).
Signed Date
Patient's home address:
GP Name and address:
Any personal/family circumstances of relevance:
*Delete whichever is not applicable
Please return this form in the enclosed addressed, prepaid envelope.
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We are conducting a survey in your area to investigate possible causes of prostate cancer.
We shall compare men WITE1 and WITHOUT prostate cancer. You have recently been
treated for BENIGN prostate disease and we should like to include you in the comparison
group. Your consultant, «TREATING_CONSULTANT», has given me permission to
approach you to invite you to take part in this important study.
If you will agree to help us in this research, it would involve you completing a diet
questionnaire which will take 2hour -12 hours. The information will be regarded as strictly
confidential and will be seen only by myself and other members of the research team. Your
decision whether to participate will not affect your future health care in any way.
People who complete the diet questionnaire will also be asked if they are willing to provide a
blood sample. You are, of course, free to decline this part of the study.
This study has been approved by the following ethical committees:
Borders Health Board, Glasgow Royal Infirmary, Lothian Health Board, Stobhill NHS Trust,
Southern General, Glasgow and the West Glasgow Hospitals NHS Trust.
I enclose a form and self addressed, prepaid envelope and I would be very grateful if you
would complete and return this to me.
Thank you for your time.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Enc. SS2, Reply Form BPH02R, SAE.
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BPH02R: BPH control reply / consent form
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
Mr «FIRST_NAME» «LAST_NAME»
*1 am willing to take part in the above study. Please send me a diet questionnaire.
*1 am willing*/not willing* for you to inform my GP that I am taking part in this
study (it is a normal courtesy for us to do this).
*1 am not willing to take part in this study.
SIGNATURE: DATE:
Title: Mr Other
My telephone number is (Home)
My telephone number is (Work)
*Delete whichever is not applicable
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Thank you for agreeing to take part in our study.
I am enclosing a food questionnaire. If you have any difficulty in completing it, please
telephone my assistant, Morag Leitch (Freephone number 0800 783 5281).




Enc. Food frequency questionnaire, information sheet
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PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Cancer, Inherited Susceptibility andDiet
Re: Name: «FIRST NAME» «LAST NAME»: Date ofbirth: «DOB»
Your patient has been approached, with the consent of the treating consultant, and has agreed
to take part in this study.
He will be completing a food frequency questionnaire and will possibly be providing a small
venepuncture blood sample for Serum and DNA analysis, in which case this patient may ask
for you to collect a blood sample from him. We hope you will agree that your practice
collects the sample; our funding includes a payment of £10 for this.
If you are not willing for your practice to collect the blood sample please let me know by
returning the enclosed form.
Thanking you for your assistance.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Enc. SSI, BPH04R, SAE
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BPH04R: GP refusal form re: blood collection
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Cancer, Inherited Susceptibility andDiet
RE: «FIRST NAME» «LAST NAME» Date ofBirth: «DOB»
I regret that I am not able to have the blood sample from the above-mentioned patient
collected by my staff.
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Thank you very much for sending me the completed dietary questionnaire. This will be very
helpful for our research.
As I indicated in the information sheet I sent you initially, we are asking everyone who, like
yourself, has completed the questionnaire if they will help us further by providing a small
blood sample. I am enclosing an information sheet. If you are willing to provide a sample,
we hope your GP will be willing to have it collected at their practice. If not, it can be
collected by my research nurse who will contact you to arrange a visit in your home at a
mutually convenient time.
Please return the form to me to indicate whether or not you wish to take part in this extra part
of the study.
Whatever your choice, please accept my thanks for your help.
The study will continue for two years and we shall not have any results available until the




Professor of Cancer Epidemiology
Enc. BPH05R, SS4, SAE
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BPH05R: Consent for blood sample from BPH control
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Disease, Inherited Susceptibility andDiet
Mr «FIRST NAME» «LAST NAME»
*1 am willing to provide a blood sample for research purposes. I have read the information
sheet (SS4BPH). [In this case, we shall send you the necessary bottles].
*1 am not willing to provide a blood sample.
Signed Date.
*PIease delete whichever is not applicable.
Please return this form using the prepaid envelope.
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Thank you for returning the form we sent you. I am now writing to send you the necessary
bottle and box for the collection of the blood sample.
We hope that the sample can be collected at your GP practice. If your practice has a nurse
you should ask for an appointment with her. If not, then please ask your GP for an
appointment but make it clear that this is a 'non-urgent' appointment. When you go to the
surgery, you should take the bottle and box. You will need to show a copy of the consent
form you have signed. Please take this second copy of information sheet SS4 to your GP
practice.
If this is not convenient for your GP, then please telephone our FREEPHONE number: 0800-
783-5281 and my research nurse will contact you to arrange a time when she will collect the
sample.
Without your help and that of the other participants, this study would have not been possible.




Enc. Copy ofConsent form, SS4BPH, Box
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8.4.4 Population Control - Glasgow GP Correspondence:







PCANDIET: A Medical Research (Epidemiological) Study ofProstate Cancer, Inherited
Susceptibility andDiet
PCANDIET is a case control study of Prostate Cancer in men in the south of Scotland (see
Study Summary). With your permission, we would like to select from your patient list, or
that of one of your partners, «Total_requested_inc_spares» patient(s) (plus 4 potential
replacements for each selected patient) as CONTROLS. With your consent, we would
approach these patients (or, if you prefer, provide you with a letter of approach to send to
them yourself). The study would involve the patient completing a food frequency
questionnaire. Possibly also, with the patient's further consent, a venepuncture blood sample
would be drawn, either by my research nurse or your practice nurse. For this second part of
the study, our funding includes making a payment of £10 to practices.
I would be grateful if you would complete and return the enclosed form, stating whether or
not you are willing for us to use your patient list for the selection of controls.
If you agree to participate, we will contact you or the appropriate contact person, in order to
arrange a suitable time for a researcher to visit your practice to select the controls.
This study has the approval of the relevant ethical committees.
If you have any other comments or wish to know more of this study, please contact me
personally at this address.
Thanking you for your assistance.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
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Encs. SSI CT01G1R, SAE.
CT01G1R: GP consent form, re: use of practice list
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility andDiet
Dr «Gpinitials» «GPSurname» «PRACADDR1»
I give* / do not give* my permission to select patients from my patient list.
Please contact myself* / Practice Manager* / other contact person* to arrange a visit.
Name of contact person:
Telephone no. of contact person:
Signed Date
If permission given, I would*/would not* be prepared to have a blood sample collected by
my staff.
*Delete whichever is not applicable
Please return this form in the enclosed addressed, prepaid envelope.
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CT01G2: Confirmation of visit






PCANDIET: A Medical Research (Epidemiological) Study ofProstate Cancer, Inherited
Susceptibility andDiet
Following our telephone conversation this morning, I am enclosing a copy of our study
summary for your information.
A research nurse and myself will visit you on «VISIT_DT» at «VISIT_TIME» as arranged.
We plan to select from Dr «GPSurname»'s patient list: «Total_requested_inc_spares» male
patient(s), plus 4 potential replacements for each primary subject, between the ages of 50 to
74 years as CONTROLS for our case-control study.
We will be randomly selecting each control set from patients having a specific month/year of
birth. The simplest method for this would be if you could give us a printout for all males
aged 50 to 74 years on the patient list, with their name, address and date of birth. If
necessary, a manual selection can be arranged. Following selection, we will leave forms for
GP consent, to be returned to us prior to approaching the patient(s).
Dr «GPSurname» may prefer to contact the selected patient(s) theirself; if so, I would be
most grateful if we could have several sheets of your practice's headed paper, in order to
prepare these approach letters for Dr «GPSurname» to sign. I realise that this is a further
task for a busy practice, but we have found that some GPs prefer to avoid their patients
receiving letters from us before they have consented to participate. For your information I
attach a copy of the letter and reply form.
Thanking you for your assistance.
Yours Sincerely
Charlotte Heald
Epidemiologist for PCANDIET Study
cc Professor Freda Alexander
Encs. SSI, copy ofCT02G, copy ofCT02R
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PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer, Inherited
Susceptibility and Diet
Thank you for allowing my researcher to select the potential subjects listed below from your patient
list.
Now, as indicated previously, I am asking for your consent to approach the first patient from the list
as a CONTROL. In order to streamline things, and to prevent unnecessary correspondence, I would
also be grateful if you would give consent to approach appropriate replacement subjects as well.
Please note that these replacements will only be approached if the previous choice is: Ineligible, you






As mentioned before in our previous letter, the study will involve the patient completing a food
frequency and possibly also, with the patient's further consent, a venepuncture blood sample being
drawn.
I would be grateful if you would complete and return the enclosed forms stating whether or not you
are willing for us to contact these patients.
You may prefer to contact the selected patient(s) yourself; if so, I would be most grateful if we could
have several sheets of your practice's headed paper, in order to prepare these approach letters for you
to sign. I realise that this is a further task for a busy practice, but we have found that some GPs prefer
to avoid their patients receiving letters from us before they have consented to participate. For your
information I attach a copy of the letter and reply form.




Professor of Cancer Epidemiology
Enc. CT01G3R, copy of CT02G(a) & CT02R, SAE
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CT01G3R: GP Consent form, re: control approach
Practice No:
Study No:
PCANDIET: A Medical Research (Epidemiological) Study of Prostate Cancer,
Inherited Susceptibility and Diet
* Please delete whichever is not applicable:




This patient is eligible / ineligible* (because of
mental incapacity or previous diagnosis of
prostate cancer).
Tel. No
If ineligible, ignore next question.
I give / do not give* my permission for you to
ask this patient to participate in PCANDIET.




This patient is eligible / ineligible* (because of
mental incapacity or previous diagnosis of
prostate cancer).
Tel. No
If ineligible, ignore next question.
I give / do not give* my permission for you to
ask this patient to participate in PCANDIET.




This patient is eligible / ineligible* (because of
mental incapacity or previous diagnosis of
prostate cancer).
Tel. No
If ineligible, ignore next question.
I give / do not give* my permission for you to
ask this patient to participate in PCANDIET.
Please turn over.
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* Please delete whichever is not applicable:




This patient is eligible / ineligible* (because of
mental incapacity or previous diagnosis of
prostate cancer).
Tel. No
Ifineligible, ignore next question.
I give / do not give* my permission for you to
ask this patient to participate in PCANDIET.




This patient is eligible / ineligible* (because of
mental incapacity or previous diagnosis of
prostate cancer).
Tel. No
If ineligible, ignore next question.
I give / do not give* my permission for you to
ask this patient to participate in PCANDIET.
Please sign below andprint name:
Signed: Date:
Name:
Are any of these patients currently receiving therapy by finasteride or other drug for benign
prostatic hyperplasia. If so, please give number and drug name(s).
Any personal/family circumstances of relevance:
Please return this form in the enclosed addressed, prepaid envelope.
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PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Cancer, InheritedSusceptibility and Diet
Re: «FIRST_NAME» «LAST_NAME» Date of Birth: «DOB»
PCANDIET is a case control study of Prostate Cancer in adults in the South of Scotland (see
Study Summary). With your permission, we would like to approach the patient named
above as a CONTROL. His name has been randomly selected from your health board's
computerised lists. The study would involve the patient completing a food frequency
questionnaire and possibly, with the patient's further consent, a venepuncture blood sample
being drawn. For this second part of the study we hope that you will agree that your practice
collects the sample; our funding includes making a payment of £10 to you for this.
I would be grateful if you would complete and return the enclosed form stating whether or
not you are willing for us to contact this patient.
This study has the approval of the relevant ethical committee(s).
If you have any other comments or wish to know more about this study, please contact me
personally at this address.
Thanking you for your assistance.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Encs. SSI, CT01R, SAE
Appendix p.362
Prostate cancer & Diet
CT01R: GP reply / consent form
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Cancer, Inherited Susceptibility and Diet
Re: «FIRST_NAME» «LAST_NAME» Date of Birth: «DOB»
* I give my permission for you to ask the above to participate in the named study.
* I wish to make the approach to this patient myself [if so, PCANDIET will send you the
literature for the patient].
* This patient is ineligible (because of mental incapacity or previous diagnosis of prostate
cancer).
* I do not wish this patient to be approached (but I believe him to be eligible).
Signed Date
If the patient agrees to participate, then I would / would not* be prepared to have a blood
sample collected bymy staff.
Is this patient currently receiving therapy by finasteride or other drug for benign prostatic
hyperplasia. If so, please give drug names(s).
Any personal / family circumstances of relevance:
*DELETE WHICH EVER IS NOT APPLICABLE
Please return this form in the enclosed addressed prepaid envelope.
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We are conducting a survey in your area to investigate possible causes of prostate cancer.
You have been RANDOMLY selected from a list of men registered with GPs in your area.
We need information from people like yourselves to help us to interpret the data from
people with this disease. Your GP, «GP», has given me permission to approach you to invite
you to take part in this important study.
If you will agree to help us in this research, it would involve you completing a diet
questionnaire which will take '/S-hour - l'Yhours. The information will be regarded as strictly
confidential and will be seen only by myself and other members of the research team. Your
decision whether to participate will not affect your future health care in any way.
People who complete the food frequency questionnaires will also be asked if they are willing
to provide a blood sample. You are, of course, free to decline this part of the study.
This study has been approved by the following ethical committees:
Borders Health Board, Glasgow Royal Infirmary, Lothian Health Board, Stobhill NHS Trust,
Southern General, Glasgow and the West Glasgow Hospitals NHS Trust.
I enclose a form and self addressed, prepaid envelope and I would be very grateful if you
would complete and return this to me.
Thank you for your time.
Yours sincerely
Freda Alexander
Professor of Cancer Epidemiology
Enc. SS2, CT02R, SAE.
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CT02R: Control reply / consent form
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Cancer, InheritedSusceptibility and Diet
«FIRST_NAME» «LAST_NAME»
*1 am willing to take part in the above study. Please send me a diet questionnaire.
*1 am not willing to take part in this study.
*1 have never had prostate cancer diagnosed
SIGNATURE DATE
Title: Mr Other
My telephone number is (Home)
My telephone number is (Work)
*Delete whichever are not applicable
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Thank you for agreeing to take part in our study.
I am enclosing a food questionnaire. If you have any difficulty in completing it, please
telephone my assistant, Morag Leitch (Freephone number 0800 783 5281).




Enc. Food frequency questionnaire, information sheet
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Thank you very much for sending me the completed dietary questionnaire. This will be very
helpful for our research.
As I indicated in the information sheet I sent you initially, we are asking everyone who, like
yourself, has completed the questionnaire if they will help us further by providing a small
blood sample. I am enclosing an information sheet. If you are willing to provide a sample,
we hope your GP will be willing to have it collected at their practice. If not, it can be
collected by my research nurse who will contact you to arrange a visit in your home at a
mutually convenient time.
Please return the form to me to indicate whether or not you wish to take part in this extra part
of the study.
Whatever your choice, please accept my thanks for your help.
The study will continue for two years and we shall not have any results available until the





Enc. CT05R, SS4, SAE
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CT05R: consent for blood sample from control
Prostate cancer & Diet
Study No. «STUDY_NO»
PCANDIET: A Medical Research (Epidemiological) Study ofProstate
Disease, Inherited Susceptibility andDiet
Mr «FIRST NAME» «LAST NAME»
*1 am willing to provide a blood sample for research purposes. I have read the information
sheet (SS4). [In this case, we shall send you the necessary bottles].
*1 am not willing to provide a blood sample.
Signed Date
*Please delete whichever is not applicable.
Please return this form using the prepaid envelope.
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Thank you for returning the form we sent you. I am now writing to send you the necessary
bottles and boxes for the collection of the blood sample.
We hope that the samples can be collected at your GP practice. If your practice has a nurse
you should ask for an appointment with her. If not, then please ask your GP for an
appointment but make it clear that this is a 'non-urgent' appointment. When you go to the
surgery, you should take the bottles and boxes. You will need to show a copy of the consent
form you have signed. Please take this second copy of information sheet SS4 to your GP
practice.
If this is not convenient for your GP, then please telephone our FREEPHONE number: 0800-
783-5281 and my research nurse will contact you to arrange a time when she will collect the
sample.
Without your help and that of the other participants, this study would have not been possible.




Enc. Consent form, SS4, Boxes
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